17651117	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ JAM-C @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , CD42b , or junctional adhesion molecule C ( @GENETgt$ JAM-C @/GENETgt$ ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17 17 17 25 25 25 17 27 25|26 25 25|26 27 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T6	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ CD42b @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , @GENETgt$ CD42b @/GENETgt$ , or junctional adhesion molecule C ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17|18 17 17|18 17 17 26 26 26 17 28 26 28 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ junctional adhesion molecule C @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to CD62P , CD42b , or @GENETgt$ junctional adhesion molecule C @/GENETgt$ ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 15 17 17 17 17 17|21|22 17|21|22 17|21|22 17|21|22 17|22 17|21|22 28 22 28 34 26|34 26|34 34 26|34 15 10 38 38 35 10	None-BC7
17651117	CHEMICAL	GENE	T1	T5	True	0	What is [Drugprot] between @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ and @GENETgt$ CD62P @/GENETgt$ ? [SEP] Isolated neutrophils and platelets resuspended in heparin-anticoagulated plasma were recirculated with and without blocking antibodies to @GENETgt$ CD62P @/GENETgt$ , CD42b , or junctional adhesion molecule C ( JAM-C ) in @CHEMICALSrc$ polyvinyl chloride @/CHEMICALSrc$ tubing using a roller pump .	2 10 2 2 2 8 8 5 10 10 10 11 14 11 14 17 16|15 15 16|15 17 17 17 17 26 26 26 17 28 26 28 34 34|29 34|29 34 34|29 15 10 38 38 35 10	None-BC7
16324695	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	21 4 4 1 9 9 9 9 14 11 9 11 14 4|13|14 4|13|14 4|13|14 4|14 4|13|14 19 14 19 21 26 26 23 23 21 29 29 26 26 21 21 38 38 38 32|38 38 32|38 32 21	None-BC7
16324695	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	20 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16 18 20 25 25 22 22 20 29 26|29 29 26|29 25 25 20 20 38 32|38 38 32|38 38 38 32 20	None-BC7
16324695	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 7 7 7|6|15 7|6|15 7|6|15 7|15 7|6|15 12 7 12 15 11|4|15 11|4|15 11|4|15 4|15 11|4|15 20 15 20 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	ACTIVATOR
16324695	CHEMICAL	GENE	T11	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 17 11 9|10 9 9|10 11 17 17 17 4 19 17 19 21 26 26 23 23 21 30 26|30 30 26|30 26 26 21 21 38 38 38 38 33 21	None-BC7
16324695	CHEMICAL	GENE	T7	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of fenoterol decreased @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ maximal relaxation ( E(max ) ) of methacholine-contracted preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	24 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13 24 24|28 28 24|28 28 24 30 28 30 30 35 35 28 40 40 39 40 24 24 24 42 46 46 43|44 43 43|44 24	AGONIST
16324695	CHEMICAL	GENE	T6	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17 25 25 17 25 26 30 30 26 30 30 35 35 43 37 35 37 37 37 37 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 9 9 9 9 15 11 9|10 9 9|10 11 15 4|13|15 4|13|15 4|13|15 4|15 4|13|15 20 15 20 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	ACTIVATOR
16324695	CHEMICAL	GENE	T12	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] To investigate the capacity of activated @GENETgt$ PKC @/GENETgt$ to regulate homologous desensitization , we incubated the smooth muscle strips with the combination of both 1 microM PMA and 1 microM @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ .	2 2 4 2 7 7 4|6 4 4|6 10 4 12 10 15 15 2 19 19 19 15 22 22 19 27 27 26 27 22 27 30 31 27|29 27 27|29 15	None-BC7
16324695	CHEMICAL	GENE	T1	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl) maleimide @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ @CHEMICALSrc$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide @/CHEMICALSrc$ ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	16 16 7 7 4|7 7 4|7 16|5|7 16|5|7 16|5|7 16|7 16|5|7 13 13 7 13 16 16 18 16 18 18 20 23 18 26 26 18 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 16 16	INHIBITOR
16324695	CHEMICAL	GENE	T2	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of @CHEMICALSrc$ fenoterol @/CHEMICALSrc$ decreased isoprenaline-induced maximal relaxation ( E(max ) ) of methacholine-contracted preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	25 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13|22 13 13|22 25 28 28 25 30 28 30 30 35 35 28 40 40 39 40 25 25 25 42 46 46 43|44 43 43|44 25	None-BC7
16324695	CHEMICAL	GENE	T11	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	20 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16 18 20 25 25 22 22 20 29 26|29 29 26|29 25 25 20 20 38 38 38 34|38 38 34|38 32 20	AGONIST
16324695	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17|20 17 17|20 26 26 17 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ GF 109203X @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( @CHEMICALSrc$ GF 109203X @/CHEMICALSrc$ ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of PMA and fenoterol were completely prevented .	16 16 9 9 9|4 9 9|4 9 9 16 11 9|11 9|11 9|11 9|11 11 16 16 18 16 18 18 20 23 18 26 26 18 26 27 31 31 27 31 31 36 36 43 38 36 38 38 43 43 16 16	INHIBITOR
16324695	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator @CHEMICALSrc$ phorbol 12-myristate 13-acetate @/CHEMICALSrc$ ( PMA ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 14 11 9 11 14 4|13|14 4|13|14 4|13|14 4|14 4|13|14 19 14 19 21 26 26 23 23 21 29 29 26 26 21 21 38 38|30 38 38|30 38 38 32 21	ACTIVATOR
16324695	CHEMICAL	GENE	T10	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 7 7 17|6|7 17|6|7 17|6|7 17|7 17|6|7 12 7 12 17 17 17 4 19 17|15 17 17|15 19 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	ACTIVATOR
16324695	CHEMICAL	GENE	T5	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Moreover , the specific @GENETgt$ PKC-inhibitor @/GENETgt$ 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl ) maleimide ( GF 109203X ) markedly increased the potency and E(max ) of isoprenaline for all conditions used , including control conditions , and the synergistic effects of @CHEMICALSrc$ PMA @/CHEMICALSrc$ and fenoterol were completely prevented .	15 15 9 9 9|4 9 9|4 9 9 15 12 12 9 12 15 15 17 15 17 17 19 22 17 25 25 17 25 26 30 30 26 30 30 35 35 43 37 35 35 35 37 37 43 43 15 15	None-BC7
16324695	CHEMICAL	GENE	T10	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( @GENETgt$ PKC @/GENETgt$ ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	22 4 4 1 9 9 9 9 17 11 9|10 9 9|10 11 17 17 17 4 19 17 17 17 19 22 27 27 24 24 22 30 30 27 27 22 22 38 38 38 38 33 22	ACTIVATOR
16324695	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ methacholine @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation ( 30 min ) of bovine tracheal smooth muscle with various concentrations ( 0.1 , 1 and 10 microM ) of fenoterol decreased isoprenaline-induced maximal relaxation ( E(max ) ) of @CHEMICALSrc$ methacholine-contracted @/CHEMICALSrc$ preparations in a concentration dependent fashion , indicating desensitization of the @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ .	24 4 4 1 4 10 10 10 10 1 13 13 10 20 20 15 15 15 15 13 20 23 13 24 27 27 24 29 27 29 29 35 32|35 35 32|35 27 40 40 39 40 24 24 24 42 46 46 43|44 43 43|44 24	None-BC7
16324695	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ PKC @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated @GENETgt$ PKC-mediated @/GENETgt$ heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16|17 16 16|17 18 21 26 26 23 23 21 29 29 26 26 21 21 38 32|38 38 32|38 38 38 32 21	ACTIVATOR
16324695	CHEMICAL	GENE	T11	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ isoprenaline @/CHEMICALSrc$ and @GENETgt$ protein kinase C @/GENETgt$ ? [SEP] Preincubation with 1 microM of the @GENETgt$ protein kinase C @/GENETgt$ ( PKC ) activator phorbol 12-myristate 13-acetate ( PMA ) caused a small but significant decrease in @CHEMICALSrc$ isoprenaline-induced @/CHEMICALSrc$ E(max ) , indicating activated PKC-mediated heterologous beta(2)-adrenoceptor desensitization .	21 4 4 1 7 7 17|6|7 17|6|7 17|6|7 17|7 17|6|7 12 7 12 17 17 17 4 19 17 19 21 26 26 23 23 21 30 24|30 30 24|30 26 26 21 21 38 38 38 38 33 21	None-BC7
16324695	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ PMA @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Preincubation with 1 microM of the protein kinase C ( PKC ) activator phorbol 12-myristate 13-acetate ( @CHEMICALSrc$ PMA @/CHEMICALSrc$ ) caused a small but significant decrease in isoprenaline-induced E(max ) , indicating activated PKC-mediated heterologous @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ desensitization .	21 4 4 1 9 9 9 9 16 11 9 11 16 16 16 4 18 16|17 16 16|17 18 21 26 26 23 23 21 29 29 26 26 21 21 38 38 38 34|38 38 34|38 32 21	None-BC7
12901032	CHEMICAL	GENE	T8	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ 200 mg/day or rofecoxib 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 28|29 29 28|29 33 30 30 30 37 29 40 40 29 29	INHIBITOR
12901032	CHEMICAL	GENE	T14	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ warfarin @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on @CHEMICALSrc$ warfarin @/CHEMICALSrc$ therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 6 3|6 6 3|6 2 2 9 2 17 17 13 17|11 17 17|11 17 17 9 22 22 22 20 1 22 22 24 24 24 22 30 30 30 33 31 31 31 37 30 40 40 30 30	None-BC7
12901032	CHEMICAL	GENE	T6	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ salsalate @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , @CHEMICALSrc$ salsalate @/CHEMICALSrc$ , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 21 21 23 23 23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	INHIBITOR
12901032	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 29 32 30 30 32|30 30 32|30 37 29 40 40 29 29	INHIBITOR
12901032	CHEMICAL	GENE	T1	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Adverse drug reactions were similar for each @GENETgt$ COX-2 @/GENETgt$ inhibitor , but the rate of edema requiring medical intervention was higher in the @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ group .	3 3 5 5 5 10 10 10|7 10 10|7 5 5 5 14 17 16 14 5 19 17 21 5 26 26 26|22 26 26|22 21 5	None-BC7
12901032	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 24|23 23 24|23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	INHIBITOR
12901032	CHEMICAL	GENE	T14	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ warfarin @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on @CHEMICALSrc$ warfarin @/CHEMICALSrc$ therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 6 3|6 6 3|6 2 2 9 2 17 9|17 17 9|17 14 17 17 17 9 22 22 22 20 1 22 22 24 24 24 22 30 30 30 33 31 31 31 37 30 40 40 30 30	None-BC7
12901032	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received celecoxib 200 mg/day or @CHEMICALSrc$ rofecoxib @/CHEMICALSrc$ 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 29 32 30 30 32|30 30 32|30 37 29 40 40 29 29	INHIBITOR
12901032	CHEMICAL	GENE	T6	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ salsalate @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , @CHEMICALSrc$ salsalate @/CHEMICALSrc$ , or acetaminophen ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 21 21 23 23 23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	INHIBITOR
12901032	CHEMICAL	GENE	T7	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ and @GENETgt$ cyclooxygenase-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a @GENETgt$ cyclooxygenase-2 @/GENETgt$ ( COX-2 ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or @CHEMICALSrc$ acetaminophen @/CHEMICALSrc$ ) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks .	30 1 5 5 2 2 8 2 16 16|9 16 16|9 13 16 16 16 8 21 21 21 19 1 21 21 23 23 24|23 23 24|23 21 30 30 30 33 31 31 31 37 30 40 40 30 30	INHIBITOR
12901032	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 ( @GENETgt$ COX-2 @/GENETgt$ ) inhibitor comparator ( traditional nonsteroidal antiinflammatory medications , salsalate , or acetaminophen ) randomly received @CHEMICALSrc$ celecoxib @/CHEMICALSrc$ 200 mg/day or rofecoxib 25 mg/day for three weeks .	29 1 5 5 2 2 8 2 16 16 12 16|11 16 16|11 16 16 8 21 21 21 19 1 21 21 23 23 23 21 29 29 28|29 29 28|29 33 30 30 30 37 29 40 40 29 29	INHIBITOR
19372559	CHEMICAL	GENE	T5	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , @GENETgt$ PDIA3 @/GENETgt$ ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13|29 13 13|29 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ high-mobility group protein B2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( @GENETgt$ high-mobility group protein B2 @/GENETgt$ , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 10 8|9|10 8|9|10 8|9|10 8|9|10 8|10 8|9|10 10 10 10 20|13 20 20|13 10 20 10 10 29 29 29 29 29 10 29 10 10 10 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , @GENETgt$ HMGB2 @/GENETgt$ ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13|14 13 13|14 13 19 13 19 13 13 29 29|22 29 29|22 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Our results dissect the roles of @GENETgt$ HMGB1-associated @/GENETgt$ proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 9 9|6 9 9|6 5 13 13 13 5 3 18 15 15 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T6	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Using the cell proliferation assay , we found that knockdown of @GENETgt$ HMGB1-associated @/GENETgt$ proteins resulted in 8-fold to 50-fold decreased chemosensitivity of A549 cells to @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ .	8 5 5 5 1 8 8 8 15 15 14 11|14 14 11|14 10 8 21 19 19 20 21 15 24 24 21 26 24|21 21 24|21 8	None-BC7
19372559	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; @GENETgt$ protein @/GENETgt$ @CHEMICALSrc$ disulfide isomerase family A member 3 @/CHEMICALSrc$ , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 24|21 24 24|21 24|13|22 24|13|22 24|13|22 24|13|22 24|13|22 24|13|22 24|13 24|13|22 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and @GENETgt$ HMGB2 @/GENETgt$ facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 18 14 14|15 14 14|15 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ High-mobility group protein 1 @/GENETgt$ ? [SEP] @GENETgt$ High-mobility group protein 1 @/GENETgt$ ( HMGB1 ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with HMGB1 in the context of DNA damage response .	0|1|13 0|1|13 0|1|13 0|1|13 1|13 0|1|13 7 1 7 13 13 13 13 32 13 17 17 14 20 20 17|15 17 17|15 23 17 13 26 13 26 26 26 32 32 32 34 32 37 37 32 41 41 41 37 32	None-BC7
19372559	CHEMICAL	GENE	T4	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of @GENETgt$ HMGB1 @/GENETgt$ and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3|4 3 3|4 5 9 5 14 14 14 14 9 14 14 14 16|20 20 16|20 14 20 14 14 29 29 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ gamma-H2AX @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no @GENETgt$ gamma-H2AX @/GENETgt$ accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 34 34 31 39 37 36|39 39 36|39 30 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T4	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ GAPDH @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , @GENETgt$ GAPDH @/GENETgt$ ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 19|13 13 19|13 13 29 29 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , @GENETgt$ PDIA3 @/GENETgt$ ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13|29 13 13|29 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ H2AX @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for @GENETgt$ H2AX @/GENETgt$ phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 35 32|35 35 32|35 31 39 38 39 30 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T5	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13 13 5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 34|5 32|34|5 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] High-mobility group protein 1 ( HMGB1 ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with @GENETgt$ HMGB1 @/GENETgt$ in the context of DNA damage response .	3 3 12 3 6 3 6 12 12 12 12 31 12 16 16 13 19 19 16|18 16 16|18 22 16 12 25 12 25 25 25 31 31 31 33 31 31 31 37 37 31 41 41 41 37 31	None-BC7
19372559	CHEMICAL	GENE	T4	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , @GENETgt$ HMGB2 @/GENETgt$ ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13|14 13 13|14 13 16|20 20 16|20 13 20 13 13 29 29 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] High-mobility group protein 1 ( @GENETgt$ HMGB1 @/GENETgt$ ) is a DNA damage sensor responsive to the incorporation of nonnatural @CHEMICALSrc$ nucleosides @/CHEMICALSrc$ into DNA ; several nuclear and cytosolic proteins are functionally integrated with HMGB1 in the context of DNA damage response .	3 3 13 3 6 3|5 3 3|5 6 13 13 13 13 32 13 17 17 14 20 20 17|18 17 17|18 23 17 13 26 13 26 26 26 32 32 32 34 32 37 37 32 41 41 41 37 32	None-BC7
19372559	CHEMICAL	GENE	T5	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of @GENETgt$ HMGB1 @/GENETgt$ and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3|4 3 3|4 5 9 5 14 14 14 14 9 14 14 14 19 14 19 14 14 29 29|22 29 29|22 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of HMGB1 and @GENETgt$ HMGB1-associated @/GENETgt$ proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 9|6 9 9|6 5 14 14 14 14 9 14 14 14 19 14 19 14 14 29 29|22 29 29|22 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ GAPDH @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , @GENETgt$ GAPDH @/GENETgt$ ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 19|13 13 19|13 13 29 29|22 29 29|22 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ HSPA8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , @GENETgt$ HSPA8 @/GENETgt$ ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 18 13 18 13 13 28 28|22 28 28|22 28 28 28 13 28 13 13 13 5 35 38 38 38 5 38 5 5|39 5 5|39 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : @GENETgt$ HMGB1 @/GENETgt$ and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 18|13 18 18|13 14 14 3 20 18 22 18 25 25 22 18 18 31 31 31 18 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T2	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ p53 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate @GENETgt$ p53 @/GENETgt$ phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 17|20 20 17|20 17 22 17 25 25 22 17 17 31 31 31 17 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	INDIRECT-UPREGULATOR
19372559	CHEMICAL	GENE	T2	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and PDIA3 has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in @GENETgt$ PDIA3 @/GENETgt$ knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 30 30 30 17 30 34 34 31 38 37 38 30 43 42 42 43 38 45 43 48 48 45 50 48|49 48 48|49 56 56|51 56 56|51 56 48 38 3	None-BC7
19372559	CHEMICAL	GENE	T4	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; @GENETgt$ protein disulfide isomerase family A member 3 @/GENETgt$ , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|21|23 13|23 13|21|23 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HMGB1 @/GENETgt$ ? [SEP] The functional role of HMGB1 and @GENETgt$ HMGB1-associated @/GENETgt$ proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 9|6 9 9|6 5 14 14 14 14 9 14 14 14 16|20 20 16|20 14 20 14 14 29 29 29 29 29 14 29 14 14 14 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T4	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and @GENETgt$ heat shock 70 kDa protein 8 @/GENETgt$ , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13 13 5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 32|34|5 34|5 32|34|5 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T2	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ and @GENETgt$ PDIA3 @/GENETgt$ ? [SEP] Our results dissect the roles of HMGB1-associated proteins in DNA damage response : HMGB1 and HMGB2 facilitate p53 phosphorylation after exposure to genotoxic stress , and @GENETgt$ PDIA3 @/GENETgt$ has been found essential for H2AX phosphorylation ( no gamma-H2AX accumulated after 24 - 72 hours of incubation with 1 micromol/L of @CHEMICALSrc$ cytarabine @/CHEMICALSrc$ in PDIA3 knockdown cells ) .	2 3 3 5 3 8 8 5 12 12 12 5 3 17 14 14 3 19 17 21 17 24 24 21 17 17 26|31 31 26|31 31 31 17 31 35 35 32 39 38 39 31 44 43 43 44 39 46 44 49 49 46 51 49 49 49 56 56 56 49 39 3	None-BC7
19372559	CHEMICAL	GENE	T4	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ and @GENETgt$ HSPA8 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @CHEMICALSrc$ glyceraldehyde-3-phosphate @/CHEMICALSrc$ dehydrogenase , GAPDH ; protein disulfide isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , @GENETgt$ HSPA8 @/GENETgt$ ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|19 19 16|19 13 19 13 13 28 28 28 28 28 13 28 13 13 13 5 35 38 38 38 5 38 5 5|39 5 5|39 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ high-mobility group protein B2 @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( @GENETgt$ high-mobility group protein B2 @/GENETgt$ , HMGB2 ; glyceraldehyde-3-phosphate dehydrogenase , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 10 8|9|10 8|9|10 8|9|10 8|9|10 8|10 8|9|10 10 10 10 19 10 19 10 10 29 19|29 29 19|29 29 29 29 10 29 10 10 10 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
19372559	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ disulfide @/CHEMICALSrc$ and @GENETgt$ glyceraldehyde-3-phosphate dehydrogenase @/GENETgt$ ? [SEP] The functional role of HMGB1 and HMGB1-associated proteins ( high-mobility group protein B2 , HMGB2 ; @GENETgt$ glyceraldehyde-3-phosphate dehydrogenase @/GENETgt$ , GAPDH ; protein @CHEMICALSrc$ disulfide @/CHEMICALSrc$ isomerase family A member 3 , PDIA3 ; and heat shock 70 kDa protein 8 , HSPA8 ) in DNA damage response was assessed in human carcinoma cells A549 and UO31 by transient knockdown with short interfering RNAs .	3 3 49 5 3 5 8 5 13 13 13 13 8 13 13 13 16|17|13 16|17|13 17|13 16|17|13 17 13 13 29 29|21 29 29|21 29 29 29 13 29 13 13 13 5 36 39 39 39 5 39 5 5 5 47 47 47 3 49 49 53 53 53 49 53 54 54 59 59 49 63 63 63 59 49	None-BC7
10727715	CHEMICAL	GENE	T8	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T21	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 26 26 21 11 9 9 9|29 9 9|29 37 37 32|37 32|37 37 32|37 30 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	ANTAGONIST
10727715	CHEMICAL	GENE	T10	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T11	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T21	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 27|23 27|23 27 27|23 21 11 9 9 9|28 9 9|28 37 37 37 37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T3	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T9	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T8	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8|9 8 8|9 14 14 8 14 14 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T30	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute fluoxetine-induced changes in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ : the mechanism of action of (+/-)pindolol .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 17 17 15 13 20 20 17|13 13 17|13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T11	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T22	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 27|23 27|23 27 27|23 21 11 9 9 9 36 36 36 36 31 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T29	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 15 13 10|11 11 10|11 15 17 15 20 20 17 23 23 26 23 23 15 31 31 28 28 26 31 31 26 15 15 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 15	None-BC7
10727715	CHEMICAL	GENE	T17	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 19 19 19 19 14 19 11 11 25 25 27 27 22 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T16	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] This effect has been attributed to the antagonist effects of @CHEMICALSrc$ pindolol @/CHEMICALSrc$ at the @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 5 5 5 5 9 9 9 5 11 9|10 9 9|10 18 18 18|13 18|13 18 18|13 9 5	ANTAGONIST
10727715	CHEMICAL	GENE	T17	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 19 19 19 19 14 19 11 11 25 25 28|23 28|23 28 28|23 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T21	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11 25 25 27 27 22 11 9 9 9|28 9 9|28 37 37 37 37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T30	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute fluoxetine-induced changes in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ : the mechanism of action of (+/-)pindolol .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 17 17 15 13 20 20 16|13 13 16|13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T22	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11 25 25 27 27 22 11 9 9 9 36 36 36 36 31 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T14	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 44 44 44 44 39 46 24 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	None-BC7
10727715	CHEMICAL	GENE	T32	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ changes in extracellular 5-HT : the mechanism of action of (+/-)pindolol .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 18 18 12|15 15 12|15 13 21 21 13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T9	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T31	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT : the mechanism of action of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 17 17 15 13 20 20 13 2 23 2 25 23 27 24|25 25 24|25 2	None-BC7
10727715	CHEMICAL	GENE	T13	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T14	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 45 45 40|45 40|45 45 40|45 39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T6	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T14	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 32 32 29 35 35 32|34 32 32|34 39 39 24 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T5	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T18	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 19 19 19 19 13 19 11 11 25 25 27 27 22 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T2	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T18	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a 5-HT(1A ) antagonist ) , GR127935 ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 19 19 19 19 13 19 11 11 25 25 28|23 28|23 28 28|23 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T31	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) receptors @/GENETgt$ ? [SEP] The role of 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) receptors @/GENETgt$ on the modulation of acute fluoxetine-induced changes in extracellular 5-HT : the mechanism of action of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ .	2 2 4 2 4 4 4|6|7 4|6|7 4|6|7 4|7 4|6|7 13 13 2 17 17 15 13 20 20 13 2 23 2 25 23 27 25|23 25 25|23 2	None-BC7
10727715	CHEMICAL	GENE	T22	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11 24 24 26 26 21 11 9 9 9 36 36 32|36 32|36 36 32|36 30 36 7 40 7 40 43 40 45 42|43 43 42|43 40 40 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T9	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8|12 8 8|12 13 13 16 16 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T18	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , @CHEMICALSrc$ WAY-100635 @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11|12 11 11|12 20 20 20|15 20|15 20 20|15 13 20 11 11 26 26 28 28 23 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	ANTAGONIST
10727715	CHEMICAL	GENE	T13	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 44 44 44 44 39 46 24 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	None-BC7
10727715	CHEMICAL	GENE	T7	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T13	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 24 24 21 24 29 29 29 25 33 33|30 33 33|30 29 36 36 33 39 39 24 45 45 40|45 40|45 45 40|45 39 47 24 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T19	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 19 19 19|15 19|15 19 19|15 13 19 11 11|19 11 11|19 26 26 28 28 22 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T19	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a @GENETgt$ 5-HT(1B ) @/GENETgt$ antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11|20 11 11|20 25 25 27 27 21 11 9 9 9 37 37 32|37 32|37 37 32|37 31 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T6	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T5	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T17	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ , WAY-100635 ( a @GENETgt$ 5-HT(1A ) @/GENETgt$ antagonist ) , GR127935 ( a 5-HT(1B/1D ) antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9|10 9 9|10 11 11 20 20 20|15 20|15 20 20|15 14 20 11 11 26 26 28 28 23 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	ANTAGONIST
10727715	CHEMICAL	GENE	T1	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 16 16 23 23 26 23 23 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T19	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] In the present study , we compared the pharmacology of (+/-)pindolol , WAY-100635 ( a 5-HT(1A ) antagonist ) , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ ( a @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ antagonist ) , and isamoltane ( a 5-HT(1B ) antagonist ) , when given acutely in combination with fluoxetine , using in vivo microdialysis in the frontal cortex of the freely moving rat .	4 4 4 7 7 7 7 9 7 11 9 11 11 18 18 18 18 13 18 11 11|20 11 11|20 25 25 28|23 28|23 28 28|23 21 11 9 9 9 37 37 37 37 32 37 7 41 7 41 44 41 46 44 41 41 51 49 48 55 55 55 51 60 60 59 60 55 7	None-BC7
10727715	CHEMICAL	GENE	T2	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ WAY100635 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T12	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T12	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 21	ANTAGONIST
10727715	CHEMICAL	GENE	T4	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T3	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T11	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or @CHEMICALSrc$ isamoltane @/CHEMICALSrc$ , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13 15 16|15 15 16|15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T32	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] The role of @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) receptors on the modulation of acute @CHEMICALSrc$ fluoxetine-induced @/CHEMICALSrc$ changes in extracellular 5-HT : the mechanism of action of (+/-)pindolol .	2 2 4 2|3|4 2|3|4 2|4 2|3|4 4 4 8 4 13 13 2 18 18 13|15 15 13|15 13 21 21 13 2 24 2 26 24 28 26 2	None-BC7
10727715	CHEMICAL	GENE	T10	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the 5-HT(1B/D ) receptor in addition to any activity it has at the presynaptic @GENETgt$ 5-HT(1A ) @/GENETgt$ receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 44 44 44 44 39 46 25 49 49 46 51 49 58 58 58 58|53|54 58|53|54 58|54 58|53|54 51 22	None-BC7
10727715	CHEMICAL	GENE	T29	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1A) @/GENETgt$ ? [SEP] Combination of both @GENETgt$ 5-HT(1A ) @/GENETgt$ and 5-HT(1B/1D ) autoreceptor antagonists with @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1|3|4 1|3|4 1|4 1|3|4 1 1 11 11 15 13 10|11 11 10|11 15 17 15 20 20 17 23 23 26 23 23 15 31 31 28 28 26 31 31 26 15 15 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 15	None-BC7
10727715	CHEMICAL	GENE	T12	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , GR127935 or isamoltane , we have determined that @CHEMICALSrc$ (+/-)pindolol @/CHEMICALSrc$ produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) @/GENETgt$ receptor in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 21 21 5 21 8 8 5 10 8 13 13 8 13 13 15 15 21 21 21 21 25 25|22 25 25|22 21 25 30 30 30 26 33 33 30 36 36 33 39 39 25 45 45 40|45 40|45 45 40|45 39 47 25 50 50 47 52 50 58 58 58 55 58 52 21	None-BC7
10727715	CHEMICAL	GENE	T10	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/D) receptor @/GENETgt$ ? [SEP] In addition , by comparing the combined administration of (+/-)pindolol with either WAY100635 , @CHEMICALSrc$ GR127935 @/CHEMICALSrc$ or isamoltane , we have determined that (+/-)pindolol produces much of its acute potentiation of fluoxetine-induced increases in extracellular 5-HT via its action at the @GENETgt$ 5-HT(1B/D ) receptor @/GENETgt$ in addition to any activity it has at the presynaptic 5-HT(1A ) receptor .	2 22 22 5 22 8 8 5 10 8 13 13 8 13 13|14 13 13|14 15 15 22 22 22 22 25 25 22 25 30 30 30 26 33 33 30 36 36 33 39 39 25 42 42 40|42|39 40|42|39 40|42|39 42|39 40|42|39 47 25 50 50 47 52 50 58 58 58 55 58 52 22	None-BC7
10727715	CHEMICAL	GENE	T4	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. @CHEMICALSrc$ WAY100635+GR127935+fluoxetine @/CHEMICALSrc$ and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26|19 26 26|19 22 22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T7	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ fluoxetine @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular 5-HT ( i.e. WAY100635+GR127935+fluoxetine and @CHEMICALSrc$ WAY100635+isamoltane+fluoxetine @/CHEMICALSrc$ produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 22 22 26 22 21|22 22 21|22 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
10727715	CHEMICAL	GENE	T1	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT(1B/1D) @/GENETgt$ ? [SEP] Combination of both 5-HT(1A ) and @GENETgt$ 5-HT(1B/1D ) @/GENETgt$ autoreceptor antagonists with fluoxetine produced additive increases in extracellular @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ ( i.e. WAY100635+GR127935+fluoxetine and WAY100635+isamoltane+fluoxetine produced a four- and five-fold potentiation , respectively ) , suggesting that this strategy may be useful in further augmenting the action of a SSRI in the treatment of depression .	11 4 4 1 4 1 1|11|6 1|11|6 1|11 1|11|6 11 14 13 11 14 16 14 19 19 16 16 16 23 23 26 23 23 14 31 31 28 28 26 31 31 26 14 14 42 39 42 42 42 36 45 45 42 47 45 50 50 47 53 53 47 55 53 14	None-BC7
9890894	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] Previously , we reported that a primary heparin or heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ binding site resides in a distinct sequence in immunoglobulin (Ig)-like module II of the three modules of @GENETgt$ FGFR @/GENETgt$ .	4 4 4 4 15 8 8 15 8 14 10|14 14 10|14 14 8 4 19 19 19 15 21 19 23 21 23 28 28 28 21 30 28 28 28 4	DIRECT-REGULATOR
9890894	CHEMICAL	GENE	T1	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ transmembrane receptor kinase @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of FGF , the @GENETgt$ transmembrane receptor kinase @/GENETgt$ ( FGFR ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 7 9 12 9|11|12 9|11|12 9|11|12 9|12 9|11|12 17 12 17 9 7 22 18|7 7 18|7 24 26 24 26 27 28 28 32 28 24	None-BC7
9890894	CHEMICAL	GENE	T3	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGFR1IIIc @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length @GENETgt$ FGFR1IIIc @/GENETgt$ , an isoform that otherwise absolutely rejects FGF-7 , resulted in gain of FGF-7 binding .	3 3 21 6 6 3|5 3 3|5 10 10 8|6 6 8|6 10 14 10 18 18 18 14 18 21 21 23 21 26 26 23 21	PART-OF
9890894	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length FGFR1IIIc , an isoform that otherwise absolutely rejects FGF-7 , resulted in gain of @GENETgt$ FGF-7 @/GENETgt$ binding .	3 3 20 6 6 3|5 3 3|5 10 10 6 10 13 10 17 17 17 13 17 20 20 22 20 26 26|22 26 26|22 22 20	None-BC7
9890894	CHEMICAL	GENE	T2	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Addition of a specific number of FGFR sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module II resulted in a gain in affinity for @GENETgt$ FGF-7 @/GENETgt$ .	17 5 5 5 1 8 8 5 11 11 1|10 1 1|10 15 15 11 15 17 20 20 17 22 20 24 22 22 22 17	None-BC7
9890894	CHEMICAL	GENE	T2	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module II @/GENETgt$ ? [SEP] Addition of a specific number of FGFR sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of @GENETgt$ Ig module II @/GENETgt$ resulted in a gain in affinity for FGF-7 .	18 5 5 5 1 8 8 5 11 11 1|10 1 1|10 14 11|12|14 11|12|14 11|12|14 11|14 11|12|14 18 21 21 18 23 21 25 23 18	PART-OF
9890894	CHEMICAL	GENE	T3	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Several site-specific alterations in the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of full-length FGFR1IIIc , an isoform that otherwise absolutely rejects @GENETgt$ FGF-7 @/GENETgt$ , resulted in gain of FGF-7 binding .	3 3 21 6 6 3|5 3 3|5 10 10 6 10 13 10 17 17 17 13 16|17 17 16|17 21 21 23 21 26 26 23 21	None-BC7
9890894	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGF @/GENETgt$ ? [SEP] These results suggest that a complex of Ig module II and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the FGFR ectodomain and that flanking structural domains modify @GENETgt$ FGF @/GENETgt$ affinity and determine specificity .	2 3 3 17 6 17 9 9 6 9 9 13 9|12 9 9|12 17 17 3 20 20 17 24 24 24 20 17 30 29 29 30 17 33|29 33 33|29 30 30 30 35 3	None-BC7
9890894	CHEMICAL	GENE	T6	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-2 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , @GENETgt$ FGF-2 @/GENETgt$ , and FGF-7 .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 18 18 18 18 18 18 18 13	None-BC7
9890894	CHEMICAL	GENE	T4	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ Ig module II @/GENETgt$ ? [SEP] These results suggest that a complex of @GENETgt$ Ig module II @/GENETgt$ and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the FGFR ectodomain and that flanking structural domains modify FGF affinity and determine specificity .	2 3 3 18 6 18 8 8|6|7 8|6|7 8|6|7 8|6 8|6|7 8 14 8|10 8 8|10 18 18 3 21 21 18 25 25 25 21 18 31 30 30 31 18 33 31 31 31 35 3	DIRECT-REGULATOR
9890894	CHEMICAL	GENE	T6	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module I @/GENETgt$ ? [SEP] @GENETgt$ Ig module I @/GENETgt$ and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , FGF-2 , and FGF-7 .	0|1|14 0|1|14 0|1|14 1|14 0|1|14 1 7 1|3 1 1|3 11 11 7 11 14 14 17 17 14 19 17 19 19 19 19 19 14	None-BC7
9890894	CHEMICAL	GENE	T5	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ immunoglobulin (Ig)-like module II @/GENETgt$ ? [SEP] Previously , we reported that a primary heparin or heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ binding site resides in a distinct sequence in @GENETgt$ immunoglobulin (Ig)-like module II @/GENETgt$ of the three modules of FGFR .	4 4 4 4 15 8 8 15 8 14 10|14 14 10|14 14 8 4 19 19 19 15 21 19|21 19|21 19|21 19|21 19|21 19|21 29 29 29 21 31 29 4	DIRECT-REGULATOR
9890894	CHEMICAL	GENE	T4	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR ectodomain @/GENETgt$ ? [SEP] These results suggest that a complex of Ig module II and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ is the base common active core of the @GENETgt$ FGFR ectodomain @/GENETgt$ and that flanking structural domains modify FGF affinity and determine specificity .	2 3 3 17 6 17 9 9 6 9 9 13 9|12 9 9|12 17 17 3 20 20 17 23 23 20|21|23 20|21|23 20|23 20|21|23 17 31 30 30 31 17 33 31 31 31 35 3	None-BC7
9890894	CHEMICAL	GENE	T1	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of FGF , the transmembrane receptor kinase ( @GENETgt$ FGFR @/GENETgt$ ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 7 9 14 14 14 9 16 14|15 14 14|15 16 9 7 22 20|7 7 20|7 24 26 24 26 27 28 28 32 28 24	None-BC7
9890894	CHEMICAL	GENE	T6	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-7 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of FGF-1 , FGF-2 , and @GENETgt$ FGF-7 @/GENETgt$ .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 18 18 18 18 18|21 18 18|21 13	None-BC7
9890894	CHEMICAL	GENE	T6	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ Ig module III @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of @GENETgt$ Ig module III @/GENETgt$ are dispensable for high-affinity binding of FGF-1 , FGF-2 , and FGF-7 .	2 14 2 2 6 2|5 2 2|5 9 9|6|7 9|6|7 9|6|7 9|6 9|6|7 14 14 17 17 14 19 17 19 19 19 19 19 14	PART-OF
9890894	CHEMICAL	GENE	T2	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGFR @/GENETgt$ ? [SEP] Addition of a specific number of @GENETgt$ FGFR @/GENETgt$ sequences to the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module II resulted in a gain in affinity for FGF-7 .	18 5 5 5 1 9 9|6 9 9|6 5 12 12 1|10 1 1|10 16 16 12 16 18 21 21 18 23 21 25 23 18	None-BC7
9890894	CHEMICAL	GENE	T6	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ FGF-1 @/GENETgt$ ? [SEP] Ig module I and the @CHEMICALSrc$ C-terminus @/CHEMICALSrc$ of Ig module III are dispensable for high-affinity binding of @GENETgt$ FGF-1 @/GENETgt$ , FGF-2 , and FGF-7 .	2 13 2 2 6 2|5 2 2|5 10 10 6 10 13 13 16 16 13 18 16 16 16 18 18 18 18 18 13	None-BC7
9890894	CHEMICAL	GENE	T1	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ FGF @/GENETgt$ ? [SEP] The assembly and activation of oligomeric complexes of @GENETgt$ FGF @/GENETgt$ , the transmembrane receptor kinase ( FGFR ) , and heparan @CHEMICALSrc$ sulfate @/CHEMICALSrc$ transmit intracellular signals regulating growth and function of cells .	2 24 2 2 7 7 2 9 8|7 7 8|7 9 15 15 15 9 17 15 17 9 7 22 20|7 7 20|7 24 26 24 26 27 28 28 32 28 24	None-BC7
23298863	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] The IC50 values for @GENETgt$ Gli1 @/GENETgt$ mRNA inhibition in the tumor and skin by @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ were estimated to be 0.0457 and 0.113 μg/ml , respectively .	3 3 18 8 8|4 8 8|4 8 3 11 11 8 11 11 15 8|13 8 8|13 18 18 21 21 18 21 21 21 21 21 18	INDIRECT-DOWNREGULATOR
23298863	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and the responses of Gli1 mRNA in tumor-associated stromal or skin cells and the antitumor effect of @GENETgt$ hedgehog @/GENETgt$ inhibition .	2 8 5 5 2 8 8 8 10 8 12 10 15 15 12 18 18 15 20 18|19 18 18|19 18 24 18 27 27 24 33 33 33 30 30 24 18 37 37 18 41 41|37 41 41|37 37 8	None-BC7
23298863	CHEMICAL	GENE	T4	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] The objectives of these studies were to explore the possibility of establishing of a link between the pharmacokinetics of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and the responses of @GENETgt$ Gli1 @/GENETgt$ mRNA in tumor-associated stromal or skin cells and the antitumor effect of hedgehog inhibition .	2 8 5 5 2 8 8 8 10 8 12 10 15 15 12 18 18 15 20 18|19 18 18|19 18 24 18 28 24|28 28 24|28 24 34 34 34 31 31 24 18 38 38 18 41 41 38 8	None-BC7
23298863	CHEMICAL	GENE	T5	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] To this end , we built pharmacokinetic and pharmacodynamic models that describe the relationship of the concentrations of @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ plasma to the responses of @GENETgt$ Gli1 @/GENETgt$ mRNA in the tumor ( target ) and skin ( surrogate ) and to tumor growth inhibition in mice bearing xenografts of human pancreatic tumors ( PAN-04 ) .	3 3 6 6 6 6 10 7 7 6 12 10 14 12 17 17 14 21 18|21 21 18|21 17 24 24 14 28 24|28 28 24|28 24 31 31 24 33 31 33 31 31 38 36 38 24 44 44 44 24 46 44 46 47 52 52 52 48 54 44 54 6	None-BC7
23298863	CHEMICAL	GENE	T1	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ and @GENETgt$ Smo @/GENETgt$ ? [SEP] @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ ( TAK-441 ) is a potent , selective hedgehog signaling pathway inhibitor that binds to @GENETgt$ Smo @/GENETgt$ and is being developed for the treatment of cancer .	0|14 14 0|14 4 1 4 14 14 14 8 8 14 14 14 14 16 14 18 16 16 16 16 23 23 16 26 26 23 28 26 14	None-BC7
23298863	CHEMICAL	GENE	T6	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] Pharmacokinetic and pharmacodynamic modeling of @GENETgt$ hedgehog @/GENETgt$ inhibitor @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	4 1 1 4 9 9|5 9 9|5 9 4|7 4 4|7 13 13 4 18 18 18 18 13 18 21 18 26 26 26 26 18 4	INHIBITOR
23298863	CHEMICAL	GENE	T1	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] @CHEMICALSrc$ 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide @/CHEMICALSrc$ ( TAK-441 ) is a potent , selective @GENETgt$ hedgehog @/GENETgt$ signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer .	0|15 15 0|15 4 1 4 15 15 15 8 8 9|15 15 9|15 15 15 15 17 15 19 17 17 23 23 17 26 26 23 28 26 15	None-BC7
23298863	CHEMICAL	GENE	T6	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Gli1 @/GENETgt$ ? [SEP] Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ for the inhibition of @GENETgt$ Gli1 @/GENETgt$ messenger RNA expression and antitumor efficacy in xenografted tumor model mice .	4 1 1 4 8 8 8 4|7 4 4|7 12 12 4 18 18|12 18 18|12 18 18 12 18 21 18 26 26 26 26 18 4	INDIRECT-DOWNREGULATOR
23298863	CHEMICAL	GENE	T3	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ Smo @/GENETgt$ ? [SEP] 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide ( @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ ) is a potent , selective hedgehog signaling pathway inhibitor that binds to @GENETgt$ Smo @/GENETgt$ and is being developed for the treatment of cancer .	14 3 1|2 1 1|2 3 14 14 14 8 8 14 14 14 14 16 14 18 16 16 16 16 23 23 16 26 26 23 28 26 14	DIRECT-REGULATOR
23298863	CHEMICAL	GENE	T3	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ and @GENETgt$ hedgehog @/GENETgt$ ? [SEP] 6-Ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide ( @CHEMICALSrc$ TAK-441 @/CHEMICALSrc$ ) is a potent , selective @GENETgt$ hedgehog @/GENETgt$ signaling pathway inhibitor that binds to Smo and is being developed for the treatment of cancer .	15 3 1|2 1 1|2 3 15 15 15 8 8 9|15 15 9|15 15 15 15 17 15 19 17 17 23 23 17 26 26 23 28 26 15	INHIBITOR
23142699	CHEMICAL	GENE	T3	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] Proto-oncogene @GENETgt$ PIM-1 @/GENETgt$ is a novel @CHEMICALSrc$ estrogen @/CHEMICALSrc$ receptor target associating with high grade breast tumors .	2 1|10 10 1|10 10 10 10 10|5 10 10|5 10 10 16 16 16 16 16 10 10	None-BC7
23142699	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ ERα @/GENETgt$ ? [SEP] We show that the expression of PIM-1 is induced in response to @CHEMICALSrc$ estradiol @/CHEMICALSrc$ in MCF-7 cells and that the induction is mediated by @GENETgt$ ERα-regulated @/GENETgt$ enhancers located distally upstream from the gene .	2 2 9 5 9 7 5 9 2 11 9 13 11|12 11 11|12 17 17 11 9 23 21 23 23 9 27 27|23 27 27|23 23 27 30 28 33 33 30 2	ACTIVATOR
23142699	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ Proto-oncogene @/GENETgt$ ? [SEP] @GENETgt$ Proto-oncogene @/GENETgt$ PIM-1 is a novel @CHEMICALSrc$ estrogen @/CHEMICALSrc$ receptor target associating with high grade breast tumors .	0|3 3 0|3 10 10 10 10 10|5 10 10|5 10 10 16 16 16 16 16 10 10	None-BC7
23142699	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] We show that the expression of @GENETgt$ PIM-1 @/GENETgt$ is induced in response to @CHEMICALSrc$ estradiol @/CHEMICALSrc$ in MCF-7 cells and that the induction is mediated by ERα-regulated enhancers located distally upstream from the gene .	2 2 10 5 10 7 5|6 5 5|6 10 2 12 10 14 12 12 12 18 18 12 10 24 22 24 24 10 27 27 24 27 30 28 33 33 30 2	INDIRECT-UPREGULATOR
23142699	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogens @/CHEMICALSrc$ and @GENETgt$ PIM-1 @/GENETgt$ ? [SEP] In sum , identification of @GENETgt$ PIM-1 @/GENETgt$ as an ERα target gene adds a novel potential mechanism by which @CHEMICALSrc$ estrogens @/CHEMICALSrc$ can contribute to breast cancer cell proliferation and carcinogenesis .	2 13 13 13 6 4|5 4 4|5 12 12 12 12 4 13 17 17 17 13 19 23 18|23 23 18|23 23 17 27 27 27 23 27 28 28 13	None-BC7
23142699	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogens @/CHEMICALSrc$ and @GENETgt$ ERα @/GENETgt$ ? [SEP] In sum , identification of PIM-1 as an @GENETgt$ ERα @/GENETgt$ target gene adds a novel potential mechanism by which @CHEMICALSrc$ estrogens @/CHEMICALSrc$ can contribute to breast cancer cell proliferation and carcinogenesis .	2 13 13 13 6 4 12 12 8|12 12 8|12 12 4 13 17 17 17 13 19 23 18|23 23 18|23 23 17 27 27 27 23 27 28 28 13	None-BC7
2568748	CHEMICAL	GENE	T1	T4	True	0	What is [Drugprot] between @CHEMICALSrc$ Esmolol @/CHEMICALSrc$ and @GENETgt$ beta 1-adrenergic receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Esmolol @/CHEMICALSrc$ , a unique cardioselective @GENETgt$ beta 1-adrenergic receptor @/GENETgt$ blocker with a half-life of 9 minutes , can enable some patients with relative contraindications to beta blockers to nevertheless benefit from early beta-blocking therapy .	0|20 20 0|20 1 11 11 11 11|5 11|5 11|5 11 11|5 1 14 14 11 17 17 14 1 20 20 22 20 25 25 22 28 28 25 31 31 20 35 35 35 31 20	INHIBITOR
8142113	CHEMICAL	GENE	T5	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ retinoic acid binding protein @/GENETgt$ ? [SEP] Furthermore , @CHEMICALSrc$ adapalene @/CHEMICALSrc$ does not bind to members of the cellular @GENETgt$ retinoic acid binding protein @/GENETgt$ family .	7 7 2|7 7 2|7 7 7 7 9 7 18 18 18 18|11 18|11 18|11 18|11 18 18|11 9 7	None-BC7
8142113	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ RAR alpha @/GENETgt$ ? [SEP] It has a particular selectivity profile for the known nuclear @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors with low affinity for @GENETgt$ RAR alpha @/GENETgt$ and no transactivating potential for RXR alpha .	2 2 6 6 6 2 14 14 14 14 10|14 10|14 14 10|14 6 17 17 2 19 16|17|19 16|17|19 17|19 16|17|19 17 25 25 17 28 28 25 2	None-BC7
8142113	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ RXR alpha @/GENETgt$ ? [SEP] It has a particular selectivity profile for the known nuclear @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors with low affinity for RAR alpha and no transactivating potential for @GENETgt$ RXR alpha @/GENETgt$ .	2 2 6 6 6 2 14 14 14 14 10|14 10|14 14 10|14 6 17 17 2 20 20 17 17 24 24 17 26 24|26|23 24|26|23 24|26 24|26|23 2	None-BC7
10727528	CHEMICAL	GENE	T3	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible ET-1 binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and ETA receptor antagonists should be used to evaluate the physiopathological role of @GENETgt$ ET-1 @/GENETgt$ and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 13 13 13 7 11 11 13 13 4 13 17 17 14 19 13 13 13 35 22 25 35 27 25|26 25 25|26 27 31 32 27 35 35 13 37 35 40 40 37 42 40 40 40 37 49 49 49 49 37 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T10	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of @GENETgt$ (125)I-ET-1 @/GENETgt$ ETA receptor complexes both in the absence and the presence of unlabeled ET-1 .	0|1|4 0|1|4 1|4 0|1|4 4 4 11 11|4 11 11|4 11 11 5 15 15 15 4 15 18 15 21 21 18 4	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T11	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] Salicylic acid promotes dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ ETA receptor complexes both in the absence and the presence of unlabeled @GENETgt$ ET-1 @/GENETgt$ .	2 3 3 3 10 10|5 10 10|5 10 10 4 14 14 14 3 14 17 14 20 20 17|18 17 17|18 3	None-BC7
10727528	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ endothelin-1 @/GENETgt$ ? [SEP] This study shows that aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ , its major blood metabolite , reverse contractile actions of @GENETgt$ endothelin-1 @/GENETgt$ ( ET-1 ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16 5 5|6|7 5|6|7 5|7 5|6|7 5 14 14 14 5 5 3 18 16 20 17|18 18 17|18 23 20 23 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T4	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] This study shows that @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and sodium salicylate , its major blood metabolite , reverse contractile actions of endothelin-1 ( @GENETgt$ ET-1 @/GENETgt$ ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16|4 16 16|4 5 9 5 5 14 14 14 5 5 3 18 16 20 18 22 20 20 20 22 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T9	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ rat ETA receptors @/GENETgt$ ? [SEP] Salicylates inhibit @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ binding to recombinant @GENETgt$ rat ETA receptors @/GENETgt$ .	2 2 2|5 5 2|5 2 8 8 8|5|6 8|5|6 8|5|6 8|5 8|5|6 2	None-BC7
10727528	CHEMICAL	GENE	T7	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] Inhibition of the actions of @GENETgt$ ET-1 @/GENETgt$ by @CHEMICALSrc$ salicylates @/CHEMICALSrc$ is apparently competitive .	13 4 4 1 6 4|5 4 4|5 9 4|7 4 4|7 13 13 13 13	INHIBITOR
10727528	CHEMICAL	GENE	T10	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of (125)I-ET-1 ETA receptor complexes both in the absence and the presence of unlabeled @GENETgt$ ET-1 @/GENETgt$ .	0|1|4 0|1|4 1|4 0|1|4 4 4 10 10 10 10 5 14 14 14 4 14 17 14 20 20 17 17 17 4	None-BC7
10727528	CHEMICAL	GENE	T2	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] It is concluded that @CHEMICALSrc$ salicylates @/CHEMICALSrc$ are allosteric inhibitors of @GENETgt$ ETA receptors @/GENETgt$ .	3 3 3 9 9|4 9 9|4 9 9 3 11 9|11 9|11 9|11 9|11 3	None-BC7
10727528	CHEMICAL	GENE	T3	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible @GENETgt$ ET-1 @/GENETgt$ binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and ETA receptor antagonists should be used to evaluate the physiopathological role of ET-1 and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 14 14 14 7 12 9|12 12 9|12 14 14 4 14 18 18 15 20 14 14 14 36 23 26 36 28 26 26 26 28 32 33 28 36 36 14 38 36 41 41 38 43 41 38 49 49 49 49 38 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T8	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ inhibit @GENETgt$ (125)I-ET-1 @/GENETgt$ binding to recombinant rat ETA receptors .	0|3 3 0|3 3 2|6 6 2|6 3 11 11 11 11 6 3	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T6	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Ca(2+) @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] They also prevent the intracellular @CHEMICALSrc$ Ca(2 + ) @/CHEMICALSrc$ mobilizing action of @GENETgt$ ET-1 @/GENETgt$ in cultured endothelial cells but not those of neuromedin B or UTP .	3 3 3 6 6 10|3|5|6 10|3|5|6 10|3|5|6 10|3|6 10|3|5|6 11 6 13 9|11 11 9|11 18 18 18 11 20 18 18 24 24 21 24 24 3	None-BC7
10727528	CHEMICAL	GENE	T10	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylic acid @/CHEMICALSrc$ promotes dissociation of (125)I-ET-1 @GENETgt$ ETA receptor @/GENETgt$ complexes both in the absence and the presence of unlabeled ET-1 .	0|1|4 0|1|4 1|4 0|1|4 4 4 11 11 11|5 11|5 11 11|5 5 15 15 15 4 15 18 15 21 21 18 4	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T14	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETB receptor @/GENETgt$ ? [SEP] Salicylates do not promote dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ @GENETgt$ ETB receptor @/GENETgt$ complexes .	4 4 4 4 4 12 12|6 12 12|6 12|7 12|7 12 12|7 5 4	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T13	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ETB receptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ do not promote dissociation of (125)I-ET-1 @GENETgt$ ETB receptor @/GENETgt$ complexes .	0|5 5 0|5 5 5 5 5 12 12 12|7 12|7 12 12|7 6 5	None-BC7
10727528	CHEMICAL	GENE	T18	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] Aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ inhibit endothelin @GENETgt$ ETA receptors @/GENETgt$ by an allosteric type of mechanism .	6 1 1|2|3 1|2|3 1|3 1|2|3 6 8 8|5|6 8|5|6 8|6 8|5|6 14 14 14 6 16 14 6	None-BC7
10727528	CHEMICAL	GENE	T13	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ do not promote dissociation of @GENETgt$ (125)I-ET-1 @/GENETgt$ ETB receptor complexes .	0|5 5 0|5 5 5 5 5 12 12|6 12 12|6 12 12 6 5	None-BC7
10727528	CHEMICAL	GENE	T17	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ Aspirin @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Aspirin @/CHEMICALSrc$ and sodium salicylate inhibit endothelin @GENETgt$ ETA receptors @/GENETgt$ by an allosteric type of mechanism .	0|6 6 0|6 1 5 1 6 8 8|6 8|6 8|6 8|6 14 14 14 6 16 14 6	None-BC7
10727528	CHEMICAL	GENE	T12	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETA receptors @/GENETgt$ ? [SEP] It has no influence on the rate of association of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ to @GENETgt$ ETA receptors @/GENETgt$ .	2 2 4 2 7 7 4 9 7 11 9|10 9 9|10 14 9|12|14 9|12|14 9|14 9|12|14 2	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T3	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] The results also suggest that : 1 ) irreversible ET-1 binding probably limits actions of receptor antagonists in vivo , and 2 ) an association of @CHEMICALSrc$ salicylates @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ antagonists should be used to evaluate the physiopathological role of ET-1 and may be of therapeutic interest in the treatment of ischemic heart disease .	2 4 4 4 13 13 13 7 11 11 13 13 4 13 17 17 14 19 13 13 13 36 22 25 36 27 25|26 25 25|26 27 33|28|30 33|28|30 33|30 33|28|30 27 36 36 13 38 36 41 41 38 43 41 38 49 49 49 49 38 52 52 49 56 56 56 52 4	None-BC7
10727528	CHEMICAL	GENE	T4	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and @GENETgt$ endothelin-1 @/GENETgt$ ? [SEP] This study shows that @CHEMICALSrc$ aspirin @/CHEMICALSrc$ and sodium salicylate , its major blood metabolite , reverse contractile actions of @GENETgt$ endothelin-1 @/GENETgt$ ( ET-1 ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16|4 16 16|4 5 9 5 5 14 14 14 5 5 3 18 16 20 18 18 18 23 20 23 28 28 28 18 28 32 32 28 3	None-BC7
10727528	CHEMICAL	GENE	T6	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Ca(2+) @/CHEMICALSrc$ and @GENETgt$ neuromedin B @/GENETgt$ ? [SEP] They also prevent the intracellular @CHEMICALSrc$ Ca(2 + ) @/CHEMICALSrc$ mobilizing action of ET-1 in cultured endothelial cells but not those of @GENETgt$ neuromedin B @/GENETgt$ or UTP .	3 3 3 6 6 10|3|5|6 10|3|5|6 10|3|5|6 10|3|6 10|3|5|6 11 6 13 11 17 17 17 11 19 17 17 22 18|20|22 18|20|22 20|22 18|20|22 22 22 3	None-BC7
10727528	CHEMICAL	GENE	T8	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ and @GENETgt$ rat ETA receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Salicylates @/CHEMICALSrc$ inhibit (125)I-ET-1 binding to recombinant @GENETgt$ rat ETA receptors @/GENETgt$ .	0|3 3 0|3 3 5 3 8 8 8|5|6 8|5|6 8|5|6 8|5 8|5|6 3	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T11	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ (125)I @/CHEMICALSrc$ and @GENETgt$ ETA receptor @/GENETgt$ ? [SEP] Salicylic acid promotes dissociation of @CHEMICALSrc$ (125)I-ET-1 @/CHEMICALSrc$ @GENETgt$ ETA receptor @/GENETgt$ complexes both in the absence and the presence of unlabeled ET-1 .	2 3 3 3 11 11|5 11 11|5 11|6 11|6 11 11|6 4 15 15 15 3 15 18 15 21 21 18 3	DIRECT-REGULATOR
10727528	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ and @GENETgt$ ET-1 @/GENETgt$ ? [SEP] This study shows that aspirin and @CHEMICALSrc$ sodium salicylate @/CHEMICALSrc$ , its major blood metabolite , reverse contractile actions of endothelin-1 ( @GENETgt$ ET-1 @/GENETgt$ ) in isolated rat aorta and human mammary arteries .	2 3 3 16 16 5 5|6|7 5|6|7 5|7 5|6|7 5 14 14 14 5 5 3 18 16 20 18 22 19|20 20 19|20 22 28 28 28 18 28 32 32 28 3	None-BC7
23150495	CHEMICAL	GENE	T1	T5	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Consistent with an adult-onset isolated GHD model , mutant animals are hypoglycemic and display increased @GENETgt$ insulin @/GENETgt$ sensitivity and @CHEMICALSrc$ glucose @/CHEMICALSrc$ clearance .	12 4 4 7 7 7 1 12 10 12 12 12 12 12 12 18|15 18 18|15 12 18 18|22 22 18|22 18 12	None-BC7
16213084	CHEMICAL	GENE	T5	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 22 18|22 22 18|22 22 20|14 14 20|14 22 30 25 30 30 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T7	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 30 24 22|30 30 22|30 30 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 30 24 30 30|23 30 30|23 30 22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T9	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 17|22 17|22 17|22 22 17|22 14 22 29 24 29 29 29 22 12 32 28|12 12 28|12 37 37 37 32 3	SUBSTRATE
16213084	CHEMICAL	GENE	T9	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 29 24 29 29 29 21 12 32 12|30 12 12|30 37 37 37 32 3	SUBSTRATE
16213084	CHEMICAL	GENE	T14	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 20|21|22 20|21|22 20|22 20|21|22 4 4 34 29 34 32 32 29 34 26 37 37 34|37 34|37 34|37 34|37 34|37 4	None-BC7
16213084	CHEMICAL	GENE	T9	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 14 21 25 23 24|25|21 24|25|21 24|25|21 24|25|21 25|21 24|25|21 12 32 27|12 12 27|12 37 37 37 32 3	SUBSTRATE
16213084	CHEMICAL	GENE	T12	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21 21|14 21 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 37 37 34|35|37 34|35|37 34|35|37 34|37 34|35|37 4	None-BC7
16213084	CHEMICAL	GENE	T8	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled @/GENETgt$ @CHEMICALSrc$ monocarboxylate transport system @/CHEMICALSrc$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 14 21 27 23 24|27 27 24|27 25|27|21 25|27|21 25|27|21 27|21 25|27|21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T8	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 30 24 30 25|30 30 25|30 30 21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T7	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 21 21 21 21 21 21 20|14 14 20|14 21 30 24 24|30 30 24|30 30 30 21 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T18	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40 40|35 40 40|35 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T15	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 23 20 4 4 34 26|29 29 26|29 34 32 32 29 34 25 37 37 34|35|37 34|35|37 34|35|37 34|37 34|35|37 4	SUBSTRATE
16213084	CHEMICAL	GENE	T12	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 22 22 14|22 22 14|22 22 22 17|22 22 17|22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T18	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40 40|34 40 40|34 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T2	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	3 3 17 6 6 3 11 11 8|11 11 8|11 6 14 14 3 17 17 17 17 26 21 26 24 24 21 26 18 28 26 26 26 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T1	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	4 1|4 4 1|4 17 7 7 4 11 11 11 7 14 14 4 17 17 17 17 26 21 26 24 24 21 26 18 28 26 26 26 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T14	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 21|23 21|23 21|23 21|23 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	INHIBITOR
16213084	CHEMICAL	GENE	T14	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , @CHEMICALSrc$ alpha-cyano-4-hydroxycinnamic acid @/CHEMICALSrc$ , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 20|21|23 20|21|23 21|23 20|21|23 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	INHIBITOR
16213084	CHEMICAL	GENE	T11	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 22 22 22 22 22 16|22 22 16|22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T15	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 35 26|30 30 26|30 35 33 33 30 35 26 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T11	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 22 22 13|22 13|22 22 13|22 22 22 22 7 22 25 22 4 4 35 30 35 33 33 30 35 27 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T1	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because @CHEMICALSrc$ l-lactate @/CHEMICALSrc$ reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	4 1|4 4 1|4 17 7 7 4 11 11 11 7 14 14 4 17 17 17 17 26 21 26 24 24 21 26 18 28 26 28 28 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T11	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , @CHEMICALSrc$ carbonylcyanide p-trifluoromethoxyphenylhydrazone @/CHEMICALSrc$ , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by H(+)-coupled @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 8|9|7 8|9|7 9|7 8|9|7 7 7 21 21 21 21 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 37 37 34|37 34|37 34|37 34|37 34|37 4	None-BC7
16213084	CHEMICAL	GENE	T3	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	3 3 16 6 6 3 10 10 10 6 13 13 3 16 16 16 16 26 18|21 21 18|21 26 24 24 21 26 17 28 26 28 28 28 28 16	SUBSTRATE
16213084	CHEMICAL	GENE	T2	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT2 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake even at 10mM , it is unlikely that nicotinate uptake in rat astrocytes is mediated by MCT1 and/or @GENETgt$ MCT2 @/GENETgt$ .	3 3 17 6 6 3 11 11 8|11 11 8|11 6 14 14 3 17 17 17 17 26 21 26 24 24 21 26 18 28 26 28 28 28 28 17	None-BC7
16213084	CHEMICAL	GENE	T4	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 23 23 23 17|23 17|23 17|23 23 17|23 15 23 30 25 30 30 30 23 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T15	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake by rat astrocytes is mediated by H(+)-coupled monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 35 25|30 30 25|30 35 33 33 30 35 26 40 40 40 40 35 4	None-BC7
16213084	CHEMICAL	GENE	T4	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT4 @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a low-affinity monocarboxylate transporter @GENETgt$ MCT4 @/GENETgt$ or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 22 22 22 22 22 22 20|15 15 20|15 22 30 25 30 30 30 22 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T5	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ low-affinity monocarboxylate transporter @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a @GENETgt$ low-affinity @/GENETgt$ @CHEMICALSrc$ monocarboxylate transporter @/CHEMICALSrc$ MCT4 or other unknown H(+)-coupled monocarboxylate transport system , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 23 23 23 17|23 23 17|23 18|23 18|23 23 18|23 14 23 30 25 30 30 30 23 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T16	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transport system @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ @GENETgt$ monocarboxylate transport system @/GENETgt$ .	2 4 4 4 7 7 4 7 10 7 7 7 20 20 20 20 20 20 20 7 20 23 20 4 4 33 28 33 31 31 28 33 25 37 34|37 37 34|37 33|35|37 33|35|37 33|35|37 33|37 33|35|37 4	None-BC7
16213084	CHEMICAL	GENE	T4	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ and saturable transport system , presumed to be a low-affinity monocarboxylate transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 13 13 13|7 13 13|7 8 8 13 5 13 13 22 22 22 22 22 22 15 22 26 24 24|26|22 24|26|22 24|26|22 24|26|22 26|22 24|26|22 13 33 13 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T5	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ and @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ ? [SEP] These results provide biochemical evidence of a H(+)-coupled and saturable transport system , presumed to be a low-affinity @CHEMICALSrc$ monocarboxylate @/CHEMICALSrc$ transporter MCT4 or other unknown @GENETgt$ H(+)-coupled monocarboxylate transport system @/GENETgt$ , for nicotinate in rat cerebrocortical astrocytes .	2 3 3 5 3 12 12 12 8 8 12 5 12 12 22 22 22 22 18|22 22 18|22 22 14 22 26 24 24|26|22 24|26|22 24|26|22 24|26|22 26|22 24|26|22 12 33 12 37 37 37 33 3	None-BC7
16213084	CHEMICAL	GENE	T3	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ and @GENETgt$ MCT1 @/GENETgt$ ? [SEP] Because l-lactate reduced to 67 % of the nicotinate uptake even at 10mM , it is unlikely that @CHEMICALSrc$ nicotinate @/CHEMICALSrc$ uptake in rat astrocytes is mediated by @GENETgt$ MCT1 @/GENETgt$ and/or MCT2 .	3 3 16 6 6 3 10 10 10 6 13 13 3 16 16 16 16 26 18|21 21 18|21 26 24 24 21 26 17 28 26 26 26 28 28 16	SUBSTRATE
16213084	CHEMICAL	GENE	T16	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ MCT @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical monocarboxylate transporter ( @GENETgt$ MCT @/GENETgt$ ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21 21 21 17|21 21 17|21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40|34 40 40|34 40 40 34 4	None-BC7
16213084	CHEMICAL	GENE	T16	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ H(+) @/CHEMICALSrc$ and @GENETgt$ monocarboxylate transporter @/GENETgt$ ? [SEP] This process was reduced by a protonophore , carbonylcyanide p-trifluoromethoxyphenylhydrazone , and a typical @GENETgt$ monocarboxylate transporter @/GENETgt$ ( MCT ) inhibitor , alpha-cyano-4-hydroxycinnamic acid , suggesting that nicotinate uptake by rat astrocytes is mediated by @CHEMICALSrc$ H(+)-coupled @/CHEMICALSrc$ monocarboxylate transport system .	2 4 4 4 7 7 4 7 10 7 7 7 21 21 21|14 21|14 21 21|14 21 21 21 7 21 24 21 4 4 34 29 34 32 32 29 34 26 40 40|33 40 40|33 40 40 34 4	None-BC7
23587425	CHEMICAL	GENE	T3	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ CHK1 @/GENETgt$ ? [SEP] Potency switch between @GENETgt$ CHK1 @/GENETgt$ and MK2 : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based kinase inhibitors .	2 2 4 2|3 2 2|3 4 4 2 2 11 9 9 9 11 16 16 11 2	INHIBITOR
23587425	CHEMICAL	GENE	T4	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ MK2 @/GENETgt$ ? [SEP] Potency switch between CHK1 and @GENETgt$ MK2 @/GENETgt$ : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ kinase inhibitors .	2 2 4 2 4 4|5 4 4|5 2 2 11 9 11 16|11 16 16|11 16 11 2	INHIBITOR
23587425	CHEMICAL	GENE	T4	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ kinase @/GENETgt$ ? [SEP] Potency switch between CHK1 and MK2 : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ @GENETgt$ kinase @/GENETgt$ inhibitors .	2 2 4 2 4 4 2 2 10 8 10 16|11 16 16|11 16|12 16 16|12 10 2	INHIBITOR
23587425	CHEMICAL	GENE	T3	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ MK2 @/GENETgt$ ? [SEP] Potency switch between CHK1 and @GENETgt$ MK2 @/GENETgt$ : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based kinase inhibitors .	2 2 4 2 4 4|5 4 4|5 2 2 11 9 9 9 11 16 16 11 2	INHIBITOR
23587425	CHEMICAL	GENE	T4	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-c]pyrimidine @/CHEMICALSrc$ and @GENETgt$ CHK1 @/GENETgt$ ? [SEP] Potency switch between @GENETgt$ CHK1 @/GENETgt$ and MK2 : Discovery of imidazo[1,2-a]pyrazine- and @CHEMICALSrc$ imidazo[1,2-c]pyrimidine-based @/CHEMICALSrc$ kinase inhibitors .	2 2 4 2|3 2 2|3 4 4 2 2 11 9 11 16|11 16 16|11 16 11 2	INHIBITOR
23587425	CHEMICAL	GENE	T3	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ imidazo[1,2-a]pyrazine @/CHEMICALSrc$ and @GENETgt$ kinase @/GENETgt$ ? [SEP] Potency switch between CHK1 and MK2 : Discovery of @CHEMICALSrc$ imidazo[1,2-a]pyrazine- @/CHEMICALSrc$ and imidazo[1,2-c]pyrimidine-based @GENETgt$ kinase @/GENETgt$ inhibitors .	2 2 4 2 4 4 2 2 10 8|9 8 8|9 10 16 16|12 16 16|12 10 2	INHIBITOR
11792932	CHEMICAL	GENE	T41	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ Testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : @CHEMICALSrc$ Testosterone-to-estradiol @/CHEMICALSrc$ ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , testolactone , and resulting changes in semen parameters .	1 10 2|6 6 2|6 6 10 9 9 6 1 12 10 17 17 17|13 17 17|13 12 17 17 17 10 10 22 26 26 23 10	None-BC7
11792932	CHEMICAL	GENE	T28	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of anastrozole , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratios .	2 2 4 2 6 4 6 13 10 13 10|13 13 10|13 6 6 17 17 4 17 17 17 23 23 20 29 29 29 25|29 29 25|29 4 2	None-BC7
11792932	CHEMICAL	GENE	T16	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : @CHEMICALSrc$ Testosterone-to-estradiol @/CHEMICALSrc$ ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , testolactone , and resulting changes in semen parameters .	1 10 2|6 6 2|6 6 10 9 9 6 1 12 10 17 17 17|13 17 17|13 12 17 17 17 10 10 22 26 26 23 10	None-BC7
11792932	CHEMICAL	GENE	T29	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of anastrozole , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratios .	2 2 4 2 6 4 6 13 10 13 10|13 13 10|13 6 6 17 17 4 17 17 17 23 23 20 29 29 29 25|29 29 25|29 4 2	None-BC7
11792932	CHEMICAL	GENE	T1	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ testolactone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] PURPOSE : Testosterone-to-estradiol ratio levels in infertile men improve during treatment with the @GENETgt$ aromatase @/GENETgt$ inhibitor , @CHEMICALSrc$ testolactone @/CHEMICALSrc$ , and resulting changes in semen parameters .	1 9 5 5 9 8 8 5 1 11 9 16 16 16|13 16 16|13 11 16 16 16 16 16 9 9 22 26 26 23 9	INHIBITOR
11792932	CHEMICAL	GENE	T7	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ anastrozole @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] We evaluated the effect of @CHEMICALSrc$ anastrozole @/CHEMICALSrc$ , a more selective @GENETgt$ aromatase @/GENETgt$ inhibitor , on the hormonal and semen profiles of infertile men with abnormal baseline testosterone-to-estradiol ratios .	2 2 4 2 6 4|5 4 4|5 6 14 11 14 10|14 14 10|14 6 6 18 18 4 18 18 18 24 24 21 29 29 29 29 4 2	INHIBITOR
11792932	CHEMICAL	GENE	T17	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] CONCLUSIONS : Men who are infertile with a low serum @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratio can be treated with an @GENETgt$ aromatase @/GENETgt$ inhibitor .	1 1 16 6 6 3 13 13 13 13 10|13 13 10|13 6 16 16 1 21 21 17|21 21 17|21 16 1	None-BC7
11792932	CHEMICAL	GENE	T18	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ aromatase @/GENETgt$ ? [SEP] CONCLUSIONS : Men who are infertile with a low serum @CHEMICALSrc$ testosterone-to-estradiol @/CHEMICALSrc$ ratio can be treated with an @GENETgt$ aromatase @/GENETgt$ inhibitor .	1 1 16 6 6 3 13 13 13 13 10|13 13 10|13 6 16 16 1 21 21 17|21 21 17|21 16 1	None-BC7
11972613	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of CysLT antagonists ( pranlukast and @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 9 9 6 11 9 11 11|12 11 11|12 11 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T12	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ cysteinyl leukotriene @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @CHEMICALSrc$ cysteinyl leukotriene @/CHEMICALSrc$ ( CysLT ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 8|9|21 8|9|21 9|21 8|9|21 15 15 15 21 19 19|14 19 19|14 15 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T1	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] The influence of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists on @GENETgt$ IL-5 @/GENETgt$ activity was assessed .	2 12 6 3|6 6 3|6 2 10 10|6 10 10|6 2 12 12 12	None-BC7
11972613	CHEMICAL	GENE	T15	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ cysteinyl leukotriene (CysLT) receptor @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @GENETgt$ cysteinyl leukotriene ( @/GENETgt$ @CHEMICALSrc$ CysLT ) receptor @/CHEMICALSrc$ ( CysLT1 receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 8|9|21|13 8|9|21|13 8|9|21|13 9|21|13 8|9|21|13 9|21|13 9|21|13 9|21|13 21|13 9|21|13 19 19 13 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T7	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Thus , it is likely that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ indirectly cause antigen-induced eosinophilia through @GENETgt$ IL-5 @/GENETgt$ production .	5 5 5 5 5 10 10|6 10 10|6 10 5 12 10 16 16|12 16 16|12 10 5	None-BC7
11972613	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled ovalbumin ( @GENETgt$ OVA @/GENETgt$ ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and OVA mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 15 7 5|6 5 5|6 7 5 9|5 5 9|5 11 11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T15	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by cysteinyl leukotriene ( @CHEMICALSrc$ CysLT @/CHEMICALSrc$ ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that CysLTs are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 21 10 21 15 11|15 15 11|15 15 21 19 19|15 19 19|15 15 19 7 24 24 21 26 24 26 26 7 7 37 37 37 35 37 35 30 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T5	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Increased @GENETgt$ IL-5 @/GENETgt$ activity in the serum was inhibited by both pranlukast and @CHEMICALSrc$ MCI-826 @/CHEMICALSrc$ by over 90 % .	4 1|4 4 1|4 9 7 7 4 9 9 12 12 9 12 12 12 12 19 18 19 9 9	INHIBITOR
11972613	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists ( pranlukast and MCI-826 ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 10 10|7 10 10|7 6 12 10 12 12 12 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLT @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] At the fifth challenge , the effects of @CHEMICALSrc$ CysLT @/CHEMICALSrc$ antagonists and an @GENETgt$ anti-IL-5 @/GENETgt$ antibody ( TRFK-5 ) on the occurrence of LAR , and blood and lung eosinophilia , which appeared at 5 h after challenge , were examined .	4 4 4 41 41 7 41 11 8|11 11 8|11 7 11 16 16|12 16 16|12 11 18 16 18 22 22 7 24 22 24 24 24 27 27 22 7 33 7 36 36 33 38 36 7 41 41 41	None-BC7
11972613	CHEMICAL	GENE	T8	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by cysteinyl leukotriene ( CysLT ) receptor ( @GENETgt$ CysLT1 @/GENETgt$ receptor ) antagonists in several species including humans and guinea-pigs , suggesting that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 20 10 20 14 14 14 20 18 18|15 18 18|15 14 18 7 23 23 20 25 23 25 25 7 7 37 37|29 37 37|29 37 35 37 35 29 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T13	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ ovalbumin @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled @GENETgt$ ovalbumin @/GENETgt$ ( OVA ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and OVA mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 4|15 15 4|15 8 5 8 5 9|5 5 9|5 11 11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T6	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] CONCLUSIONS : @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ produced after antigen provocation sequentially induced @GENETgt$ IL-5 @/GENETgt$ production from some immune component cells via CysLT1 receptor activation .	1 1 2|10 10 2|10 3 8 8 5 10 1 9|13 13 9|13 10 18 18 18 18 13 22 22 22 10 1	None-BC7
11972613	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] Increased @GENETgt$ IL-5 @/GENETgt$ activity in the serum was inhibited by both @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and MCI-826 by over 90 % .	4 1|4 4 1|4 9 7 7 4 9 9 12 12 9|10 9 9|10 12 12 19 18 19 9 9	INHIBITOR
11972613	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ ? [SEP] METHODS : Guinea-pigs inhaled ovalbumin ( OVA ) + @CHEMICALSrc$ Al(OH)3 @/CHEMICALSrc$ and @GENETgt$ OVA @/GENETgt$ mists alternately for sensitization and challenge , respectively , once every 2 weeks .	4 4 4 4 15 7 5 7 5 9|5 5 9|5 10 10|11 10 10|11 4 4 18 4 18 18 4 4 4 4 27 27 4 4	None-BC7
11972613	CHEMICAL	GENE	T8	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ cysteinyl leukotriene (CysLT) receptor @/GENETgt$ ? [SEP] BACKGROUND : Allergic airway eosinophilia is suppressed by @GENETgt$ cysteinyl leukotriene ( CysLT ) receptor @/GENETgt$ ( CysLT1 receptor ) antagonists in several species including humans and guinea-pigs , suggesting that @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ are directly or indirectly involved in induction of the response .	1 1 5 5 7 7 1 20 8|9|20 8|9|20 8|9|20 8|9|20 8|9|20 8|9|20 9|20 8|9|20 18 18 9 18 7 23 23 20 25 23 25 25 7 7 37 24|37 37 24|37 37 35 37 35 29 39 37 42 42 39 7	None-BC7
11972613	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and @GENETgt$ IL-5 @/GENETgt$ ? [SEP] OBJECTIVE : We examined the effect of CysLT antagonists ( @CHEMICALSrc$ pranlukast @/CHEMICALSrc$ and MCI-826 ) on antigen inhalation-induced eosinophilia in peripheral blood and lung , and on @GENETgt$ IL-5 @/GENETgt$ activity in serum during late increase of airway resistance ( late asthmatic response , LAR ) in sensitized guinea-pigs .	1 4 4 1 6 4 9 9 6 11 9|10 9 9|10 11 11 11 19 19 19 6 22 22 19 22 22 4 4 30 26|30 30 26|30 1 32 30 35 35 30 38 38 35 42 42 42 38 42 42 44 48 48 42 1	None-BC7
11972613	CHEMICAL	GENE	T6	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ and @GENETgt$ CysLT1 @/GENETgt$ ? [SEP] CONCLUSIONS : @CHEMICALSrc$ CysLTs @/CHEMICALSrc$ produced after antigen provocation sequentially induced IL-5 production from some immune component cells via @GENETgt$ CysLT1 @/GENETgt$ receptor activation .	1 1 2|10 10 2|10 3 8 8 5 10 1 12 10 17 17 17 17 12 22 17|22 22 17|22 22 10 1	ACTIVATOR
11972613	CHEMICAL	GENE	T16	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Cysteinyl leukotriene @/CHEMICALSrc$ and @GENETgt$ interleukin-5 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Cysteinyl leukotriene-dependent @/CHEMICALSrc$ @GENETgt$ interleukin-5 @/GENETgt$ production leading to eosinophilia during late asthmatic response in guinea-pigs .	0|1 0|1 1 0|1 1|6 6 1|6 1 6 9 7 13 13 13 7 15 13 1	None-BC7
12123767	CHEMICAL	GENE	T3	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] In addition to this pronounced loss of function , @GENETgt$ M1766L @/GENETgt$ also showed a 10-fold increase in the persistent late @CHEMICALSrc$ sodium @/CHEMICALSrc$ current .	2 13 6 6 6 2 8 6 13 9|13 13 9|13 13 13 16 16 13 23 23 23 23 19|23 23 19|23 16 13	None-BC7
12123767	CHEMICAL	GENE	T4	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] CONCLUSIONS : These findings suggest that @GENETgt$ M1766L-SCN5A @/GENETgt$ channel dysfunction may contribute to the basis of lethal arrhythmias , displays an overlapping electrophysiological phenotype , and represents the first @CHEMICALSrc$ sodium @/CHEMICALSrc$ channelopathy rescued by drug .	1 1 4 5 1 12 10|6 10 10|6 10 12 12 5 15 15 12 18 18 15 12 12 24 24 24 20 12 12 12 32 32 32|28 32 32|28 27 32 35 33 1	None-BC7
12123767	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] A novel @GENETgt$ SCN5A @/GENETgt$ arrhythmia mutation , M1766L , with expression defect rescued by @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ .	6 6 2|6 6 2|6 6 6 6 6 6 12 12 6 12 15 13 13 13 6	None-BC7
12123767	CHEMICAL	GENE	T1	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] RESULTS : The @GENETgt$ M1766L @/GENETgt$ mutation caused a significant decrease in the @CHEMICALSrc$ sodium @/CHEMICALSrc$ channel expression .	1 1 6 3|6 6 3|6 7 1 10 10 7 16 16 11|15 15 11|15 16 10 1	None-BC7
12123767	CHEMICAL	GENE	T9	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ and @GENETgt$ M1766L @/GENETgt$ ? [SEP] A novel SCN5A arrhythmia mutation , @GENETgt$ M1766L @/GENETgt$ , with expression defect rescued by @CHEMICALSrc$ mexiletine @/CHEMICALSrc$ .	5 5 5 5 5 5 5|6 5 5|6 5 12 12 5 12 15 13 13 13 5	None-BC7
12123767	CHEMICAL	GENE	T4	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] CONCLUSIONS : These findings suggest that @GENETgt$ M1766L-SCN5A @/GENETgt$ channel dysfunction may contribute to the basis of lethal arrhythmias , displays an overlapping electrophysiological phenotype , and represents the first @CHEMICALSrc$ sodium @/CHEMICALSrc$ channelopathy rescued by drug .	1 1 4 5 1 12 10|6 10 10|6 10 12 12 5 15 15 12 18 18 15 12 12 24 24 24 20 12 12 12 32 32 32|28 32 32|28 27 32 35 33 1	None-BC7
12123767	CHEMICAL	GENE	T5	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ SCN5A @/GENETgt$ ? [SEP] OBJECTIVE : Mutations in the cardiac @CHEMICALSrc$ sodium @/CHEMICALSrc$ channel gene , @GENETgt$ SCN5A @/GENETgt$ , cause congenital long QT syndrome ( LQT3 ) , Brugada syndrome , idiopathic ventricular fibrillation , and conduction disease by distinct cellular and clinical electrophysiological phenotypes .	1 1 15 10 10 10 10|6 10 10|6 10 3 10 10 10 10 3 1 19 19 19 15 21 19 21 19 25 19 19 29 29 19 19 19 33 19 36 36 15 36 36 36 36 1	None-BC7
12719755	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ Angiotensin II @/CHEMICALSrc$ and @GENETgt$ angiotensin AT1 receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Angiotensin II @/CHEMICALSrc$ acting on @GENETgt$ angiotensin AT1 receptors @/GENETgt$ at the central nervous system appears to have an important role in these modulatory processes .	0|1|15 0|1|15 1|15 0|1|15 1 6 3|4|6 3|4|6 3|4|6 4|6 3|4|6 14 14 14 14 4 15 17 15 20 20 17 24 24 24 17 15	None-BC7
12719755	CHEMICAL	GENE	T4	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ pancuronium bromide @/CHEMICALSrc$ and @GENETgt$ AT1 receptor @/GENETgt$ ? [SEP] We investigated the effect of @GENETgt$ AT1 receptor @/GENETgt$ blockade in the NTS on the response to stimulation of HDA in anaesthetised rats treated with the neuromuscular blocking agent @CHEMICALSrc$ pancuronium bromide @/CHEMICALSrc$ .	2 2 4 2 9 9|5 9|5 9 9|5 4 12 12 9 15 15 4 17 15 19 17 22 22 17 22 29 29 27 29 29 26|29|23 26|29|23 29|23 26|29|23 2	INHIBITOR
12719755	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ angiotensin @/CHEMICALSrc$ and @GENETgt$ Angiotensin II @/GENETgt$ ? [SEP] @GENETgt$ Angiotensin II @/GENETgt$ acting on @CHEMICALSrc$ angiotensin @/CHEMICALSrc$ AT1 receptors at the central nervous system appears to have an important role in these modulatory processes .	0|1|15 0|1|15 1|15 0|1|15 1 9 9|3 9 9|3 9 4 14 14 14 14 4 15 17 15 20 20 17 24 24 24 17 15	None-BC7
12719755	CHEMICAL	GENE	T6	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ losartan @/CHEMICALSrc$ and @GENETgt$ Angiotensin AT1 receptor @/GENETgt$ ? [SEP] @GENETgt$ Angiotensin AT1 receptor @/GENETgt$ antagonist @CHEMICALSrc$ losartan @/CHEMICALSrc$ and the defence reaction in the anaesthetised rat .	0|6 0|6 0|6 6 0|6 6 2|6 6 2|6 6 11 11 6 15 15 15 11 6	ANTAGONIST
15723099	CHEMICAL	GENE	T30	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 41|46 46 41|46 46 41 11	None-BC7
15723099	CHEMICAL	GENE	T3	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10 18 10 10 38 25 25 38 27 25 27 26|27 27 26|27 38 38 36 33 36 38 36 21 42 41 42 38 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T1	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10|18|15 10|18|15 10|18 10|18|15 10 10 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 10	ANTAGONIST
15723099	CHEMICAL	GENE	T9	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptors @/GENETgt$ ? [SEP] Dextromethorphan and @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ are high-affinity ligands at @GENETgt$ sigma1 receptors @/GENETgt$ .	7 1 1|2 1 1|2 7 7 7 9 9|7 9|7 9|7 9|7 7	DIRECT-REGULATOR
15723099	CHEMICAL	GENE	T3	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24 26 26|27 26 26|27 37 37 35 32 35 37 35 20 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T2	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24|25 24 24|25 26 26 37 37 35 32 35 37 35 20 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T25	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ activator protein (AP)-1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in c-fos/c-jun expression , @GENETgt$ activator protein (AP)-1 @/GENETgt$ DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 11 11 8 11 18|11 18|11 18|11 18 18|11 18 11 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	INHIBITOR
15723099	CHEMICAL	GENE	T31	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T25	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ c-fos @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	INDIRECT-DOWNREGULATOR
15723099	CHEMICAL	GENE	T2	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24|25 24 24|25 26 26 37 37 35 32 35 37 35 20 41 40 41 37 46 41|46 46 41|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T26	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ activator protein (AP)-1 @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in c-fos/c-jun expression , @GENETgt$ activator protein (AP)-1 @/GENETgt$ DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 11 11 8 11 18|11 18|11 18|11 18 18|11 18 11 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	ACTIVATOR
15723099	CHEMICAL	GENE	T31	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 41|46 46 41|46 46 41 11	None-BC7
15723099	CHEMICAL	GENE	T34	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ analog dimemorfan attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of dextromethorphan .	5 1|5 5 1|5 5 6 6 8 6 13 8|13 8|13 13 8|13 6 6 6 18 18 15 20 18 6	ACTIVATOR
15723099	CHEMICAL	GENE	T2	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 18 18 18 18|13 18|13 18 18|13 18 10 18 10 10 38 25 25 38 27 24|25 25 24|25 27 27 38 38 36 33 36 38 36 21 42 41 42 38 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T31	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 11 5 3 5 5|6 5 5|6 11 11 11 19 19 19 19|13 19|13 19 19|13 19 11 19 11 11 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T25	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ and @GENETgt$ c-jun @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dimemorfan @/CHEMICALSrc$ pre-treatment also attenuated the KA-induced increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	0|3 3 0|3 5 5 5 8 8 5 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 5	INDIRECT-DOWNREGULATOR
15723099	CHEMICAL	GENE	T30	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective @GENETgt$ sigma1 receptor @/GENETgt$ antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of AP-1 transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 19 19 19 19|13 19|13 19 19|13 19 11 19 11 11 38 26 26 38 28 26 28 28 38 38 36 33 36 38 36 22 42 41 42 38 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T32	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The dextromethorphan analog dimemorfan attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ .	4 4 4 5 5 7 5 12 8|12 8|12 12 8|12 5 5 5 17 17 14 19 16|17 17 16|17 5	None-BC7
15723099	CHEMICAL	GENE	T33	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The dextromethorphan analog @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ attenuates kainate-induced seizures via @GENETgt$ sigma1 receptor @/GENETgt$ activation : comparison with the effects of dextromethorphan .	4 4 4 3|6 6 3|6 6 8 6 13 8|13 8|13 13 8|13 6 6 6 18 18 15 20 18 6	ACTIVATOR
15723099	CHEMICAL	GENE	T1	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 16|17|10 16|17|10 17|10 16|17|10 10 10 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|36|39 42|36|39 42|39 42|36|39 37 46 46 46 42 10	None-BC7
15723099	CHEMICAL	GENE	T1	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist @CHEMICALSrc$ BD 1047 @/CHEMICALSrc$ , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 16|17|10 16|17|10 17|10 16|17|10 10 10 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 41 40 41 37 46 40|46 46 40|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T30	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptor @/GENETgt$ ? [SEP] The anticonvulsant action of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or dimemorfan is , at least in part , related to @GENETgt$ sigma1 receptor-activated @/GENETgt$ modulation of AP-1 transcription factors .	3 3 11 5 3|4 3 3|4 5 5 11 11 11 18 18 18 18 18 18 11 18 11 11 37 25 25 37 27 25 27 27 37 37 35 32 35 37 35 21 42 42|37|39 42|37|39 42|39 42|37|39 37 46 46 46 42 11	None-BC7
15723099	CHEMICAL	GENE	T3	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ and @GENETgt$ AP-1 @/GENETgt$ ? [SEP] The anticonvulsant action of dextromethorphan or dimemorfan was significantly counteracted by a selective sigma1 receptor antagonist BD 1047 , suggesting that the anticonvulsant action of dextromethorphan or @CHEMICALSrc$ dimemorfan @/CHEMICALSrc$ is , at least in part , related to sigma1 receptor-activated modulation of @GENETgt$ AP-1 @/GENETgt$ transcription factors .	3 3 10 5 3 5 5 10 10 10 17 17 17 17 17 17 10 17 10 10 37 24 24 37 26 24 26 26|27 26 26|27 37 37 35 32 35 37 35 20 41 40 41 37 46 41|46 46 41|46 46 41 10	None-BC7
15723099	CHEMICAL	GENE	T4	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ Dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma1 receptors @/GENETgt$ ? [SEP] @CHEMICALSrc$ Dextromethorphan @/CHEMICALSrc$ and dimemorfan are high-affinity ligands at @GENETgt$ sigma1 receptors @/GENETgt$ .	0|7 7 0|7 1 1 7 7 7 9 9|7 9|7 9|7 9|7 7	DIRECT-REGULATOR
15723099	CHEMICAL	GENE	T26	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ c-jun @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	INDIRECT-UPREGULATOR
15723099	CHEMICAL	GENE	T26	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ KA @/CHEMICALSrc$ and @GENETgt$ c-fos @/GENETgt$ ? [SEP] Dimemorfan pre-treatment also attenuated the @CHEMICALSrc$ KA-induced @/CHEMICALSrc$ increases in @GENETgt$ c-fos/c-jun @/GENETgt$ expression , activator protein (AP)-1 DNA-binding activity , and loss of cells in the CA1 and CA3 fields of the hippocampus .	2 4 4 4 8 8|5 8 8|5 4 12 8|12 12 8|12 8 12 18 18 18 18 12 8 8 8 23 21 29 29 25 26 26 21 32 32 29 4	INDIRECT-UPREGULATOR
23572389	CHEMICAL	GENE	T1	T4	True	0	What is [Drugprot] between @CHEMICALSrc$ calcium @/CHEMICALSrc$ and @GENETgt$ E-cadherin @/GENETgt$ ? [SEP] @GENETgt$ E-cadherin @/GENETgt$ is a transmembrane glycoprotein that mediates @CHEMICALSrc$ calcium-dependent @/CHEMICALSrc$ interactions between adjacent epithelial cells .	0|6 6 0|6 6 6 6 6 8 6 11|7 11 11|7 8 15 15 15 11 6	None-BC7
23314054	CHEMICAL	GENE	T4	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] Fragment-based design , synthesis , and biological evaluation of @CHEMICALSrc$ N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide @/CHEMICALSrc$ derivatives as novel @GENETgt$ Mcl-1 @/GENETgt$ inhibitors .	2 2 2 2 4 4 8 4 12 9|12 12 9|12 4 17 17 17|13 17 17|13 2 2	INHIBITOR
23314054	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] A novel potent compound , @CHEMICALSrc$ N-benzyl-5-(4-isopropylthiophenol)-2-hydroxyl nicotinamide @/CHEMICALSrc$ ( 12c ) , which binds @GENETgt$ Mcl-1 @/GENETgt$ with an IC(50 ) value of 54 nM was obtained .	4 4 4 26 4 4|5|6 4|5|6 4|6 4|5|6 10 6 10 4 14 4 12|14 14 12|14 21 21 21 21 14 24 24 21 26 26 26	DIRECT-REGULATOR
23314054	CHEMICAL	GENE	T3	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ 3-thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile @/CHEMICALSrc$ and @GENETgt$ Mcl-1 @/GENETgt$ ? [SEP] We have previously reported a nanomolar inhibitor of antiapoptotic @GENETgt$ Mcl-1 @/GENETgt$ protein , @CHEMICALSrc$ 3-thiomorpholin-8-oxo-8H-acenaphtho [ 1,2-b ] pyrrole-9-carbonitrile @/CHEMICALSrc$ ( S1 ) .	4 4 4 4 7 7 4 12 12 9|12 12 9|12 7 12 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 12|21|14 21 12 21 4	INHIBITOR
1666997	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT1A @/GENETgt$ ? [SEP] By contrast , neither @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ nor amitriptyline can be considered as possible ligands of @GENETgt$ 5-HT1A @/GENETgt$ and 5-HT1B receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11|4 11 11|4 5 5 11 11 11 14 14 11 16 14 14 14 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T3	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ ? [SEP] Finally we explored whether acute and/or chronic administration of @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ or amitriptyline affected the levels of opioid peptides and the @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS )	3 3 3 14 14 5 5 5 10 8|9 8 8|9 10 10 3 16 14 19 19 16 19 22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|21|22 19|20|21|22 32 32 22 35 35 32 35 39 39 35 16 43 43 40 3	None-BC7
1666997	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT1B @/GENETgt$ ? [SEP] By contrast , neither @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ nor amitriptyline can be considered as possible ligands of 5-HT1A and @GENETgt$ 5-HT1B @/GENETgt$ receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11|4 11 11|4 5 5 11 11 11 14 14 11 16 14 16 16 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Interestingly , @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ binds with a good affinity ( IC50 = 0.30 microM ) to @GENETgt$ 5-HT3 @/GENETgt$ receptors labelled by [3H]zacopride in cortical membranes .	5 5 2|5 5 2|5 5 9 9 9 5 11 9 11 14 12 11 19 19|15 19 19|15 5 19 22 20 25 25 20 5	DIRECT-REGULATOR
1666997	CHEMICAL	GENE	T15	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the @GENETgt$ 5-HT3-dependent @/GENETgt$ Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on 5-HT3 receptors .	2 9 2 8 8|4 8 8|4 8 3 9 13 13 13 9 15 13 19 19 19 13 21 19 21 24 22 24 21 21 13 34 34|28 34 34|28 34 34 13 37 37 34 9	None-BC7
1666997	CHEMICAL	GENE	T4	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ ? [SEP] Finally we explored whether acute and/or chronic administration of amoxapine or @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ affected the levels of opioid peptides and the @GENETgt$ mu and delta classes of opioid receptors @/GENETgt$ in various regions of the brain and the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS )	3 3 3 14 14 5 5 5 10 8 10 10|11 10 10|11 3 16 14 19 19 16 19 22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|20|21|22 19|21|22 19|20|21|22 32 32 22 35 35 32 35 39 39 35 16 43 43 40 3	None-BC7
1666997	CHEMICAL	GENE	T5	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and amitriptyline interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by [3H]ketanserin in cortical membranes .	4 1 4 5 5 12 8 12|7 12 12|7 8 8 5 16 16 16 12 20 16|20 20 16|20 16 20 23 21 26 26 21 5	DIRECT-REGULATOR
1666997	CHEMICAL	GENE	T6	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both amoxapine and @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by [3H]ketanserin in cortical membranes .	4 1 4 5 5 12 8 12 8 8|9 8 8|9 5 16 16 16 12 20 16|20 20 16|20 16 20 23 21 26 26 21 5	DIRECT-REGULATOR
1666997	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]zacopride @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Interestingly , amoxapine binds with a good affinity ( IC50 = 0.30 microM ) to @GENETgt$ 5-HT3 @/GENETgt$ receptors labelled by @CHEMICALSrc$ [3H]zacopride @/CHEMICALSrc$ in cortical membranes .	4 4 4 4 8 8 8 4 10 8 10 13 11 10 18 18|15 18 18|15 4 18 21 19 19 19 25 25 19 4	DIRECT-REGULATOR
1666997	CHEMICAL	GENE	T14	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the @GENETgt$ 5-HT3-dependent @/GENETgt$ Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on 5-HT3 receptors .	2 9 2 8 8|4 8 8|4 8 3 9 14 9|14 14 9|14 14 9 16 14 20 20 20 14 22 20 22 25 23 25 22 22 14 34 34 34 34 14 37 37 34 9	None-BC7
1666997	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a @GENETgt$ 5-HT3 @/GENETgt$ antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on 5-HT3 receptors .	2 8 2 7 7 7 3 8 13 9|13 13 9|13 13 8 15 13 20 20 16|20 20 16|20 13 22 20 22 25 23 25 22 22 13 34 34 34 34 13 37 37 34 8	ANTAGONIST
1666997	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]ketanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] In vitro binding studies showed that both amoxapine and amitriptyline interact in the nanomolar range with @GENETgt$ 5-HT2 @/GENETgt$ receptors labelled by @CHEMICALSrc$ [3H]ketanserin @/CHEMICALSrc$ in cortical membranes .	4 1 4 5 5 11 8 11 8 8 5 15 15 15 11 19 16|19 19 16|19 15 19 22 20 20 20 26 26 20 5	DIRECT-REGULATOR
1666997	CHEMICAL	GENE	T14	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas amitriptyline is essentially inactive on @GENETgt$ 5-HT3 @/GENETgt$ receptors .	2 8 2 7 7 7 3 8 13 9|13 13 9|13 13 8 15 13 19 19 19 13 21 19 21 24 22 24 21 21 13 33 33 33 33 13 37 33|37 37 33|37 33 8	None-BC7
1666997	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT1B @/GENETgt$ ? [SEP] By contrast , neither amoxapine nor @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ can be considered as possible ligands of 5-HT1A and @GENETgt$ 5-HT1B @/GENETgt$ receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11 5 5|6 5 5|6 11 11 11 14 14 11 16 14 16 16 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
1666997	CHEMICAL	GENE	T15	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a @GENETgt$ 5-HT3 @/GENETgt$ antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on 5-HT3 receptors .	2 8 2 7 7 7 3 8 12 12 12 8 14 12 19 19 16|19 19 16|19 12 21 19 21 24 22 24 21 21 12 34 34|28 34 34|28 34 34 12 37 37 34 8	None-BC7
1666997	CHEMICAL	GENE	T2	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT receptors @/GENETgt$ ? [SEP] The second part of this study consisted of looking for possible changes in central @GENETgt$ 5-HT receptors @/GENETgt$ 24 h after either a single or a repeated ( for 14 days ) treatment with amoxapine ( 10 mg/kg i.p . each day ) or @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ ( 10 mg/kg i.p . ) .	3 3 7 6 6 3 7 9 7 12 12 9 15 15 12|14|15 12|14|15 12|15 12|14|15 19 9 23 23 23 9 23 26 23 30 30 30 23 30 23 34 32 37 37 38 23 7 41 41 41 41 41 41 41 48 48 49 44 44 41 41	None-BC7
1666997	CHEMICAL	GENE	T15	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT3 @/GENETgt$ ? [SEP] Complementary experiments using the 5-HT3-dependent Bezold-Jarisch reflex confirmed that amoxapine really acts in vivo as a 5-HT3 antagonist ( IC50 = 50 micrograms/kg i.v . ) , whereas @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ is essentially inactive on @GENETgt$ 5-HT3 @/GENETgt$ receptors .	2 8 2 7 7 7 3 8 12 12 12 8 14 12 18 18 18 12 20 18 20 23 21 23 20 20 12 33 33|28 33 33|28 33 33 12 37 33|37 37 33|37 33 8	None-BC7
1666997	CHEMICAL	GENE	T1	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ and @GENETgt$ 5-HT receptors @/GENETgt$ ? [SEP] The second part of this study consisted of looking for possible changes in central @GENETgt$ 5-HT receptors @/GENETgt$ 24 h after either a single or a repeated ( for 14 days ) treatment with @CHEMICALSrc$ amoxapine @/CHEMICALSrc$ ( 10 mg/kg i.p . each day ) or amitriptyline ( 10 mg/kg i.p . ) .	3 3 7 6 6 3 7 9 7 12 12 9 15 15 12|14|15 12|14|15 12|15 12|14|15 19 9 23 23 23 9 23 26 23 30 30 30 23 30 23 34 32|31 32 32|31 38 38 39 23 7 42 42 42 42 42 48 48 49 45 45 42 42	None-BC7
1666997	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ and @GENETgt$ 5-HT1A @/GENETgt$ ? [SEP] By contrast , neither amoxapine nor @CHEMICALSrc$ amitriptyline @/CHEMICALSrc$ can be considered as possible ligands of @GENETgt$ 5-HT1A @/GENETgt$ and 5-HT1B receptors because their affinities for these sites are in the micromolar range ( or even worse ) .	2 11 11 5 11 5 5|6 5 5|6 11 11 11 14 14 11 16 14 14 14 16 16 16 31 23 31 26 26 23 31 31 31 31 11 35 35 35 31 35 11	None-BC7
23402628	CHEMICAL	GENE	T8	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ thiol @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of ω-tertiary amine self-assembled @CHEMICALSrc$ thiol @/CHEMICALSrc$ monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 9 9 6 9 9|6 9 9|6 2 13 13 13 2 15 15 17 15 19 17 22 22 19 21|22 22 21|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ ω-tertiary amine @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of @CHEMICALSrc$ ω-tertiary amine @/CHEMICALSrc$ self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 9 9|3|7 9|3|7 9|7 9|3|7 9 9 2 13 13 13 2 15 15 17 15 19 17 22 22 19 20|22 22 20|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Oxidation with @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ was similarly assessed , and adhesion of lysozyme and @GENETgt$ fibrinogen @/GENETgt$ from phosphate buffered saline was then assayed by QCM and imaged by AFM .	8 3 1|2|3 1|2|3 1|3 1|2|3 8 8 8 8 8 23 13 11 13 12|13 13 12|13 20 19 20 11 23 23 8 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T11	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Tertiary amine @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] @CHEMICALSrc$ Tertiary amine-functionalized @/CHEMICALSrc$ sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas tertiary amine N-oxides and triethylene glycol-terminated monolayers are consistent with small protein aggregates .	0|4 0|4 4 0|4 5 5 5 9 9 6 6 6 5 5 15 15 21 15 18 19 21 21 5 25 25 25 21 5	None-BC7
23402628	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Oxidation with @CHEMICALSrc$ hydrogen peroxide @/CHEMICALSrc$ was similarly assessed , and adhesion of @GENETgt$ lysozyme @/GENETgt$ and fibrinogen from phosphate buffered saline was then assayed by QCM and imaged by AFM .	8 3 1|2|3 1|2|3 1|3 1|2|3 8 8 8 8 8 23 13 10|11 11 10|11 13 13 20 19 20 11 23 23 8 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ ω-tertiary amine @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of @CHEMICALSrc$ ω-tertiary amine @/CHEMICALSrc$ self-assembled thiol monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 9 9|3|7 9|3|7 9|7 9|3|7 9 9 2 13 13 13 2 15 15 17 15 19 17 22 22 19 22 23 22|23 23 22|23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T10	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphate @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Oxidation with hydrogen peroxide was similarly assessed , and adhesion of @GENETgt$ lysozyme @/GENETgt$ and fibrinogen from @CHEMICALSrc$ phosphate @/CHEMICALSrc$ buffered saline was then assayed by QCM and imaged by AFM .	7 4 4 1 7 7 7 7 7 23 12 10|11 10 10|11 12 12 20 19|15 19 19|15 20 10 23 23 7 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T8	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ thiol @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of ω-tertiary amine self-assembled @CHEMICALSrc$ thiol @/CHEMICALSrc$ monolayers to tertiary amine N-oxides is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 9 9 6 9 9|6 9 9|6 2 13 13 13 2 15 15 17 15 19 17 22 22 19 22 23 23 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T10	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphate @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Oxidation with hydrogen peroxide was similarly assessed , and adhesion of lysozyme and @GENETgt$ fibrinogen @/GENETgt$ from @CHEMICALSrc$ phosphate @/CHEMICALSrc$ buffered saline was then assayed by QCM and imaged by AFM .	7 4 4 1 7 7 7 7 7 23 12 10 12 12|13 12 12|13 20 19|15 19 19|15 20 10 23 23 7 25 23 23 23 29 27 23	None-BC7
23402628	CHEMICAL	GENE	T12	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Selective oxidation of ω-tertiary amine self-assembled thiol monolayers to @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ is shown to transform the adhesion of model proteins @GENETgt$ lysozyme @/GENETgt$ and fibrinogen upon them .	2 15 8 8 6 8 8 2 10 9|10|2 9|10|2 9|10|2 10|2 9|10|2 15 15 17 15 19 17 22 22 19 19|22 22 19|22 23 23 28 19 15	None-BC7
23402628	CHEMICAL	GENE	T14	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ triethylene glycol @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Tertiary amine-functionalized sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas tertiary amine N-oxides and @CHEMICALSrc$ triethylene glycol-terminated @/CHEMICALSrc$ monolayers are consistent with small protein aggregates .	3 3 4 4 4 8 8 5|7 5 5|7 4 4 14 14 21 14 16|19|14 16|19|14 16|19 16|19|14 21 21 4 25 25 25 21 4	None-BC7
23402628	CHEMICAL	GENE	T13	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ lysozyme @/GENETgt$ ? [SEP] Tertiary amine-functionalized sensors adsorbed multilayers of aggregated @GENETgt$ lysozyme @/GENETgt$ , whereas @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and triethylene glycol-terminated monolayers are consistent with small protein aggregates .	3 3 4 4 4 8 8 5|7 5 5|7 4 4 10|12|21 10|12|21 10|12|21 12|21 10|12|21 12 18 19 21 21 4 25 25 25 21 4	None-BC7
23402628	CHEMICAL	GENE	T12	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] Selective oxidation of ω-tertiary amine self-assembled thiol monolayers to @CHEMICALSrc$ tertiary amine N-oxides @/CHEMICALSrc$ is shown to transform the adhesion of model proteins lysozyme and @GENETgt$ fibrinogen @/GENETgt$ upon them .	2 15 8 8 6 8 8 2 10 9|10|2 9|10|2 9|10|2 10|2 9|10|2 15 15 17 15 19 17 22 22 19 22 23 21|23 23 21|23 28 19 15	None-BC7
10640321	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 18|19 19 18|19 19 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	AGONIST
10640321	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 19 19 8 8 26 8 28 26 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T18	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] In this study , the activity of the @GENETgt$ delta-opioid receptor @/GENETgt$ subtype-selective agonist , @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , was investigated in a guinea pig model of citric acid-induced cough .	3 3 20 20 6 20 13 13 8|12|13 8|12|13 12|13 8|12|13 13 6 13 12|13|15 12|13|15 13|15 12|13|15 6 20 20 25 25 25 25 20 29 29 29 25 20	AGONIST
10640321	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18|19 18 18|19 18 9 9 9|25|23 9|25|23 9|25 9|25|23 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T7	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9|10|11 9|10|11 9|11 9|10|11 11 9 16|9|13 16|9|13 16|9 16|9|13 20 16 20 20 20 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T6	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] These studies provide compelling evidence that the antitussive effects of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ in this guinea pig cough model are mediated by agonist activity at the @GENETgt$ delta-opioid receptor @/GENETgt$ .	2 3 3 5 3 21 9 9 21 11 9|10|11 9|10|11 9|11 9|10|11 19 19 19 19 19 9 21 5 24 24 21 27 27 24|27 24|27 24|27 24|27 3	AGONIST
10640321	CHEMICAL	GENE	T16	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-receptor @/GENETgt$ ? [SEP] The @GENETgt$ delta-receptor @/GENETgt$ antagonist , SB 244525 ( 10 mg/kg , i.p . ) , inhibited the antitussive effect of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	4 1|4 4 1|4 16 4 4 6 10 10 6 10 10 10 10 16 16 19 19 16 21 19|21 19|21 19|21 19|21 26 26 21 26 26 26 26 16	AGONIST
10640321	CHEMICAL	GENE	T19	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 10 10 10 10 5 5 13 5 13 13 13 13 5 18|5 5 18|5 23 23 19 23 26 23 26 26 26 23 19 33 5 35 33 38 38 35 40 40|38 40|38 40|38 40|38 40|38 40 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T11	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 19 19 9 9 26 9 28 26 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] In this study , the activity of the @GENETgt$ delta-opioid receptor @/GENETgt$ subtype-selective agonist , SB 227122 , was investigated in a guinea pig model of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough .	3 3 19 19 6 19 13 13 8|12|13 8|12|13 12|13 8|12|13 13 6 13 13 15 6 19 19 24 24 24 24 19 29 29|23 29|23 29 29|23 24 19	None-BC7
10640321	CHEMICAL	GENE	T17	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11|6 11 11|6 11 11 5 5 14 5 14 14 14 14 5 5 23 23 20 23 26 23 26 26 26 23 20 33 5 35 33 38 38 35 40 40|38 40|38 40|38 40|38 40|38 40 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T1	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu- and kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of @GENETgt$ mu- and kappa-receptor @/GENETgt$ agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 10 10 10 10 5 5 13 5 13 13 13 13 5 5 22 22 19 22 25 22 25 25 25 22 19 32 5 34 32 37 37 34 39 37|38|39 37|38|39 37|38|39 37|39 37|38|39 39 5 5 5 49 49 49 53 53 53 49 55 51|53|55 51|53|55 53|55 51|53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T11	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ citric acid @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of @CHEMICALSrc$ citric acid-induced @/CHEMICALSrc$ cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 31 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18 18 9 9 24|9|23 24|9|23 24|9 24|9|23 28 24 28 28 31 33 31 38 32|38 32|38 38 32|38 33 40 38 38 33 44 42 44 44 44 44 44 44 52 44 44 31 31	None-BC7
10640321	CHEMICAL	GENE	T14	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 17 6 6 11 11 8 11 11 11 11 6 17 20 20 17 22 20 22 24|21|22 24|21|22 24|22 24|21|22 17 17 38 32 32 38 35 35 32 38 38 28 17	AGONIST
10640321	CHEMICAL	GENE	T12	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ naloxone @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , @CHEMICALSrc$ naloxone @/CHEMICALSrc$ ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or SB 227122 , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 17 5 5|6 5 5|6 11 11 7 11 11 11 11 5 17 20 20 17 22 20 22 22 24 17 17 36 31 31 36 34 34 31 36 34|27|36 34|27|36 27|36 34|27|36 17	None-BC7
10640321	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and @CHEMICALSrc$ hydrocodone @/CHEMICALSrc$ ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 18|19 19 18|19 19 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T14	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 16 5 5 10 10 7 10 10 10 10 5 16 19 19 16 21 19 21 21|22|23 21|22|23 21|23 21|22|23 16 16 36 31 31 36 34 34 31 36 33|27|36 33|27|36 27|36 33|27|36 16	AGONIST
10640321	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8|9|12 8|9|12 8|12 8|9|12 12 8 18 8 20 18 20 20 20 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	AGONIST
10640321	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16 18 18 18 9 9 24|9|23 24|9|23 24|9 24|9|23 28 24|25|28 24|25|28 24|28 24|25|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	AGONIST
10640321	CHEMICAL	GENE	T8	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 16|15 15 16|15 19 19 19 9 9 27 9 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	AGONIST
10640321	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of @CHEMICALSrc$ codeine @/CHEMICALSrc$ or SB 227122 , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 17 6 6 11 11 8 11 11 11 11 6 17 20 20 17 22 19|20 20 19|20 22 22 25 17 17 38 32 32 38 35 35 32 38 38 28 17	AGONIST
10640321	CHEMICAL	GENE	T8	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , mu-opioid receptor ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 16 9 18 16|17 16 16|17 18 18 18 9 9 9|25|23 9|25|23 9|25 9|25|23 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( codeine and hydrocodone ) , and kappa-opioid receptor ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 17 19 19 19 8 8 26 8 28 25|26|28 25|26|28 26|28 25|26|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T15	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 244525 @/CHEMICALSrc$ and @GENETgt$ delta-receptor @/GENETgt$ ? [SEP] The @GENETgt$ delta-receptor @/GENETgt$ antagonist , @CHEMICALSrc$ SB 244525 @/CHEMICALSrc$ ( 10 mg/kg , i.p . ) , inhibited the antitussive effect of SB 227122 ( 20 mg/kg , i.p . ) .	4 1|4 4 1|4 17 4 4|6 4|6 4|6 4|6 11 11 6 11 11 11 11 17 17 20 20 17 22 20 22 26 26 22 26 26 26 26 17	ANTAGONIST
10640321	CHEMICAL	GENE	T19	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 10 10 10 10 5 5 13 5 13 13 13 13 5 18|5 5 18|5 24 24|20 24 24|20 19 24 27 24 27 27 27 24 19 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	ANTAGONIST
10640321	CHEMICAL	GENE	T3	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist rimcazole ( 3 mg/kg , i.p . ) inhibited the antitussive effect of @CHEMICALSrc$ dextromethorphan @/CHEMICALSrc$ ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of SB 227122 .	5 1|5 5 1|5 5 13 8 8 5 8 8 8 8 13 16 16 13 18 16 16 16 22 22 18 22 22 22 22 18 30 30 18 18 33 18 18 36 34 36 13	AGONIST
10640321	CHEMICAL	GENE	T2	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ rimcazole @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist @CHEMICALSrc$ rimcazole @/CHEMICALSrc$ ( 3 mg/kg , i.p . ) inhibited the antitussive effect of dextromethorphan ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of SB 227122 .	5 1|5 5 1|5 5 3|14 14 3|14 9 9 5 9 9 9 9 14 17 17 14 19 17 22 22 19 22 22 22 22 19 30 30 19 19 33 19 19 36 34 36 14	ANTAGONIST
10640321	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ and @GENETgt$ mu-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( SB 227122 ) , @GENETgt$ mu-opioid receptor @/GENETgt$ ( codeine and hydrocodone ) , and kappa-opioid receptor ( @CHEMICALSrc$ BRL 52974 @/CHEMICALSrc$ ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9 11 11 9 9|14|15 9|14|15 9|15 9|14|15 19 15 19 19 19 9 9 26 9 28 25|26|28 25|26|28 26|28 25|26|28 28 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T17	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11|6 11 11|6 11 11 5 5 14 5 14 14 14 14 5 5 24 24|20 24 24|20 20 24 27 24 27 27 27 24 20 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T1	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ kappa-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( mu-receptor antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( @GENETgt$ kappa-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 10 10 10 10 5 5 13 5 13 13 13 13 5 5 23 20|23 23 20|23 19 23 26 23 26 26 26 23 19 33 5 35 33 38 38 35 40 38 40 40 40 5 5 5 49 49 49 53 53 53 49 55 53|55 53|55 53|55 53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T12	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ naloxone @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective @GENETgt$ opioid receptor @/GENETgt$ antagonist , @CHEMICALSrc$ naloxone @/CHEMICALSrc$ ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of codeine or SB 227122 , indicating that the antitussive activity of both compounds is opioid receptor-mediated .	6 6 2|6 2|6 6 2|6 18 6 5|6 6 5|6 12 12 8 12 12 12 12 6 18 21 21 18 23 21 23 23 25 18 18 38 32 32 38 35 35 32 38 38 28 18	ANTAGONIST
10640321	CHEMICAL	GENE	T4	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ sigma-receptor @/GENETgt$ ? [SEP] The @GENETgt$ sigma-receptor @/GENETgt$ antagonist rimcazole ( 3 mg/kg , i.p . ) inhibited the antitussive effect of dextromethorphan ( 30 mg/kg , i.p . ) , a sigma-receptor agonist , but not that of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ .	5 1|5 5 1|5 5 13 8 8 5 8 8 8 8 13 16 16 13 18 16 21 21 18 21 21 21 21 18 29 29 18 18 32 18 18 35 33|35 33|35 33|35 33|35 13	None-BC7
10640321	CHEMICAL	GENE	T19	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and @CHEMICALSrc$ norbinaltorphimine @/CHEMICALSrc$ ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 11 11 11 8|11 11 8|11 5 5 14 5 14 14 14 14 5 18|5 5 18|5 24 24 20 24 27 24 27 27 27 24 20 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	None-BC7
10640321	CHEMICAL	GENE	T17	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with @CHEMICALSrc$ beta-funaltrexamine @/CHEMICALSrc$ ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of SB 227122 ( 20 mg/kg , i.p . ) .	2 50 50 5 50 12 12|6 12 12|6 12 8|12 12 8|12 5 5 15 5 15 15 15 15 5 5 24 24 21 24 27 24 27 27 27 24 21 34 5 36 34 39 39 36 41 39 41 41 41 5 5 5 50 50 50 54 54 54 50 56 54 56 60 60 56 60 60 60 60 50	ANTAGONIST
10640321	CHEMICAL	GENE	T7	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ kappa-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the delta-opioid receptor ( @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ) , mu-opioid receptor ( codeine and hydrocodone ) , and @GENETgt$ kappa-opioid receptor @/GENETgt$ ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 9 9 9 5 11 9|10|11 9|10|11 9|11 9|10|11 11 9 17 9 19 17 19 19 19 9 9 9|22|25 9|22|25 9|25 9|22|25 29 25 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T1	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ and @GENETgt$ mu-receptor @/GENETgt$ ? [SEP] In contrast , combined pretreatment with beta-funaltrexamine ( @GENETgt$ mu-receptor @/GENETgt$ antagonist ; 20 mg/kg , s.c . ) and norbinaltorphimine ( kappa-receptor antagonist ; 20 mg/kg , s.c . ) , at doses that inhibited the antitussive activity of mu- and kappa-receptor agonists , respectively , was without effect on the antitussive response of @CHEMICALSrc$ SB 227122 @/CHEMICALSrc$ ( 20 mg/kg , i.p . ) .	2 49 49 5 49 11 11 11 8|11 11 8|11 5 5 14 5 14 14 14 14 5 5 23 23 20 23 26 23 26 26 26 23 20 33 5 35 33 38 38 35 40 38 40 40 40 5 5 5 49 49 49 53 53 53 49 55 53|55 53|55 53|55 53|55 60 60 55 60 60 60 60 49	None-BC7
10640321	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ delta-opioid receptor @/GENETgt$ ? [SEP] Parenteral administration of selective agonists of the @GENETgt$ delta-opioid receptor @/GENETgt$ ( SB 227122 ) , mu-opioid receptor ( @CHEMICALSrc$ codeine @/CHEMICALSrc$ and hydrocodone ) , and kappa-opioid receptor ( BRL 52974 ) produced dose-related inhibition of citric acid-induced cough with ED(50 ) values of 7.3 , 5.2 , 5.1 , and 5.3 mg/kg , respectively .	2 32 5 5 2 8 8 8|5|7 8|5|7 8|5 8|5|7 12 8 12 12 8 17 8 19 16|17 17 16|17 19 19 19 8 8 27 8 29 27 29 29 32 34 32 38 38 38 34 40 38 38 34 44 42 44 44 44 44 44 44 52 44 44 32 32	None-BC7
10640321	CHEMICAL	GENE	T13	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ codeine @/CHEMICALSrc$ and @GENETgt$ opioid receptor @/GENETgt$ ? [SEP] The nonselective opioid receptor antagonist , naloxone ( 3 mg/kg , i.m . ) , attenuated the antitussive effects of @CHEMICALSrc$ codeine @/CHEMICALSrc$ or SB 227122 , indicating that the antitussive activity of both compounds is @GENETgt$ opioid receptor-mediated @/GENETgt$ .	5 5 5 5 16 5 5 10 10 7 10 10 10 10 5 16 19 19 16 21 19|20 19 19|20 21 21 24 16 16 36 31 31 36 34 34 31 36 34|27|36 34|27|36 27|36 34|27|36 16	AGONIST
23504356	CHEMICAL	GENE	T1	T3	True	0	What is [Drugprot] between @CHEMICALSrc$ fenfluramine @/CHEMICALSrc$ and @GENETgt$ secretin @/GENETgt$ ? [SEP] While studies of @CHEMICALSrc$ fenfluramine @/CHEMICALSrc$ , @GENETgt$ secretin @/GENETgt$ , opiates , and mood stabilizers generally find no effect , mixed results suggest more research is needed on antidepressants and atypical antipsychotics .	16 16 4 2|3 2 2|3 4 4|5 4 4|5 7 7 10 4 14 4 16 22 18 16 22 21 22 22 24 26 26 22 28 26 28 31 28 22	None-BC7
23506741	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-18 @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF-α , IL-1β , @GENETgt$ IL-18 @/GENETgt$ , IL-17A and IFN-γ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 18|15 15 18|15 15 15 22 22 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ cytokines @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory @GENETgt$ cytokines @/GENETgt$ in colon , including TNF-α , IL-1β , IL-18 , IL-17A and IFN-γ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 9|6 6 9|6 13 10 13 16 13 16 16 16 16 16 16 22 22 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-17A @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF-α , IL-1β , IL-18 , @GENETgt$ IL-17A @/GENETgt$ and IFN-γ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 15 15 20|15 15 20|15 21 21 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ TNF-α @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including @GENETgt$ TNF-α @/GENETgt$ , IL-1β , IL-18 , IL-17A and IFN-γ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12|14 12 12|14 15 15 15 15 15 15 22 22 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T1	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a @/CHEMICALSrc$ and @GENETgt$ caspase-1 @/GENETgt$ ? [SEP] Furthermore , a decreased CD11c(+ ) macrophage infiltration in colons and inactivation of @GENETgt$ caspase-1 @/GENETgt$ in peritoneal macrophages were detected in @CHEMICALSrc$ Fc11a-2-treated @/CHEMICALSrc$ mice .	20 20 8 8 8 8 8 20 10 8 10 10 14 12|13 12 12|13 18 18 12 20 20 24 24|20 24 24|20 20 20	INHIBITOR
23506741	CHEMICAL	GENE	T5	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ , for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 21 21 13 27 27 11 34 34 34 32 34 34 27 36 27 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T9	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IL-1β @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF-α , @GENETgt$ IL-1β @/GENETgt$ , IL-18 , IL-17A and IFN-γ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 16|15 15 16|15 15 15 15 15 22 22 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T11	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ benzo[d]imidazole @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] A novel @CHEMICALSrc$ benzo[d]imidazole @/CHEMICALSrc$ derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	5 5 2|5 5 2|5 6 6 8 6 15 12 12 15 15 15 8 17 6 21 17|21 21 17|21 17 6	INHIBITOR
23506741	CHEMICAL	GENE	T6	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sulfate @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran @CHEMICALSrc$ sulfate @/CHEMICALSrc$ sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 13 26 26 11 34 34 34|28 34 34|28 32 34 34 26 36 26 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T9	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ IFN-γ @/GENETgt$ ? [SEP] Moreover , protein and mRNA levels of DSS-induced proinflammatory cytokines in colon , including TNF-α , IL-1β , IL-18 , IL-17A and @GENETgt$ IFN-γ @/GENETgt$ , were markedly suppressed by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ .	28 28 28 3 3 3 10 10 10 6 12 10 12 15 12 15 15 15 15 15 15 21 21|22 21 21|22 3 28 28 28 30 28 28 28 28	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of pro-caspase-1 , pro-IL-1β and pro-IL-18 which in turn suppressed the activation of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 17 17 17 17 25 24 25 15 27 25 31 27|31 31 27|31 27 9	INHIBITOR
23506741	CHEMICAL	GENE	T4	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of @CHEMICALSrc$ 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole @/CHEMICALSrc$ , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran sulfate sodium (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11|12 11 11|12 13 20 20 20 20 13 22 20 22 13 27 27 11 34 34 34 32 34 34 27 36 27 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T7	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] In the present study , we aimed at examining the effect of 1-ethyl-5-methyl-2-phenyl-1H-benzo[d]imidazole , a synthetic small molecular compound also named Fc11a-2 , for the treatment of dextran sulfate @CHEMICALSrc$ sodium @/CHEMICALSrc$ (DSS)-induced experimental colitis in mice via targeting @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 7 7 7 7 9 7 11 9 13 11 13 19 19 19 19 13 21 19 21 13 26 26 11 34 34 34 32|29 32 32|29 34 34 26 36 26 38 9 41|37 41 41|37 38 7	None-BC7
23506741	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ myeloperoxidase @/GENETgt$ ? [SEP] In addition , the disease activity index , histopathologic scores and @GENETgt$ myeloperoxidase @/GENETgt$ activity were also significantly reduced by @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ treatment .	2 18 18 7 7 7 18 7 10 18 10 11|14 14 11|14 10 18 18 18 18 22 18|22 22 18|22 18 18	INHIBITOR
23506741	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] Taken together , our results demonstrate the ability of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ to inhibit @GENETgt$ NLRP3 @/GENETgt$ inflammasome activation and its potential use in the treatment of inflammatory bowel diseases .	6 1 6 5 6 6 8 6 10 8|9 8 8|9 13 8 17|12 17 17|12 17 13 17 21 21 17 24 24 21 28 28 28 24 6	INHIBITOR
23506741	CHEMICAL	GENE	T2	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ pro-caspase-1 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of @GENETgt$ pro-caspase-1 @/GENETgt$ , pro-IL-1β and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 15 15 17 17 17 17 26 25 26 15 28 26 31 31 28 9	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T10	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ NLRP3 @/GENETgt$ ? [SEP] A novel benzo[d]imidazole derivate prevents the development of dextran sulfate @CHEMICALSrc$ sodium-induced @/CHEMICALSrc$ murine experimental colitis via inhibition of @GENETgt$ NLRP3 @/GENETgt$ inflammasome .	4 4 4 5 5 7 5 15 11 11 10|15 15 10|15 15 15 7 17 5 21 17|21 21 17|21 17 5	None-BC7
23506741	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ pro-IL-18 @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of pro-caspase-1 , pro-IL-1β and @GENETgt$ pro-IL-18 @/GENETgt$ which in turn suppressed the activation of NLRP3 inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 17 17 17 17|19 17 17|19 26 25 26 15 28 26 31 31 28 9	INDIRECT-DOWNREGULATOR
23506741	CHEMICAL	GENE	T2	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ and @GENETgt$ pro-IL-1β @/GENETgt$ ? [SEP] The mechanism of action of @CHEMICALSrc$ Fc11a-2 @/CHEMICALSrc$ was related to the inhibition of the cleavage of pro-caspase-1 , @GENETgt$ pro-IL-1β @/GENETgt$ and pro-IL-18 which in turn suppressed the activation of NLRP3 inflammasome .	2 9 4 2 6 4|5 4 4|5 9 9 12 12 9 15 15 12 17 15 17 17 17 17 17 17 26 25 26 15 28 26 31 31 28 9	INDIRECT-DOWNREGULATOR
23127600	CHEMICAL	GENE	T8	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ glucose oxidase @/GENETgt$ ? [SEP] As revealed by @GENETgt$ glucose oxidase @/GENETgt$ ( GOD ) and radioimmunoassay ( RIA ) , both dimethyldiguanide ( DC , 0.6gkg(-1)d(-1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg(-1)d(-1 ) ) treatments significantly resulted in down-regulation of blood @CHEMICALSrc$ glucose @/CHEMICALSrc$ and insulin levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	2 36 4 34|3|4 34|3|4 34|4 34|3|4 8 4 8 4 4 13 11 13 11 17 4 19 17 19 19 19 19 17 17 29 29 29 25 31 29 29 29 36 36 36 38 36 41 41 38 38 38 41 45 41 47 41 36 58 51 58 55 55 55 51 58 58 36 61 61 58 36	None-BC7
23127600	CHEMICAL	GENE	T1	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ polyphenols @/CHEMICALSrc$ and @GENETgt$ NF-κB @/GENETgt$ ? [SEP] These findings demonstrate that cinnamon @CHEMICALSrc$ polyphenols @/CHEMICALSrc$ can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity , as well as attenuating cytotoxicity via inhibition of iNOS , @GENETgt$ NF-κB @/GENETgt$ activation .	2 3 3 9 6 9|5 9 9|5 9 3 14 14 11 11 9 17 17 9 21 21 21 17 23 21 26 26 23 29 29 23 23 23 34 34 31 31 23 36 36 23 39 42 39 44 48 48 48|44 48 48|44 42 3	INHIBITOR
23127600	CHEMICAL	GENE	T7	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ dimethyldiguanide @/CHEMICALSrc$ and @GENETgt$ glucose oxidase @/GENETgt$ ? [SEP] As revealed by @GENETgt$ glucose oxidase @/GENETgt$ ( GOD ) and radioimmunoassay ( RIA ) , both @CHEMICALSrc$ dimethyldiguanide @/CHEMICALSrc$ ( DC , 0.6gkg(-1)d(-1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg(-1)d(-1 ) ) treatments significantly resulted in down-regulation of blood glucose and insulin levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	2 37 4 35|3|4 35|3|4 35|4 35|3|4 8 4 8 4 4 13 11 13 11 17 4|14 4 4|14 20 17 20 20 20 20 17 17 30 30 30 26 32 30 30 30 37 37 37 39 37 42 42 39 42 45 42 47 42 37 58 51 58 55 55 55 51 58 58 37 61 61 58 37	None-BC7
23127600	CHEMICAL	GENE	T8	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] As revealed by glucose oxidase ( GOD ) and radioimmunoassay ( RIA ) , both dimethyldiguanide ( DC , 0.6gkg(-1)d(-1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg(-1)d(-1 ) ) treatments significantly resulted in down-regulation of blood @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	2 35 5 5 33 7 5 7 5 5 12 10 12 10 16 5 18 16 18 18 18 18 16 16 28 28 28 24 30 28 28 28 35 35 35 37 35 40 40 37|39 37 37|39 40 41|45 45 41|45 40 47 40 35 58 51 58 55 55 55 51 58 58 35 61 61 58 35	None-BC7
23127600	CHEMICAL	GENE	T1	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ polyphenols @/CHEMICALSrc$ and @GENETgt$ iNOS @/GENETgt$ ? [SEP] These findings demonstrate that cinnamon @CHEMICALSrc$ polyphenols @/CHEMICALSrc$ can exert the hypoglycemic and hypolipidemic effects through the mechanisms that may be associated with repairing pancreatic beta cells in diabetic mice and improving its anti-oxidative capacity , as well as attenuating cytotoxicity via inhibition of @GENETgt$ iNOS @/GENETgt$ , NF-κB activation .	2 3 3 9 6 9|5 9 9|5 9 3 14 14 11 11 9 17 17 9 21 21 21 17 23 21 26 26 23 29 29 23 23 23 34 34 31 31 23 36 36 23 39 42 39 44 48|42 48 48|42 48 48 42 3	INHIBITOR
23127600	CHEMICAL	GENE	T7	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ dimethyldiguanide @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] As revealed by glucose oxidase ( GOD ) and radioimmunoassay ( RIA ) , both @CHEMICALSrc$ dimethyldiguanide @/CHEMICALSrc$ ( DC , 0.6gkg(-1)d(-1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg(-1)d(-1 ) ) treatments significantly resulted in down-regulation of blood glucose and @GENETgt$ insulin @/GENETgt$ levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	2 36 5 5 34 7 5 7 5 5 12 10 12 10 16 5|15 5 5|15 19 16 19 19 19 19 16 16 29 29 29 25 31 29 29 29 36 36 36 38 36 41 41 38 41 41|45 45 41|45 41 47 41 36 58 51 58 55 55 55 51 58 58 36 61 61 58 36	INDIRECT-DOWNREGULATOR
23127600	CHEMICAL	GENE	T6	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] As revealed by @CHEMICALSrc$ glucose @/CHEMICALSrc$ oxidase ( GOD ) and radioimmunoassay ( RIA ) , both dimethyldiguanide ( DC , 0.6gkg(-1)d(-1 ) ) and CPS ( 0.3 , 0.6 , 1.2gkg(-1)d(-1 ) ) treatments significantly resulted in down-regulation of blood glucose and @GENETgt$ insulin @/GENETgt$ levels in serum , while the levels of oxidative stress markers were markedly lowered through ELISA assay .	2 36 6 3|6 6 3|6 34 8 6 8 6 6 13 11 13 11 17 6 19 17 19 19 19 19 17 17 29 29 29 25 31 29 29 29 36 36 36 38 36 41 41 38 41 41|45 45 41|45 41 47 41 36 58 51 58 55 55 55 51 58 58 36 61 61 58 36	None-BC7
16371234	CHEMICAL	GENE	T8	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ p44 @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced PGE2 production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including @GENETgt$ p44/p42 @/GENETgt$ ERK after PS liposomes treatment .	3 3 23 6 6 3 11 9 11 11 3 11 15 15 11 15 19 19 11 23 23 23 23 26|23 26 26|23 23 28 23 30 28 34 34|30 34 34|30 30 38 37 38 28 23	None-BC7
16371234	CHEMICAL	GENE	T16	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E2 @/CHEMICALSrc$ and @GENETgt$ prostaglandin E synthases @/GENETgt$ ? [SEP] Involvement of COX-1 and up-regulated @GENETgt$ prostaglandin E synthases @/GENETgt$ in phosphatidylserine liposome-induced @CHEMICALSrc$ prostaglandin E2 @/CHEMICALSrc$ production by microglia .	1 3 1 1 1 5|6 5|6 5|6 5|6 5|6 16 12 16 16|9 16|9 16 16|9 5 18 5 1	PRODUCT-OF
16371234	CHEMICAL	GENE	T6	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ mPGES-2 @/GENETgt$ ? [SEP] These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1 , especially @GENETgt$ mPGES-2 @/GENETgt$ , plays the pivotal role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by microglia .	2 4 4 4 22 7 22 10 10 7 14 14 14 7 16 14 16 19 16|18 16 16|18 22 4 25 25 22 31 28 31 27|31 31 27|31 22 33 22 4	PRODUCT-OF
16371234	CHEMICAL	GENE	T7	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ PS-specific receptor @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other PS-recognizing receptors , possibly @GENETgt$ PS-specific receptor @/GENETgt$ , could also promote PGE2 production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	3 3 25 6 6 3 12 9 12 9|12 12 9|12 3 12 16 16 12 16 19 17|19|12 17|19|12 19|12 17|19|12 25 25 25 25 27 25 29 25 31 29 34 34 31 38 37 38 29 25	None-BC7
16371234	CHEMICAL	GENE	T15	T45	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ and @GENETgt$ Cyclooxygenase @/GENETgt$ ? [SEP] @GENETgt$ Cyclooxygenase @/GENETgt$ (COX)-2 and membrane-bound @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ synthase-1 ( mPGES-1 ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	0|3 3 0|3 14 3 9 9|4 9|4 9 9|4 3 11 9 11 14 14 16 14 18 16 20 18 20 18 26 26 26 18 14	None-BC7
16371234	CHEMICAL	GENE	T3	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production was significantly suppressed by indomethacin , a preferential @GENETgt$ COX-1 @/GENETgt$ inhibitor , but not by NS-398 , a selective COX-2 inhibitor .	10 10 4 7 4|7 7 4|7 10 10 10 10 12 10 12 18 18 18|14 18 18|14 12 12 12 23 23 12 23 28 28 28 23 10	None-BC7
16371234	CHEMICAL	GENE	T7	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ PS-recognizing receptors @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other @GENETgt$ PS-recognizing receptors @/GENETgt$ , possibly PS-specific receptor , could also promote PGE2 production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	3 3 25 6 6 3 12 9 12 9|12 12 9|12 3 12 15 12|13|15 12|13|15 12|15 12|13|15 15 21 21 12 25 25 25 25 27 25 29 25 31 29 34 34 31 38 37 38 29 25	None-BC7
16371234	CHEMICAL	GENE	T8	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ PS-specific receptor @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced PGE2 production , other PS-recognizing receptors , possibly @GENETgt$ PS-specific receptor @/GENETgt$ , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	3 3 24 6 6 3 11 9 11 11 3 11 15 15 11 15 18 17|18|11 17|18|11 18|11 17|18|11 24 24 24 24 27|22 27 27|22 24 29 24 31 29 34 34 31 38 37 38 29 24	None-BC7
16371234	CHEMICAL	GENE	T14	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ class B scavenger receptor @/GENETgt$ ? [SEP] The specific ligand for @GENETgt$ class B scavenger receptor @/GENETgt$ ( SR-B ) , high density lipoprotein , significantly suppressed PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production .	3 3 19 5 3|4|5 3|4|5 3|4|5 3|4|5 3|5 3|4|5 11 5 11 5 16 16 5 19 19 19 21 24 24|17 24 24|17 19 19	None-BC7
16371234	CHEMICAL	GENE	T8	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ p42 @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced PGE2 production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including @GENETgt$ p44/p42 @/GENETgt$ ERK after PS liposomes treatment .	3 3 23 6 6 3 11 9 11 11 3 11 15 15 11 15 19 19 11 23 23 23 23 26|23 26 26|23 23 28 23 30 28 34 34|30 34 34|30 30 38 37 38 28 23	None-BC7
16371234	CHEMICAL	GENE	T14	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ high density lipoprotein @/GENETgt$ ? [SEP] The specific ligand for class B scavenger receptor ( SR-B ) , @GENETgt$ high density lipoprotein @/GENETgt$ , significantly suppressed PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production .	3 3 19 8 8 8 8 3 10 8 10 8 8|12|13 8|12|13 8|12|13 8|13 8|12|13 19 19 19 21 24 24|18 24 24|18 19 19	None-BC7
16371234	CHEMICAL	GENE	T4	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ indomethacin @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced PGE2 production was significantly suppressed by @CHEMICALSrc$ indomethacin @/CHEMICALSrc$ , a preferential @GENETgt$ COX-1 @/GENETgt$ inhibitor , but not by NS-398 , a selective COX-2 inhibitor .	9 9 4 6 6 9 9 9 9 11 9|10 9 9|10 11 18 18 18|14 18 18|14 11 11 11 23 23 11 23 28 28 28 23 9	INHIBITOR
16371234	CHEMICAL	GENE	T15	T46	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ and @GENETgt$ (COX)-2 @/GENETgt$ ? [SEP] Cyclooxygenase @GENETgt$ (COX)-2 @/GENETgt$ and membrane-bound @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ synthase-1 ( mPGES-1 ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	2 1|14 14 1|14 2 9 9|4 9|4 9 9|4 2 11 9 11 14 14 16 14 18 16 20 18 20 18 26 26 26 18 14	None-BC7
16371234	CHEMICAL	GENE	T8	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ PS-recognizing receptors @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced PGE2 production , other @GENETgt$ PS-recognizing receptors @/GENETgt$ , possibly PS-specific receptor , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	3 3 24 6 6 3 11 9 11 11 3 11 14 11|13|14 11|13|14 11|14 11|13|14 14 20 20 11 24 24 24 24 27|22 27 27|22 24 29 24 31 29 34 34 31 38 37 38 29 24	None-BC7
16371234	CHEMICAL	GENE	T3	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production was significantly suppressed by indomethacin , a preferential COX-1 inhibitor , but not by NS-398 , a selective @GENETgt$ COX-2 @/GENETgt$ inhibitor .	10 10 4 7 4|7 7 4|7 10 10 10 10 12 10 12 17 17 17 12 12 12 22 22 12 22 28 28 24|28 28 24|28 22 10	None-BC7
16371234	CHEMICAL	GENE	T8	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ SR-BI @/GENETgt$ ? [SEP] Although @GENETgt$ SR-BI @/GENETgt$ plays an essential role in PS liposome-induced PGE2 production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	4 1|4 4 1|4 24 7 7 4 12 10 12 12 4 12 16 16 12 16 20 20 12 24 24 24 24 27|23 27 27|23 24 29 24 31 29 34 34 31 38 37 38 29 24	None-BC7
16371234	CHEMICAL	GENE	T8	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ ERK @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced PGE2 production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by transducing intracellular signals including p44/p42 @GENETgt$ ERK @/GENETgt$ after PS liposomes treatment .	3 3 23 6 6 3 11 9 11 11 3 11 15 15 11 15 19 19 11 23 23 23 23 26|23 26 26|23 23 28 23 30 28 33 33 30|31 30 30|31 38 37 38 28 23	None-BC7
16371234	CHEMICAL	GENE	T4	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ indomethacin @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced PGE2 production was significantly suppressed by @CHEMICALSrc$ indomethacin @/CHEMICALSrc$ , a preferential COX-1 inhibitor , but not by NS-398 , a selective @GENETgt$ COX-2 @/GENETgt$ inhibitor .	9 9 4 6 6 9 9 9 9 11 9|10 9 9|10 11 17 17 17 11 11 11 22 22 11 22 28 28 24|28 28 24|28 22 9	None-BC7
16371234	CHEMICAL	GENE	T7	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ SR-BI @/GENETgt$ ? [SEP] Although @GENETgt$ SR-BI @/GENETgt$ plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote PGE2 production by transducing intracellular signals including p44/p42 ERK after PS liposomes treatment .	4 1|4 4 1|4 25 7 7 4 13 10 13 9|13 13 9|13 4 13 17 17 13 17 21 21 13 25 25 25 25 27 25 29 25 31 29 34 34 31 38 37 38 29 25	None-BC7
16371234	CHEMICAL	GENE	T15	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ and @GENETgt$ mPGES-1 @/GENETgt$ ? [SEP] Cyclooxygenase (COX)-2 and membrane-bound @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ synthase-1 ( @GENETgt$ mPGES-1 @/GENETgt$ ) were induced by treatment with lipopolysaccharide ( LPS ) but not with PS liposomes .	2 14 2 8 8|4 8|4 8 8|4 2 10 8|7 8 8|7 10 14 14 16 14 18 16 20 18 20 18 26 26 26 18 14	None-BC7
16371234	CHEMICAL	GENE	T18	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphatidylserine @/CHEMICALSrc$ and @GENETgt$ prostaglandin E synthases @/GENETgt$ ? [SEP] Involvement of COX-1 and up-regulated @GENETgt$ prostaglandin E synthases @/GENETgt$ in @CHEMICALSrc$ phosphatidylserine @/CHEMICALSrc$ liposome-induced prostaglandin E2 production by microglia .	1 3 1 1 1 5|6 5|6 5|6 5|6 5|6 16 13|7 13 13|7 16 16 16 5 18 5 1	None-BC7
16371234	CHEMICAL	GENE	T17	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Involvement of @GENETgt$ COX-1 @/GENETgt$ and up-regulated @CHEMICALSrc$ prostaglandin E @/CHEMICALSrc$ synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia .	1 3 1|2 1 1|2 1 1 10|5 10|5 10 10|5 6 16 13 16 16 16 6 18 6 1	None-BC7
16371234	CHEMICAL	GENE	T14	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ SR-B @/GENETgt$ ? [SEP] The specific ligand for class B scavenger receptor ( @GENETgt$ SR-B @/GENETgt$ ) , high density lipoprotein , significantly suppressed PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production .	3 3 19 8 8 8 8 3 10 8|9 8 8|9 10 8 16 16 8 19 19 19 21 24 24|20 24 24|20 19 19	None-BC7
16371234	CHEMICAL	GENE	T7	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ p42 @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote PGE2 production by transducing intracellular signals including @GENETgt$ p44/p42 @/GENETgt$ ERK after PS liposomes treatment .	3 3 24 6 6 3 12 9 12 9|12 12 9|12 3 12 16 16 12 16 20 20 12 24 24 24 24 26 24 28 24 30 28 34 34|30 34 34|30 30 38 37 38 28 24	None-BC7
16371234	CHEMICAL	GENE	T6	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ PGESs @/GENETgt$ ? [SEP] These observations strongly suggest that the up-regulation of terminal @GENETgt$ PGESs @/GENETgt$ that are preferentially coupled with COX-1 , especially mPGES-2 , plays the pivotal role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by microglia .	2 4 4 4 22 7 22 10 10 9|7 7 9|7 15 15 15 7 17 15 17 20 17 22 4 25 25 22 31 28 31 27|31 31 27|31 22 33 22 4	PRODUCT-OF
16371234	CHEMICAL	GENE	T5	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ NS-398 @/CHEMICALSrc$ and @GENETgt$ COX-2 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced PGE2 production was significantly suppressed by indomethacin , a preferential COX-1 inhibitor , but not by @CHEMICALSrc$ NS-398 @/CHEMICALSrc$ , a selective @GENETgt$ COX-2 @/GENETgt$ inhibitor .	9 9 4 6 6 9 9 9 9 11 9 11 16 16 16 11 11 11 21 21 11|20 11 11|20 21 28 28 24|28 28 24|28 21 9	INHIBITOR
16371234	CHEMICAL	GENE	T16	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ prostaglandin E2 @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Involvement of @GENETgt$ COX-1 @/GENETgt$ and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced @CHEMICALSrc$ prostaglandin E2 @/CHEMICALSrc$ production by microglia .	1 3 1|2 1 1|2 1 1 9 9 6 16 12 16 16|11 16|11 16 16|11 6 18 6 1	PRODUCT-OF
16371234	CHEMICAL	GENE	T7	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ p44 @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote PGE2 production by transducing intracellular signals including @GENETgt$ p44/p42 @/GENETgt$ ERK after PS liposomes treatment .	3 3 24 6 6 3 12 9 12 9|12 12 9|12 3 12 16 16 12 16 20 20 12 24 24 24 24 26 24 28 24 30 28 34 34|30 34 34|30 30 38 37 38 28 24	None-BC7
16371234	CHEMICAL	GENE	T6	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with @GENETgt$ COX-1 @/GENETgt$ , especially mPGES-2 , plays the pivotal role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production by microglia .	2 4 4 4 22 7 22 10 10 7 14 14 14 7 16 14|15 14 14|15 16 20 16 22 4 25 25 22 31 28 31 27|31 31 27|31 22 33 22 4	PRODUCT-OF
16371234	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ NS-398 @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Furthermore , PS liposome-induced PGE2 production was significantly suppressed by indomethacin , a preferential @GENETgt$ COX-1 @/GENETgt$ inhibitor , but not by @CHEMICALSrc$ NS-398 @/CHEMICALSrc$ , a selective COX-2 inhibitor .	9 9 4 6 6 9 9 9 9 11 9 11 17 17 17|14 17 17|14 11 11 11 22 22 11|20 11 11|20 22 28 28 28 22 9	None-BC7
16371234	CHEMICAL	GENE	T18	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphatidylserine @/CHEMICALSrc$ and @GENETgt$ COX-1 @/GENETgt$ ? [SEP] Involvement of @GENETgt$ COX-1 @/GENETgt$ and up-regulated prostaglandin E synthases in @CHEMICALSrc$ phosphatidylserine @/CHEMICALSrc$ liposome-induced prostaglandin E2 production by microglia .	1 3 1|2 1 1|2 1 1 9 9 6 16 9|13 13 9|13 16 16 16 6 18 6 1	None-BC7
16371234	CHEMICAL	GENE	T7	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ and @GENETgt$ ERK @/GENETgt$ ? [SEP] Although SR-BI plays an essential role in PS liposome-induced @CHEMICALSrc$ PGE2 @/CHEMICALSrc$ production , other PS-recognizing receptors , possibly PS-specific receptor , could also promote PGE2 production by transducing intracellular signals including p44/p42 @GENETgt$ ERK @/GENETgt$ after PS liposomes treatment .	3 3 24 6 6 3 12 9 12 9|12 12 9|12 3 12 16 16 12 16 20 20 12 24 24 24 24 26 24 28 24 30 28 33 33 30|31 30 30|31 38 37 38 28 24	None-BC7
23339678	CHEMICAL	GENE	T4	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ ketorolac @/CHEMICALSrc$ and @GENETgt$ eCG @/GENETgt$ ? [SEP] Sixty-four female mice ( ICR ) were injected with @CHEMICALSrc$ ketorolac @/CHEMICALSrc$ ( 0 , 7.5 , 15 and 30 µg/d ) for 3 d starting from the day of @GENETgt$ eCG @/GENETgt$ treatment .	3 3 8 5 3 5 8 8 10 8|9 8 8|9 20 20 13 13 13 13 17 17 10 20 24 24 8 24 28 28 25 32 32|28 32 32|28 28 8	None-BC7
20615127	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ T3 @/CHEMICALSrc$ and @GENETgt$ NCoR @/GENETgt$ ? [SEP] However , a glutathione-S-transferase pull-down assay showed reduced binding of R316C with @GENETgt$ NCoR @/GENETgt$ in the absence of @CHEMICALSrc$ T3 @/CHEMICALSrc$ and impaired release in the presence of T3 .	7 7 6 5 6 7 7 9 7 11 9 13 9|12 9 9|12 17 17 9 19 17 17 17 9 23 9 26 26 23 28 26 7	None-BC7
20615127	CHEMICAL	GENE	T5	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] Our findings suggest that @GENETgt$ R316C @/GENETgt$ causes reduced association with and impaired release of NCoR , resulting in RTH predominantly at the pituitary level , and that slightly elevated serum TSH level with high dose of @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ might be optimum for normal growth .	2 3 3 7 4|7 7 4|7 3 9 7 9 10 13 9 15 13 7 7 19 17 17 24 24 24 17 7 7 41 29 32 32 32 41 35 35 32 37 35 35 35 41 41 7 44 44 41 3	None-BC7
20615127	CHEMICAL	GENE	T5	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ and @GENETgt$ TSH @/GENETgt$ ? [SEP] Our findings suggest that R316C causes reduced association with and impaired release of NCoR , resulting in RTH predominantly at the pituitary level , and that slightly elevated serum @GENETgt$ TSH @/GENETgt$ level with high dose of @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ might be optimum for normal growth .	2 3 3 6 6 3 8 6 8 9 12 8 14 12 6 6 18 16 16 23 23 23 16 6 6 41 28 32 32 32|29 32 32|29 41 35 35 32 37 35 35 35 41 41 6 44 44 41 3	INDIRECT-UPREGULATOR
20615127	CHEMICAL	GENE	T1	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ glutathione @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] However , a @CHEMICALSrc$ glutathione-S-transferase @/CHEMICALSrc$ pull-down assay showed reduced binding of @GENETgt$ R316C @/GENETgt$ with NCoR in the absence of T3 and impaired release in the presence of T3 .	8 8 7 3|6 6 3|6 7 8 8 10 8 12 10 10 10 15 10 18 18 10 20 18 10 23 10 26 26 23 28 26 8	None-BC7
20615127	CHEMICAL	GENE	T10	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ T3 @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] Consistent with the results of a computer analysis , the binding of @GENETgt$ R316C @/GENETgt$ to triiodothyronine ( @CHEMICALSrc$ T3 @/CHEMICALSrc$ ) was significantly decreased to 38 % that of the wild type .	23 4 4 1 8 8 8 4 23 11 23 13 11|12 11 11|12 16 11 18 16 16 16 18 23 23 23 26 26 23 23 31 31 31 27 23	DIRECT-REGULATOR
20615127	CHEMICAL	GENE	T6	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] As the RTH mutant , @GENETgt$ R316C @/GENETgt$ , was new , the optimum dose of @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ was unclear .	4 4 4 10 4 4|5 4 4|5 4 10 10 19 14 14 19 16 14 14 14 19 10 19	None-BC7
20615127	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ T3 @/CHEMICALSrc$ and @GENETgt$ NCoR @/GENETgt$ ? [SEP] However , a glutathione-S-transferase pull-down assay showed reduced binding of R316C with @GENETgt$ NCoR @/GENETgt$ in the absence of T3 and impaired release in the presence of @CHEMICALSrc$ T3 @/CHEMICALSrc$ .	7 7 6 5 6 7 7 9 7 11 9 13 9|12 9 9|12 17 17 9 19 17 9 22 9 25 25 22 27 25 25 25 7	None-BC7
20615127	CHEMICAL	GENE	T4	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ T3 @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] However , a glutathione-S-transferase pull-down assay showed reduced binding of @GENETgt$ R316C @/GENETgt$ with NCoR in the absence of T3 and impaired release in the presence of @CHEMICALSrc$ T3 @/CHEMICALSrc$ .	7 7 6 5 6 7 7 9 7 11 9|10 9 9|10 14 9 17 17 9 19 17 9 22 9 25 25 22 27 25 25 25 7	None-BC7
20615127	CHEMICAL	GENE	T7	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ thyroxine @/CHEMICALSrc$ and @GENETgt$ TSH @/GENETgt$ ? [SEP] SUMMARY : The patient was a newborn female having severe hypothyroidism with a free @CHEMICALSrc$ thyroxine @/CHEMICALSrc$ level of 0.36 ng/dL and a serum @GENETgt$ TSH @/GENETgt$ level of 177 microU/mL. A scintiscan showed ectopic lingual thyroid tissue without a normal thyroid gland .	32 8 4 8 8 8 8 32 8 11 9 17 17 17 17|14 17 17|14 9 20 20 17 17 26 26 26|22 26 26|22 17 31 29 31 31 26 32 36 36 36 32 41 41 41 41 32 32	None-BC7
20615127	CHEMICAL	GENE	T8	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ and @GENETgt$ TSH @/GENETgt$ ? [SEP] Supplementation with @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ at a dose of > 350 microg/day did not normalize the serum @GENETgt$ TSH @/GENETgt$ level ; however , the patient showed normal growth and intelligence at 14 years of age .	14 3 1|2 1 1|2 7 7 1 9 11 9 1 14 14 14 19 19 19|15 19 19|15 14 14 25 25 24 25 14 27 25 27 27 32 32 27 34 32 14	None-BC7
20615127	CHEMICAL	GENE	T9	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ triiodothyronine @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] Consistent with the results of a computer analysis , the binding of @GENETgt$ R316C @/GENETgt$ to @CHEMICALSrc$ triiodothyronine @/CHEMICALSrc$ ( T3 ) was significantly decreased to 38 % that of the wild type .	23 4 4 1 8 8 8 4 23 11 23 13 11|12 11 11|12 16 11|14 11 11|14 19 16 19 23 23 23 26 26 23 23 31 31 31 27 23	DIRECT-REGULATOR
20615127	CHEMICAL	GENE	T3	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ T3 @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] However , a glutathione-S-transferase pull-down assay showed reduced binding of @GENETgt$ R316C @/GENETgt$ with NCoR in the absence of @CHEMICALSrc$ T3 @/CHEMICALSrc$ and impaired release in the presence of T3 .	7 7 6 5 6 7 7 9 7 11 9|10 9 9|10 14 9 17 17 9 19 17 17 17 9 23 9 26 26 23 28 26 7	None-BC7
20615127	CHEMICAL	GENE	T1	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ glutathione @/CHEMICALSrc$ and @GENETgt$ NCoR @/GENETgt$ ? [SEP] However , a @CHEMICALSrc$ glutathione-S-transferase @/CHEMICALSrc$ pull-down assay showed reduced binding of R316C with @GENETgt$ NCoR @/GENETgt$ in the absence of T3 and impaired release in the presence of T3 .	8 8 7 3|6 6 3|6 7 8 8 10 8 12 10 14 10|12 10 10|12 18 18 10 20 18 10 23 10 26 26 23 28 26 8	None-BC7
20615127	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ and @GENETgt$ NCoR @/GENETgt$ ? [SEP] Our findings suggest that R316C causes reduced association with and impaired release of @GENETgt$ NCoR @/GENETgt$ , resulting in RTH predominantly at the pituitary level , and that slightly elevated serum TSH level with high dose of @CHEMICALSrc$ levothyroxine @/CHEMICALSrc$ might be optimum for normal growth .	2 3 3 6 6 3 8 6 8 9 12 8 14 12|13 12 12|13 6 6 19 17 17 24 24 24 17 6 6 41 29 32 32 32 41 35 35 32 37 35 35 35 41 41 6 44 44 41 3	None-BC7
20615127	CHEMICAL	GENE	T2	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ S @/CHEMICALSrc$ and @GENETgt$ NCoR @/GENETgt$ ? [SEP] However , a @CHEMICALSrc$ glutathione-S-transferase @/CHEMICALSrc$ pull-down assay showed reduced binding of R316C with @GENETgt$ NCoR @/GENETgt$ in the absence of T3 and impaired release in the presence of T3 .	8 8 7 3|6 6 3|6 7 8 8 10 8 12 10 14 10|12 10 10|12 18 18 10 20 18 10 23 10 26 26 23 28 26 8	None-BC7
20615127	CHEMICAL	GENE	T2	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ S @/CHEMICALSrc$ and @GENETgt$ R316C @/GENETgt$ ? [SEP] However , a @CHEMICALSrc$ glutathione-S-transferase @/CHEMICALSrc$ pull-down assay showed reduced binding of @GENETgt$ R316C @/GENETgt$ with NCoR in the absence of T3 and impaired release in the presence of T3 .	8 8 7 3|6 6 3|6 7 8 8 10 8 12 10 10 10 15 10 18 18 10 20 18 10 23 10 26 26 23 28 26 8	None-BC7
17594192	CHEMICAL	GENE	T9	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ phenserine @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] This effect probably involves interaction of @CHEMICALSrc$ phenserine @/CHEMICALSrc$ with a regulatory element in the 5'-untranslated region of the @GENETgt$ APP @/GENETgt$ gene that controls APP expression .	2 4 4 4 4 7 5|6 5 5|6 12 12 12 5 16 16 16 12 21 21 17|21 21 17|21 16 23 21 25 23 4	DIRECT-REGULATOR
17594192	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ phenserine @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] This effect probably involves interaction of @CHEMICALSrc$ phenserine @/CHEMICALSrc$ with a regulatory element in the 5'-untranslated region of the APP gene that controls @GENETgt$ APP @/GENETgt$ expression .	2 4 4 4 4 7 5|6 5 5|6 12 12 12 5 16 16 16 12 20 20 20 16 22 20 25|21 25 25|21 22 4	None-BC7
17594192	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ iron @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] Phenserine apparently reduces translational efficiency of @GENETgt$ APP @/GENETgt$ mRNA into protein , a process that may involve an interaction with iron and/or an @CHEMICALSrc$ iron-responsive @/CHEMICALSrc$ element .	3 3 3 5 3 9 9|6 9 9|6 5 11 5 11 14 11 17 17 14 19 17 21 19 21 26 26|22 26 26|22 21 3	None-BC7
17594192	CHEMICAL	GENE	T14	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of AChE , whereas (+)-phenserine ( ' posiphen ' ) has weak activity as an @GENETgt$ AChE @/GENETgt$ inhibitor and can be dosed much higher .	0|5 5 0|5 5 5 5 9 6 9 5 12 12 9 5 18 18 18 18 5 20 18 22 20 18 18 31 28 28 25 28 28 5 33 31 38 38 34|38 38 34|38 33 31 42 42 31 44 42 31	None-BC7
17594192	CHEMICAL	GENE	T7	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ physostigmine @/CHEMICALSrc$ and @GENETgt$ acetylcholinesterase @/GENETgt$ ? [SEP] Phenserine , a derivative of @CHEMICALSrc$ physostigmine @/CHEMICALSrc$ , was first described as an inhibitor of @GENETgt$ acetylcholinesterase @/GENETgt$ ( AChE ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	11 1 4 1 6 4|5 4 4|5 1 11 11 11 14 14 11 16 14 14 14 19 16 19 11 23 11 25 23 25 30 30 30 26 32 30 32 32 11	INHIBITOR
17594192	CHEMICAL	GENE	T1	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ , a derivative of physostigmine , was first described as an inhibitor of acetylcholinesterase ( @GENETgt$ AChE @/GENETgt$ ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	0|11 11 0|11 1 5 1 7 5 1 11 11 11 14 14 11 16 14 18 16 16 16 18 11 23 11 25 23 25 30 30 30 26 32 30 32 32 11	INHIBITOR
17594192	CHEMICAL	GENE	T8	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ deserves attention for an additional quality of action : in addition to inhibiting AChE , it modulates the amount of beta-amyloid precursor protein ( @GENETgt$ APP @/GENETgt$ ) in neuronal cell culture by reducing APP translation .	0|3 3 0|3 3 3 8 8 8 3 10 8 3 13 19 15 13 15 19 19 3 21 19 25 25 25 21 27 25 25 25 27 33 33 33 21 35 19 37 35 3	None-BC7
17594192	CHEMICAL	GENE	T13	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ phenserine @/CHEMICALSrc$ and @GENETgt$ Abeta @/GENETgt$ ? [SEP] As a consequence , @CHEMICALSrc$ phenserine @/CHEMICALSrc$ reduces beta-amyloid peptide ( @GENETgt$ Abeta @/GENETgt$ ) formation in vitro and in vivo .	3 3 7 7 4|7 7 4|7 7 9 14 11 9 9 9 11 7 16 17 7 19 17 7	INDIRECT-DOWNREGULATOR
17594192	CHEMICAL	GENE	T14	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of @GENETgt$ AChE @/GENETgt$ , whereas (+)-phenserine ( ' posiphen ' ) has weak activity as an AChE inhibitor and can be dosed much higher .	0|5 5 0|5 5 5 5 9 6 9 5 12 12 9 5 18 18 18 18 5 20 18 22 20 20 20 18 18 32 29 29 26 29 29 5 34 32 38 38 38 34 32 42 42 32 44 42 32	None-BC7
17594192	CHEMICAL	GENE	T2	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ (-)-phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : @CHEMICALSrc$ (-)-phenserine @/CHEMICALSrc$ is the active enantiomer for inhibition of @GENETgt$ AChE @/GENETgt$ , whereas (+)-phenserine ( ' posiphen ' ) has weak activity as an AChE inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 18|12 18 18|12 18 18 18 4 20 18 22 20 20 20 18 18 32 29 29 26 29 29 4 34 32 38 38 38 34 32 42 42 32 44 42 32	INHIBITOR
17594192	CHEMICAL	GENE	T3	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ (+)-phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of @GENETgt$ AChE @/GENETgt$ , whereas @CHEMICALSrc$ (+)-phenserine @/CHEMICALSrc$ ( ' posiphen ' ) has weak activity as an AChE inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 17 17 17 17 4 19 17 21 19|20 19 19|20 17 17 32|23 32 32|23 29 29 25 29 29 4 34 32 38 38 38 34 32 42 42 32 44 42 32	None-BC7
17594192	CHEMICAL	GENE	T4	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ posiphen @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of @GENETgt$ AChE @/GENETgt$ , whereas (+)-phenserine ( ' @CHEMICALSrc$ posiphen @/CHEMICALSrc$ ' ) has weak activity as an AChE inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 17 17 17 17 4 19 17 21 19|20 19 19|20 17 17 32 28 28 25|26 25 25|26 28 28 4 34 32 38 38 38 34 32 42 42 32 44 42 32	None-BC7
17594192	CHEMICAL	GENE	T8	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ beta-amyloid precursor protein @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ deserves attention for an additional quality of action : in addition to inhibiting AChE , it modulates the amount of @GENETgt$ beta-amyloid precursor protein @/GENETgt$ ( APP ) in neuronal cell culture by reducing APP translation .	0|3 3 0|3 3 3 8 8 8 3 10 8 3 13 19 15 13 15 19 19 3 21 19 23 21|23 21|23 21|23 21|23 21|23 28 23 28 33 33 33 21 35 19 37 35 3	None-BC7
17594192	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ deserves attention for an additional quality of action : in addition to inhibiting @GENETgt$ AChE @/GENETgt$ , it modulates the amount of beta-amyloid precursor protein ( APP ) in neuronal cell culture by reducing APP translation .	0|3 3 0|3 3 3 8 8 8 3 10 8 3 13 20 15 13 14|15 15 14|15 20 20 3 22 20 26 26 26 22 28 26 28 33 33 33 22 35 20 37 35 3	INHIBITOR
17594192	CHEMICAL	GENE	T2	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ (-)-phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : @CHEMICALSrc$ (-)-phenserine @/CHEMICALSrc$ is the active enantiomer for inhibition of AChE , whereas (+)-phenserine ( ' posiphen ' ) has weak activity as an @GENETgt$ AChE @/GENETgt$ inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 18|12 18 18|12 18 18 18 4 20 18 22 20 18 18 31 28 28 25 28 28 4 33 31 38 38 34|38 38 34|38 33 31 42 42 31 44 42 31	None-BC7
17594192	CHEMICAL	GENE	T11	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ iron @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] Phenserine apparently reduces translational efficiency of @GENETgt$ APP @/GENETgt$ mRNA into protein , a process that may involve an interaction with @CHEMICALSrc$ iron @/CHEMICALSrc$ and/or an iron-responsive element .	3 3 3 5 3 9 9|6 9 9|6 5 11 5 11 14 11 17 17 14 19 17 21 19 19 19 21 26 26 21 3	None-BC7
17594192	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ (+)-phenserine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of AChE , whereas @CHEMICALSrc$ (+)-phenserine @/CHEMICALSrc$ ( ' posiphen ' ) has weak activity as an @GENETgt$ AChE @/GENETgt$ inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 17 17 17 17 4 19 17 21 19 17 17 31|23 31 31|23 28 28 24 28 28 4 33 31 38 38 34|38 38 34|38 33 31 42 42 31 44 42 31	INHIBITOR
17594192	CHEMICAL	GENE	T7	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ physostigmine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine , a derivative of @CHEMICALSrc$ physostigmine @/CHEMICALSrc$ , was first described as an inhibitor of acetylcholinesterase ( @GENETgt$ AChE @/GENETgt$ ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	11 1 4 1 6 4|5 4 4|5 1 11 11 11 14 14 11 16 14 18 16 16 16 18 11 23 11 25 23 25 30 30 30 26 32 30 32 32 11	INHIBITOR
17594192	CHEMICAL	GENE	T4	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ posiphen @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Phenserine is also unique because of differing actions of its enantiomers : (-)-phenserine is the active enantiomer for inhibition of AChE , whereas (+)-phenserine ( ' @CHEMICALSrc$ posiphen @/CHEMICALSrc$ ' ) has weak activity as an @GENETgt$ AChE @/GENETgt$ inhibitor and can be dosed much higher .	4 4 4 4 8 5 8 4 11 11 8 4 17 17 17 17 4 19 17 21 19 17 17 31 27 27 24|26 24 24|26 27 27 4 33 31 38 38 34|38 38 34|38 33 31 42 42 31 44 42 31	INHIBITOR
17594192	CHEMICAL	GENE	T1	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ acetylcholinesterase @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ , a derivative of physostigmine , was first described as an inhibitor of @GENETgt$ acetylcholinesterase @/GENETgt$ ( AChE ) and was shown to improve cognition in various experimental paradigms in rodents and dogs .	0|11 11 0|11 1 5 1 7 5 1 11 11 11 14 14 11 16 14 14 14 19 16 19 11 23 11 25 23 25 30 30 30 26 32 30 32 32 11	INHIBITOR
17594192	CHEMICAL	GENE	T10	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ apparently reduces translational efficiency of @GENETgt$ APP @/GENETgt$ mRNA into protein , a process that may involve an interaction with iron and/or an iron-responsive element .	0|4 4 0|4 4 4 6 4 10 10|6 10 10|6 6 12 6 12 15 12 18 18 15 20 18 22 20 22 26 26 22 4	INDIRECT-DOWNREGULATOR
17594192	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ and @GENETgt$ APP @/GENETgt$ ? [SEP] @CHEMICALSrc$ Phenserine @/CHEMICALSrc$ deserves attention for an additional quality of action : in addition to inhibiting AChE , it modulates the amount of beta-amyloid precursor protein ( APP ) in neuronal cell culture by reducing @GENETgt$ APP @/GENETgt$ translation .	0|3 3 0|3 3 3 8 8 8 3 10 8 3 13 19 15 13 15 19 19 3 21 19 25 25 25 21 27 25 27 32 32 32 21 34 19 33|37 37 33|37 34 3	INDIRECT-DOWNREGULATOR
17594192	CHEMICAL	GENE	T13	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ phenserine @/CHEMICALSrc$ and @GENETgt$ beta-amyloid @/GENETgt$ ? [SEP] As a consequence , @CHEMICALSrc$ phenserine @/CHEMICALSrc$ reduces @GENETgt$ beta-amyloid @/GENETgt$ peptide ( Abeta ) formation in vitro and in vivo .	3 3 7 7 4|7 7 4|7 7 10|6 10 10|6 14 12 10 12 7 16 17 7 19 17 7	INDIRECT-DOWNREGULATOR
23290724	CHEMICAL	GENE	T8	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ N @/CHEMICALSrc$ and @GENETgt$ prion protein PrP(C) @/GENETgt$ ? [SEP] The cellular @GENETgt$ prion protein PrP(C ) @/GENETgt$ consists of two domains -- a flexible @CHEMICALSrc$ N-terminal @/CHEMICALSrc$ domain , which participates in copper and zinc regulation , and a largely helical C-terminal domain that converts to β sheet in the course of prion disease .	3 3 8|2|3 8|2|3 8|2|3 8|2|3 8|3 8|2|3 8 11 11 8 11 17 17 17|10 17 17|10 11 17 20 17 22 25 22 22 20 17 17 32 30 32 32 17 34 32 37 37 34 40 40 34 43 43 40 8	PART-OF
23290724	CHEMICAL	GENE	T5	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ N @/CHEMICALSrc$ and @GENETgt$ PrP(C) @/GENETgt$ ? [SEP] Here , we identify a Zn²⁺-driven @CHEMICALSrc$ N-terminal @/CHEMICALSrc$ to C-terminal tertiary interaction in @GENETgt$ PrP(C ) @/GENETgt$ .	4 4 4 4 7 7 4|6 4 4|6 12 12 12 4 14 12|4 12|4 12|4 12|4 4	PART-OF
23290724	CHEMICAL	GENE	T6	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ PrP(C) @/GENETgt$ ? [SEP] Here , we identify a Zn²⁺-driven N-terminal to @CHEMICALSrc$ C-terminal @/CHEMICALSrc$ tertiary interaction in @GENETgt$ PrP(C ) @/GENETgt$ .	4 4 4 4 7 7 4 12 8|12 12 8|12 12 4 14 12|4 12|4 12|4 12|4 4	PART-OF
23290724	CHEMICAL	GENE	T4	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ Zn²⁺ @/CHEMICALSrc$ and @GENETgt$ PrP(C) @/GENETgt$ ? [SEP] Here , we identify a @CHEMICALSrc$ Zn²⁺-driven @/CHEMICALSrc$ N-terminal to C-terminal tertiary interaction in @GENETgt$ PrP(C ) @/GENETgt$ .	4 4 4 4 8 8|5 8 8|5 4 12 12 12 4 14 12|4 12|4 12|4 12|4 4	None-BC7
23290724	CHEMICAL	GENE	T1	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ copper @/CHEMICALSrc$ and @GENETgt$ prion protein PrP(C) @/GENETgt$ ? [SEP] The cellular @GENETgt$ prion protein PrP(C ) @/GENETgt$ consists of two domains -- a flexible N-terminal domain , which participates in @CHEMICALSrc$ copper @/CHEMICALSrc$ and zinc regulation , and a largely helical C-terminal domain that converts to β sheet in the course of prion disease .	3 3 8|2|3 8|2|3 8|2|3 8|2|3 8|3 8|2|3 8 11 11 8 11 16 16 16 11 16 19 16 21 16|25 25 16|25 21 21 19 16 16 32 30 32 32 16 34 32 37 37 34 40 40 34 43 43 40 8	None-BC7
23290724	CHEMICAL	GENE	T3	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ C @/CHEMICALSrc$ and @GENETgt$ prion protein PrP(C) @/GENETgt$ ? [SEP] The cellular @GENETgt$ prion protein PrP(C ) @/GENETgt$ consists of two domains -- a flexible N-terminal domain , which participates in copper and zinc regulation , and a largely helical @CHEMICALSrc$ C-terminal @/CHEMICALSrc$ domain that converts to β sheet in the course of prion disease .	3 3 8|2|3 8|2|3 8|2|3 8|2|3 8|3 8|2|3 8 11 11 8 11 16 16 16 11 16 19 16 21 24 21 21 19 16 16 32 29 32 32|25 32 32|25 16 34 32 37 37 34 40 40 34 43 43 40 8	PART-OF
23290724	CHEMICAL	GENE	T9	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ Zinc @/CHEMICALSrc$ and @GENETgt$ prion protein @/GENETgt$ ? [SEP] @CHEMICALSrc$ Zinc @/CHEMICALSrc$ drives a tertiary fold in the @GENETgt$ prion protein @/GENETgt$ with familial disease mutation sites at the interface .	0|3 3 0|3 3 6 6 3 9 9 9|3|7 9|3|7 9|3 9|3|7 16 16 16 16 3 19 19 3 3	None-BC7
23290724	CHEMICAL	GENE	T2	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ zinc @/CHEMICALSrc$ and @GENETgt$ prion protein PrP(C) @/GENETgt$ ? [SEP] The cellular @GENETgt$ prion protein PrP(C ) @/GENETgt$ consists of two domains -- a flexible N-terminal domain , which participates in copper and @CHEMICALSrc$ zinc @/CHEMICALSrc$ regulation , and a largely helical C-terminal domain that converts to β sheet in the course of prion disease .	3 3 8|2|3 8|2|3 8|2|3 8|2|3 8|3 8|2|3 8 11 11 8 11 16 16 16 11 16 19 16 21 25 21 18|21 21 18|21 19 16 16 32 30 32 32 16 34 32 37 37 34 40 40 34 43 43 40 8	None-BC7
17632107	CHEMICAL	GENE	T8	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ rosiglitazone @/CHEMICALSrc$ and @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ ? [SEP] On the other hand , the activities of @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ were not changed by Wy-14643 , ETYA , @CHEMICALSrc$ rosiglitazone @/CHEMICALSrc$ , nor PUFAs .	4 4 4 16 16 7 16 9 8|9|7 8|9|7 8|9|7 8|9|7 9|7 8|9|7 16 16 16 18 16 18 18 20 17|18 18 17|18 18 18 18 16	None-BC7
17632107	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ PPARgamma @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four peroxisome proliferator-activated receptors ( PPARs ) , PPARalpha1 , PPARalpha2 , PPARbeta , and @GENETgt$ PPARgamma @/GENETgt$ , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 11 11 11 11 6 13 11 13 11 11 16 16 16 16 16 16 16|22 16 16|22 11 30 30 30 30 11 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 54|47 54 54|47 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T1	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ ETYA @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 and alpha2 @/GENETgt$ ? [SEP] The activities of torafugu @GENETgt$ PPARalpha1 and alpha2 @/GENETgt$ were also enhanced 5.6- and 6.3-fold by @CHEMICALSrc$ ETYA @/CHEMICALSrc$ at 1 microM , respectively , but not by Wy-14643 at this concentration .	2 11 5 5 2|4|5 2|4|5 2|4|5 2|5 2|4|5 11 11 11 11 12 12 16 11|12 11 11|12 20 20 11 20 20 20 25 27 27 20 30 30 11 11	None-BC7
17632107	CHEMICAL	GENE	T9	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ peroxisome proliferator-activated receptors @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four @GENETgt$ peroxisome proliferator-activated receptors @/GENETgt$ ( PPARs ) , PPARalpha1 , PPARalpha2 , PPARbeta , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 9 9 8|9|6 8|9|6 8|9|6 9|6 8|9|6 14 9 14 9 9 17 17 17 17 17 17 17 9 30 30 30 30 9 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 45|54 54 45|54 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ 5,8,11,14-eicosatetraynoic acid @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu @GENETgt$ PPARalpha1 @/GENETgt$ was enhanced 4.5- and 11.5-fold by Wy-14643 and @CHEMICALSrc$ 5,8,11,14-eicosatetraynoic acid @/CHEMICALSrc$ ( ETYA ) each at 10 microM , respectively , whereas that of PPARalpha2 , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 9 6 6 3|5 3 3|5 9 9 9 9 9 14 9 14 16|14 16|14 16|14 16|14 20 16 20 14 25 25 9 25 9 9 9 9 32 30 32 32 32 32 40 40 40 32 44 44 44 40 40 40 9	ACTIVATOR
17632107	CHEMICAL	GENE	T9	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ PPARs @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four peroxisome proliferator-activated receptors ( @GENETgt$ PPARs @/GENETgt$ ) , PPARalpha1 , PPARalpha2 , PPARbeta , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 11 11 11 11 6 13 11|12 11 11|12 13 11 11 17 17 17 17 17 17 17 11 30 30 30 30 11 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 54|47 54 54|47 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ ETYA @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu @GENETgt$ PPARalpha1 @/GENETgt$ was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid ( @CHEMICALSrc$ ETYA @/CHEMICALSrc$ ) each at 10 microM , respectively , whereas that of PPARalpha2 , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 9 6 6 3|5 3 3|5 9 9 9 9 9 14 9 14 17 14 19 17 17 17 19 14 25 25 9 25 9 9 9 9 32 30 32 32 32 32 40 40 40 32 44 44 44 40 40 40 9	ACTIVATOR
17632107	CHEMICAL	GENE	T11	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and @GENETgt$ PPARalpha2 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and 5,8,11,14-eicosatetraynoic acid ( ETYA ) each at 10 microM , respectively , whereas that of @GENETgt$ PPARalpha2 @/GENETgt$ , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 8 6 6 3 8 8 8 8 8 13 8|12 8 8|12 13 17 13 19 17 19 13 24 24 8 24 8 8 8 8 31 29 29 29 31 31 31 31 40 40 40 31 44 44 44 40 40 40 8	DIRECT-REGULATOR
17632107	CHEMICAL	GENE	T4	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ docosahexaenoic acid @/CHEMICALSrc$ and @GENETgt$ torafugu PPARalphas @/GENETgt$ ? [SEP] Furthermore , the activities of the two @GENETgt$ torafugu PPARalphas @/GENETgt$ were enhanced 4.3- and 7.6-fold by arachidonic acid , 4.4- and 5.2-fold by @CHEMICALSrc$ docosahexaenoic acid @/CHEMICALSrc$ , and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM , respectively .	12 12 4 12 8 8 8 8|4|7 8|4|7 8|4 8|4|7 12 12 12 13 13 18 18 12 18 18 18 24 24 24|18|21 24|18|21 24|18 24|18|21 18 18 18 18 18 34 34 12 12 38 38 12 38 12 12	ACTIVATOR
17632107	CHEMICAL	GENE	T3	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ arachidonic acid @/CHEMICALSrc$ and @GENETgt$ torafugu PPARalphas @/GENETgt$ ? [SEP] Furthermore , the activities of the two @GENETgt$ torafugu PPARalphas @/GENETgt$ were enhanced 4.3- and 7.6-fold by @CHEMICALSrc$ arachidonic acid @/CHEMICALSrc$ , 4.4- and 5.2-fold by docosahexaenoic acid , and 6.7- and 8.0-fold by eicosapentaenoic acid each at 50 microM , respectively .	12 12 4 12 8 8 8 8|4|7 8|4|7 8|4 8|4|7 12 12 12 13 13 17 17|12|14 17|12|14 17|12 17|12|14 17 17 17 26 26 26 17 17 17 17 17 17 34 34 12 12 38 38 12 38 12 12	ACTIVATOR
17632107	CHEMICAL	GENE	T2	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 and alpha2 @/GENETgt$ ? [SEP] The activities of torafugu @GENETgt$ PPARalpha1 and alpha2 @/GENETgt$ were also enhanced 5.6- and 6.3-fold by ETYA at 1 microM , respectively , but not by @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ at this concentration .	2 11 5 5 2|4|5 2|4|5 2|4|5 2|5 2|4|5 11 11 11 11 12 12 16 11 19 19 11 19 19 19 24 26 26 19|22 19 19|22 30 30 11 11	None-BC7
17632107	CHEMICAL	GENE	T9	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four peroxisome proliferator-activated receptors ( PPARs ) , @GENETgt$ PPARalpha1 @/GENETgt$ , PPARalpha2 , PPARbeta , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 11 11 11 11 6 13 11 13 11 11|15 11 11|15 16 16 16 16 16 16 16 11 30 30 30 30 11 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 54|47 54 54|47 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T9	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ PPARbeta @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four peroxisome proliferator-activated receptors ( PPARs ) , PPARalpha1 , PPARalpha2 , @GENETgt$ PPARbeta @/GENETgt$ , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 11 11 11 11 6 13 11 13 11 11 16 16 16 16|19 16 16|19 16 16 16 11 30 30 30 30 11 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 54|47 54 54|47 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ ETYA @/CHEMICALSrc$ and @GENETgt$ PPARalpha2 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and 5,8,11,14-eicosatetraynoic acid ( @CHEMICALSrc$ ETYA @/CHEMICALSrc$ ) each at 10 microM , respectively , whereas that of @GENETgt$ PPARalpha2 @/GENETgt$ , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 8 6 6 3 8 8 8 8 8 13 8 13 16 13 18 16|17 16 16|17 18 13 24 24 8 24 8 8 8 8 31 29 29 29 31 31 31 31 40 40 40 31 44 44 44 40 40 40 8	DIRECT-REGULATOR
17632107	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ Although torafugu PPARs @/GENETgt$ ? [SEP] @GENETgt$ Although torafugu PPARs @/GENETgt$ showed a high similarity in the primary structure to other vertebrate counterparts , torafugu PPARalpha2 and gamma contained additional sequences of 21 and 28 @CHEMICALSrc$ amino acids @/CHEMICALSrc$ , respectively , as in the case of other teleost fish species when compared with African clawed frog counterparts .	0|1|5 0|1|5 0|1|5 1|5 0|1|5 22 8 8 5 12 12 12 8 16 16 16 12 16 19 22 19 19 22 24 22 29 29 26 26 24|25|29 24|25|29 24|29 24|25|29 22 22 22 38 38 38 22 43 43 43 43 38 45 48 47 45 22 50 48 22	None-BC7
17632107	CHEMICAL	GENE	T9	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ and @GENETgt$ PPARalpha2 @/GENETgt$ ? [SEP] Structural and functional properties were investigated for four peroxisome proliferator-activated receptors ( PPARs ) , PPARalpha1 , @GENETgt$ PPARalpha2 @/GENETgt$ , PPARbeta , and PPARgamma , from torafugu pufferfish Takifugu rubripes and determined for their transcriptional activity by the reporter assay using reporter plasmids containing three copies of the @CHEMICALSrc$ acyl-CoA @/CHEMICALSrc$ oxidase PPAR response element .	6 1 1 1 6 6 11 11 11 11 6 13 11 13 11 11 16 16|17 16 16|17 16 16 16 16 16 11 30 30 30 30 11 6 6 36 36 36 32 40 40 40 36 32 43 41 43 46 44 54 54 54|47 54 54|47 54 54 54 46 6	None-BC7
17632107	CHEMICAL	GENE	T11	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and @GENETgt$ PPARalpha1 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu @GENETgt$ PPARalpha1 @/GENETgt$ was enhanced 4.5- and 11.5-fold by @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and 5,8,11,14-eicosatetraynoic acid ( ETYA ) each at 10 microM , respectively , whereas that of PPARalpha2 , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 9 6 6 3|5 3 3|5 9 9 9 9 9 14 9|12 9 9|12 14 18 14 20 18 20 14 25 25 9 25 9 9 9 9 32 30 32 32 32 32 40 40 40 32 44 44 44 40 40 40 9	ACTIVATOR
17632107	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ torafugu PPARalpha2 and gamma @/GENETgt$ ? [SEP] Although torafugu PPARs showed a high similarity in the primary structure to other vertebrate counterparts , @GENETgt$ torafugu PPARalpha2 and gamma @/GENETgt$ contained additional sequences of 21 and 28 @CHEMICALSrc$ amino acids @/CHEMICALSrc$ , respectively , as in the case of other teleost fish species when compared with African clawed frog counterparts .	4 3 4 22 7 7 4 11 11 11 7 15 15 15 11 15 16|17|22 16|17|22 16|17|22 16|17|22 17|22 16|17|22 22 24 22 29 29 26 26 24|29 24|29 24|29 24|29 22 22 22 38 38 38 22 43 43 43 43 38 45 48 47 45 22 50 48 22	None-BC7
17632107	CHEMICAL	GENE	T6	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ and @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ ? [SEP] On the other hand , the activities of @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ were not changed by @CHEMICALSrc$ Wy-14643 @/CHEMICALSrc$ , ETYA , rosiglitazone , nor PUFAs .	4 4 4 16 16 7 16 9 8|9|7 8|9|7 8|9|7 8|9|7 9|7 8|9|7 16 16 16 18 16|13 16 16|13 18 18 21 18 18 18 18 16	None-BC7
17632107	CHEMICAL	GENE	T12	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ 5,8,11,14-eicosatetraynoic acid @/CHEMICALSrc$ and @GENETgt$ PPARalpha2 @/GENETgt$ ? [SEP] The transcriptional activity of torafugu PPARalpha1 was enhanced 4.5- and 11.5-fold by Wy-14643 and @CHEMICALSrc$ 5,8,11,14-eicosatetraynoic acid @/CHEMICALSrc$ ( ETYA ) each at 10 microM , respectively , whereas that of @GENETgt$ PPARalpha2 @/GENETgt$ , 4.5- and 7.3-fold at the same concentration of the respective ligands , respectively .	3 3 8 6 6 3 8 8 8 8 8 13 8 13 13|14|15 13|14|15 13|15 13|14|15 19 15 19 13 24 24 8 24 8 8 8 8 31 28|29 29 28|29 31 31 31 31 40 40 40 31 44 44 44 40 40 40 8	DIRECT-REGULATOR
17632107	CHEMICAL	GENE	T7	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ ETYA @/CHEMICALSrc$ and @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ ? [SEP] On the other hand , the activities of @GENETgt$ torafugu PPARbeta and gamma @/GENETgt$ were not changed by Wy-14643 , @CHEMICALSrc$ ETYA @/CHEMICALSrc$ , rosiglitazone , nor PUFAs .	4 4 4 16 16 7 16 9 8|9|7 8|9|7 8|9|7 8|9|7 9|7 8|9|7 16 16 16 18 16 18 18|15 18 18|15 20 18 18 18 18 16	None-BC7
17632107	CHEMICAL	GENE	T5	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ eicosapentaenoic acid @/CHEMICALSrc$ and @GENETgt$ torafugu PPARalphas @/GENETgt$ ? [SEP] Furthermore , the activities of the two @GENETgt$ torafugu PPARalphas @/GENETgt$ were enhanced 4.3- and 7.6-fold by arachidonic acid , 4.4- and 5.2-fold by docosahexaenoic acid , and 6.7- and 8.0-fold by @CHEMICALSrc$ eicosapentaenoic acid @/CHEMICALSrc$ each at 50 microM , respectively .	12 12 4 12 8 8 8 8|4|7 8|4|7 8|4 8|4|7 12 12 12 13 13 18 18 12 18 18 18 25 25 25 18 18 18 18 18 18 32 32|12|29 32|12|29 32|12 32|12|29 12 38 38 12 38 12 12	ACTIVATOR
20012638	CHEMICAL	GENE	T6	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Bricanyl @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Terbutaline ( @CHEMICALSrc$ Bricanyl @/CHEMICALSrc$ ) and its prodrug Bambuterol ( Bambec ) are highly potent @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ agonists often used in asthma patients .	18 3 1|2 1 1|2 3 1 9 9 1 11 9 11 18 15 18 18|14 18 18|14 18 20 18 23 23 20 18	AGONIST
20012638	CHEMICAL	GENE	T1	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Terbutaline @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] @CHEMICALSrc$ Terbutaline @/CHEMICALSrc$ ( Bricanyl ) and its prodrug Bambuterol ( Bambec ) are highly potent @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ agonists often used in asthma patients .	0|18 18 0|18 4 1 4 1 9 9 1 11 9 11 18 15 18 18|14 18 18|14 18 20 18 23 23 20 18	AGONIST
20012638	CHEMICAL	GENE	T13	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Bambec @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Terbutaline ( Bricanyl ) and its prodrug Bambuterol ( @CHEMICALSrc$ Bambec @/CHEMICALSrc$ ) are highly potent @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ agonists often used in asthma patients .	18 3 1 3 1 8 8 1 10 8|9 8 8|9 10 18 15 18 18|14 18 18|14 18 20 18 23 23 20 18	AGONIST
20012638	CHEMICAL	GENE	T11	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ Bambuterol @/CHEMICALSrc$ and @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ ? [SEP] Terbutaline ( Bricanyl ) and its prodrug @CHEMICALSrc$ Bambuterol @/CHEMICALSrc$ ( Bambec ) are highly potent @GENETgt$ beta(2)-adrenoceptor @/GENETgt$ agonists often used in asthma patients .	18 3 1 3 1 8 8 1|7 1 1|7 11 8 11 18 15 18 18|14 18 18|14 18 20 18 23 23 20 18	AGONIST
23500061	CHEMICAL	GENE	T1	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ Src homology region 2 domain-containing tyrosine phosphatase-1 @/GENETgt$ ? [SEP] Herein , we report ischemic-reperfused myocardial infarction ( MI ) repair with siRNA against @GENETgt$ Src homology region 2 domain-containing @/GENETgt$ @CHEMICALSrc$ tyrosine phosphatase-1 @/CHEMICALSrc$ ( SHP-1 ) , which is known as a key factor involved in regulating the progress of apoptosis in many cell types .	4 4 4 4 7 7 11 9 7 9 4 13 11 21 21|14 21|14 21|14 21|14 21|14 21 21|14 21|13|15 21|13|15 21|13 21|13|15 25 21 25 21 30 30 21 34 34 34 30 34 37 35 39 37 41 39 45 45 45 39 4	None-BC7
23500061	CHEMICAL	GENE	T2	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ polyethyleneimine @/CHEMICALSrc$ and @GENETgt$ SHP-1 @/GENETgt$ ? [SEP] A low molecular weight @CHEMICALSrc$ polyethyleneimine @/CHEMICALSrc$ modified with deoxycholic acid (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of @GENETgt$ SHP-1 @/GENETgt$ siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles .	5 5 5 5 4|15 15 4|15 5 13 13 13 12 13 7 15 15 19 19 19 15 23 19|23 23 19|23 19 25 15 30 30 30 30 25 32 30 38 33 38 37 38 25 43 43 43 43 38 15	None-BC7
23500061	CHEMICAL	GENE	T4	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ deoxycholic acid @/CHEMICALSrc$ and @GENETgt$ SHP-1 @/GENETgt$ ? [SEP] Anti-apoptotic cardioprotective effects of @GENETgt$ SHP-1 @/GENETgt$ gene silencing against ischemia-reperfusion injury : Use of @CHEMICALSrc$ deoxycholic acid-modified @/CHEMICALSrc$ low molecular weight polyethyleneimine as a cardiac siRNA-carrier .	3 3 3 8 8|4 8 8|4 8 3 11 11 8 3 3 21 21|13|15 21|13|15 21|15 21|13|15 21 21 21 13 25 25 25 13 3	None-BC7
23500061	CHEMICAL	GENE	T5	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ polyethyleneimine @/CHEMICALSrc$ and @GENETgt$ SHP-1 @/GENETgt$ ? [SEP] Anti-apoptotic cardioprotective effects of @GENETgt$ SHP-1 @/GENETgt$ gene silencing against ischemia-reperfusion injury : Use of deoxycholic acid-modified low molecular weight @CHEMICALSrc$ polyethyleneimine @/CHEMICALSrc$ as a cardiac siRNA-carrier .	3 3 3 8 8|4 8 8|4 8 3 11 11 8 3 3 20 16 20 20 20 20 18|13 13 18|13 25 25 25 13 3	None-BC7
23500061	CHEMICAL	GENE	T1	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ SHP-1 @/GENETgt$ ? [SEP] Herein , we report ischemic-reperfused myocardial infarction ( MI ) repair with siRNA against Src homology region 2 domain-containing @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase-1 ( @GENETgt$ SHP-1 @/GENETgt$ ) , which is known as a key factor involved in regulating the progress of apoptosis in many cell types .	4 4 4 4 7 7 11 9 7 9 4 13 11 22 22 22 22 22 22 19|22 22 19|22 13 24 22 22 22 24 22 30 30 22 34 34 34 30 34 37 35 39 37 41 39 45 45 45 39 4	None-BC7
23500061	CHEMICAL	GENE	T3	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ deoxycholic acid @/CHEMICALSrc$ and @GENETgt$ SHP-1 @/GENETgt$ ? [SEP] A low molecular weight polyethyleneimine modified with @CHEMICALSrc$ deoxycholic acid @/CHEMICALSrc$ (PEI1.8-DA)-based delivery strategy was suggested for the cardiac application of @GENETgt$ SHP-1 @/GENETgt$ siRNA to overcome the poor gene delivery efficiency to myocardium due to the highly charged structures of the compact cardiac muscles .	5 5 5 5 15 5 13 13|7 13|7 13 13|7 12 13 6 15 15 19 19 19 15 23 18|23 23 18|23 19 25 15 30 30 30 30 25 32 30 38 33 38 37 38 25 43 43 43 43 38 15	None-BC7
20091113	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ SLC6A3 @/GENETgt$ ? [SEP] We evaluated associations between mood , cognitive and cardiovascular responses to @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and four polymorphisms in the dopamine transporter ( @GENETgt$ SLC6A3 @/GENETgt$ ): rs460000 , rs3756450 , rs37022 and rs6869645 .	2 2 2 5 3 5 5 5 5 5 12 10|11 10 10|11 12 16 12 20 20 20 16 22 20 20 20 22 5 5 5 27 27 29 29 2	None-BC7
20091113	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ dopamine transporter @/GENETgt$ ? [SEP] We evaluated associations between mood , cognitive and cardiovascular responses to @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and four polymorphisms in the @GENETgt$ dopamine transporter @/GENETgt$ ( SLC6A3 ): rs460000 , rs3756450 , rs37022 and rs6869645 .	2 2 2 5 3 5 5 5 5 5 12 10|11 10 10|11 12 16 12 19 19 16|17|19 16|17|19 16|19 16|17|19 23 19 23 5 5 5 27 27 29 29 2	None-BC7
20091113	CHEMICAL	GENE	T6	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ and @GENETgt$ dopamine transporter @/GENETgt$ ? [SEP] Polymorphisms in @GENETgt$ dopamine transporter @/GENETgt$ ( SLC6A3 ) are associated with stimulant effects of @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ : an exploratory pharmacogenetic study using healthy volunteers .	10 3 1|2|3 1|2|3 1|3 1|2|3 7 3 7 10 10 13 13 10 15 12|13 13 12|13 10 21 21 21 10 21 24 22 10	ACTIVATOR
20091113	CHEMICAL	GENE	T6	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ and @GENETgt$ SLC6A3 @/GENETgt$ ? [SEP] Polymorphisms in dopamine transporter ( @GENETgt$ SLC6A3 @/GENETgt$ ) are associated with stimulant effects of @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ : an exploratory pharmacogenetic study using healthy volunteers .	10 4 4 1 6 4|5 4 4|5 6 10 10 13 13 10 15 13 13 13 10 21 21 21 10 21 24 22 10	ACTIVATOR
20091113	CHEMICAL	GENE	T5	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ dopamine @/CHEMICALSrc$ and @GENETgt$ SLC6A3 @/GENETgt$ ? [SEP] Polymorphisms in @CHEMICALSrc$ dopamine @/CHEMICALSrc$ transporter ( @GENETgt$ SLC6A3 @/GENETgt$ ) are associated with stimulant effects of D-amphetamine : an exploratory pharmacogenetic study using healthy volunteers .	11 5 2|5 5 2|5 1 7 5 5 5 7 11 11 14 14 11 16 14 11 21 21 21 11 21 24 22 11	None-BC7
20091113	CHEMICAL	GENE	T3	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ dopamine @/CHEMICALSrc$ and @GENETgt$ SLC6A3 @/GENETgt$ ? [SEP] We evaluated associations between mood , cognitive and cardiovascular responses to d-amphetamine and four polymorphisms in the @CHEMICALSrc$ dopamine @/CHEMICALSrc$ transporter ( @GENETgt$ SLC6A3 @/GENETgt$ ): rs460000 , rs3756450 , rs37022 and rs6869645 .	2 2 2 5 3 5 5 5 5 5 12 10 12 15 12 20 20 17|20 20 17|20 15 22 20 20 20 22 5 5 5 27 27 29 29 2	None-BC7
19244097	CHEMICAL	GENE	T31	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited @CHEMICALSrc$ d-amphetamine-induced @/CHEMICALSrc$ @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 27|22 27 27|22 27|23 27 27|23 22 29 27 31 29 34 34 31 39 39 39 39 31 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T42	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular @GENETgt$ DAT @/GENETgt$ substrate .	7 1 1|2 1 1|2 7 7 7 10 10 7 10 13 11 13 13 7 7 25 22 22 22 25 25 25 17 31 31 31 27|31 31 27|31 25 7	None-BC7
19244097	CHEMICAL	GENE	T16	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ ) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16 19 19 19 16 25 16 25 28 32|27 32 32|27 32 32 12 37 37 34 37 32 32 42 39 42 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T15	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16 19 19|20 19 19|20 19 16 26 16 26 29 32 32 32 12 37 37 34 37 32 32 42 39 42 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T40	T54	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20041 , which does not alter @GENETgt$ DAT-mediated @/GENETgt$ DA release measured with [(3)H]DA , reversed the effect of @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ .	15 1 6 6 6 1 10|6 10 10|6 10 6 10 13 11 15 15 17 15 19 17 17 17 15	None-BC7
19244097	CHEMICAL	GENE	T25	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ RTI-55 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( @CHEMICALSrc$ RTI-55 @/CHEMICALSrc$ ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	17 3 1 3 1 1 8 6 8 6 6 6 14 12 14 17 17 26 26 21 26 23 21|22 21 21|22 23 17 17 17 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 17	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T29	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 23 23 9 9|10 9 9|10 9 15 9 19 19 19 15 19 9 23 7 26 26 23 28 26 30 28 33 33 30 39 39 34|39 39 34|39 39 30 39 39 45 45 45 23 7	None-BC7
19244097	CHEMICAL	GENE	T27	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]dopamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited @CHEMICALSrc$ [(3)H]dopamine @/CHEMICALSrc$ uptake .	17 3 1 3 1 1 8 6 8 6 6 6 14 12 14 17 17 25 25 21 25 23 21 23 17 17 17 30 30 27 32 30 35 35 34|30 30 34|30 30 27 40 27 43|39 43 43|39 40 17	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T44	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated @CHEMICALSrc$ DA @/CHEMICALSrc$ release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular @GENETgt$ DAT @/GENETgt$ substrate .	6 1 1 6 6 6 10 10|7 10 10|7 6 10 13 11 13 13 6 6 25 22 22 22 25 25 25 17 31 31 31 27|31 31 27|31 25 6	None-BC7
19244097	CHEMICAL	GENE	T33	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ MPP(+) @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( @CHEMICALSrc$ MPP(+))or[(3)H]dopamine @/CHEMICALSrc$ from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 25 25 22 27 25 29 27|28 27 27|28 33 33 29 39 39 34|39 39 34|39 39 29 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T34	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]dopamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( @CHEMICALSrc$ MPP(+))or[(3)H]dopamine @/CHEMICALSrc$ from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 25 25 22 27 25 29 27|28 27 27|28 33 33 29 39 39 34|39 39 34|39 39 29 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T11	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	18 3 1|2 1 1|2 3 1 1 9 7 9 7 7 7 15 13 15 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T28	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 23 8|23 23 8|23 9 9 9 15 9 19 19 19 15 19 9 23 7 26 26 23 28 26 30 28 33 33 30 39 39 34|39 39 34|39 39 30 39 39 45 45 45 23 7	None-BC7
19244097	CHEMICAL	GENE	T17	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of @CHEMICALSrc$ D-amphetamine-induced @/CHEMICALSrc$ DAT-mediated DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 37 32|37 37 32|37 33 37 31 31 42 39 42 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T20	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) [(3)H]DA uptake and @CHEMICALSrc$ d-amphetamine-induced @/CHEMICALSrc$ DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 37 37 33 33 33 37 31 31 42 39 42 12 42 42|47 47 42|47 47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T2	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)-3,4-methylenedioxyamphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited @GENETgt$ DAT-mediated @/GENETgt$ DA release induced by DA or @CHEMICALSrc$ (+/-)-3,4-methylenedioxyamphetamine @/CHEMICALSrc$ , demonstrating that the observed partial inhibition is not specific for a particular DAT substrate .	6 1 1 6 6 6 10|6 10 10|6 10 6 10 13 11 13 13 13 13 6 6 26 23 23 23 26 26 26 18 31 31 31 31 26 6	None-BC7
19244097	CHEMICAL	GENE	T32	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]1-methyl-4-phenylpyridinium @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of @CHEMICALSrc$ [(3)H]1-methyl-4-phenylpyridinium @/CHEMICALSrc$ ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 25 25 22 27 25|26 25 25|26 30 27 33 33 30 39 39 34|39 39 34|39 39 30 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T41	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular @GENETgt$ DAT @/GENETgt$ substrate .	0|7 7 0|7 1 1 7 7 7 10 10 7 10 13 11 13 13 7 7 25 22 22 22 25 25 25 17 31 31 31 27|31 31 27|31 25 7	None-BC7
19244097	CHEMICAL	GENE	T43	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] @CHEMICALSrc$ N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	0|18 18 0|18 4 1 4 1 1 9 7 9 7 7 7 15 13 15 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T26	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ [(125)I]RTI-55 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of @CHEMICALSrc$ [(125)I]RTI-55 @/CHEMICALSrc$ from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	17 3 1 3 1 1 8 6 8 6 6 6 14 12 14 17 17 25 25 21 25 23 21 23 17 17 17 30 30 27 32 30|31 30 30|31 36 36 34|30 30 34|30 30 27 41 27 43 41 17	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T35	T55	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] Recent studies identified novel allosteric modulators of the dopamine ( @CHEMICALSrc$ DA @/CHEMICALSrc$ ) transporter ( @GENETgt$ DAT @/GENETgt$ ) .	2 3 3 6 6 3 16 16 16 16 16|10 16 16|10 16 16 16 14|6 6 14|6 16 3	None-BC7
19244097	CHEMICAL	GENE	T1	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by @CHEMICALSrc$ DA @/CHEMICALSrc$ or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular @GENETgt$ DAT @/GENETgt$ substrate .	6 1 1 6 6 6 9 9 6 9 12 10|11 10 10|11 12 12 6 6 25 22 22 22 25 25 25 17 31 31 31 27|31 31 27|31 25 6	None-BC7
19244097	CHEMICAL	GENE	T14	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16|18 16 16|18 19 19 19 16 26 16 26 29 32 32 32 12 38 38 33|34 34 33|34 38 32 32 43 40 43 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T13	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , @CHEMICALSrc$ N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	18 3 1 3 1 1|5 1 1|5 9 6 9 6 6 6 15 13 15 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T35	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ dopamine (DA) transporter @/GENETgt$ ? [SEP] Recent studies identified novel allosteric modulators of the @GENETgt$ dopamine ( @/GENETgt$ @CHEMICALSrc$ DA ) transporter @/CHEMICALSrc$ ( DAT ) .	2 3 3 6 6 3 17 17 8|17 8|17 17 8|17 9|17 9|17 9|17 17 9|17 17 6 17 3	None-BC7
19244097	CHEMICAL	GENE	T36	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ @CHEMICALSrc$ DA @/CHEMICALSrc$ release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 25 25 22 27 25 29 27 32 32 29 39 39 34|39 39 34|39 35|39 39 35|39 29 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T19	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 37 37 33 33 33 37 31 31 43 39 43|39 43 43|39 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T18	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced DAT-mediated @CHEMICALSrc$ DA @/CHEMICALSrc$ release and 2 ) [(3)H]DA uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 37 37 33 34|37 37 34|37 31 31 42 39 42 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T33	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ MPP(+) @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( @CHEMICALSrc$ MPP(+))or[(3)H]dopamine @/CHEMICALSrc$ from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 26 26|23 26 26|23 22 28 26 30 28 28 28 34 34 30 39 39 39 39 30 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T44	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited @GENETgt$ DAT-mediated @/GENETgt$ @CHEMICALSrc$ DA @/CHEMICALSrc$ release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular DAT substrate .	6 1 1 6 6 6 11|6 11 11|6 11|7 11 11|7 6 11 14 12 14 14 6 6 26 23 23 23 26 26 26 18 31 31 31 31 26 6	None-BC7
19244097	CHEMICAL	GENE	T2	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ (+/-)-3,4-methylenedioxyamphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited DAT-mediated DA release induced by DA or @CHEMICALSrc$ (+/-)-3,4-methylenedioxyamphetamine @/CHEMICALSrc$ , demonstrating that the observed partial inhibition is not specific for a particular @GENETgt$ DAT @/GENETgt$ substrate .	6 1 1 6 6 6 9 9 6 9 12 10 12 12|13 12 12|13 6 6 25 22 22 22 25 25 25 17 31 31 31 27|31 31 27|31 25 6	None-BC7
19244097	CHEMICAL	GENE	T17	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ D-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of @CHEMICALSrc$ D-amphetamine-induced @/CHEMICALSrc$ @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 38 32|38 38 32|38 33 33 33 38 31 31 43 40 43 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T23	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	18 3 1 3 1 1 8 6 8 6 6 6 14 12|13 12 12|13 14 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T42	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ also partially inhibited @GENETgt$ DAT-mediated @/GENETgt$ DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular DAT substrate .	7 1 1|2 1 1|2 7 7 7 11|6 11 11|6 11 7 11 14 12 14 14 7 7 26 23 23 23 26 26 26 18 31 31 31 31 26 7	None-BC7
19244097	CHEMICAL	GENE	T20	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2 ) [(3)H]DA uptake and @CHEMICALSrc$ d-amphetamine-induced @/CHEMICALSrc$ @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 36 36 33 36 31 31 41 38 41 12 41 42|47 47 42|47 43|47 47 43|47 41 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T30	T55	True	0	What is [Drugprot] between @CHEMICALSrc$ dopamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] Recent studies identified novel allosteric modulators of the @CHEMICALSrc$ dopamine @/CHEMICALSrc$ ( DA ) transporter ( @GENETgt$ DAT @/GENETgt$ ) .	2 3 3 6 6 3 16 16 8|16 16 8|16 16 16 16 16 16 14|6 6 14|6 16 3	None-BC7
19244097	CHEMICAL	GENE	T36	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " DAT-mediated @CHEMICALSrc$ DA @/CHEMICALSrc$ release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 26 26|23 26 26|23 22 28 26 30 28 33 33 30 39 39 39 35|39 39 35|39 30 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T38	T54	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20041 , which does not alter @GENETgt$ DAT-mediated @/GENETgt$ @CHEMICALSrc$ DA @/CHEMICALSrc$ release measured with [(3)H]DA , reversed the effect of SoRI-20040 .	16 1 6 6 6 1 11|6 11 11|6 11|7 11 11|7 6 11 14 12 16 16 18 16 20 18 16	None-BC7
19244097	CHEMICAL	GENE	T19	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2 ) @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 36 36 33 36 31 31 42 38 42|39 42 42|39 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T29	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 23 23 9 9|10 9 9|10 9 15 9 19 19 19 15 19 9 23 7 27 27|23 27 27|23 23 29 27 31 29 34 34 31 39 39 39 39 31 39 39 45 45 45 23 7	None-BC7
19244097	CHEMICAL	GENE	T14	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced DAT-mediated DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16|18 16 16|18 19 19 19 16 26 16 26 29 32 32 32 12 37 37 34 37 32 32 42 39 42 12 42 47 43|47 47 43|47 42 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T22	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and @CHEMICALSrc$ N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine @/CHEMICALSrc$ ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	18 3 1 3 1 1 8 6 8 6 6 11|6 6 11|6 15 12 15 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T24	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( SoRI-20040 ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited @CHEMICALSrc$ [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester @/CHEMICALSrc$ ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	17 3 1 3 1 1 8 6 8 6 6 6 14 12 14 17 17 17|18|26 17|18|26 17|18|26 17|18|26 18|26 17|18|26 24 18 24 17 17 17 31 31 28 33 31 36 36 31 31 31 31 28 41 28 43 41 17	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T31	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ d-amphetamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited @CHEMICALSrc$ d-amphetamine-induced @/CHEMICALSrc$ DAT-mediated release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " @GENETgt$ DAT-mediated @/GENETgt$ DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 26|22 26 26|22 26 22 28 26 30 28 33 33 30 39 39 34|39 39 34|39 39 30 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T39	T54	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20041 , which does not alter @GENETgt$ DAT-mediated @/GENETgt$ DA release measured with @CHEMICALSrc$ [(3)H]DA @/CHEMICALSrc$ , reversed the effect of SoRI-20040 .	16 1 6 6 6 1 10|6 10 10|6 10 6 10 13 11 11 11 16 16 18 16 20 18 16	None-BC7
19244097	CHEMICAL	GENE	T16	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16 19 19 19 16 25 16 25 28 32|27 32 32|27 32 32 12 38 38 33|34 34 33|34 38 32 32 43 40 43 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T1	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] SoRI-20040 and SoRI-9804 also partially inhibited @GENETgt$ DAT-mediated @/GENETgt$ DA release induced by @CHEMICALSrc$ DA @/CHEMICALSrc$ or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular DAT substrate .	6 1 1 6 6 6 10|6 10 10|6 10 6 10 13 11 11 11 13 13 6 6 26 23 23 23 26 26 26 18 31 31 31 31 26 6	None-BC7
19244097	CHEMICAL	GENE	T34	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]dopamine @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( @CHEMICALSrc$ MPP(+))or[(3)H]dopamine @/CHEMICALSrc$ from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 26 26|23 26 26|23 22 28 26 30 28 28 28 34 34 30 39 39 39 39 30 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T15	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ DA release and 2 ) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 32 16 19 16 19 19|20 19 19|20 19 16 26 16 26 29 32 32 32 12 38 38 33|34 34 33|34 38 32 32 43 40 43 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T37	T54	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] @CHEMICALSrc$ SoRI-20041 @/CHEMICALSrc$ , which does not alter @GENETgt$ DAT-mediated @/GENETgt$ DA release measured with [(3)H]DA , reversed the effect of SoRI-20040 .	0|16 16 0|16 1 7 7 7 1 11|6 11 11|6 11 7 11 14 12 16 16 18 16 20 18 16	None-BC7
19244097	CHEMICAL	GENE	T28	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that @CHEMICALSrc$ SoRI-9804 @/CHEMICALSrc$ and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of [(3)H]1-methyl-4-phenylpyridinium ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 23 8|23 23 8|23 9 9 9 15 9 19 19 19 15 19 9 23 7 27 27|23 27 27|23 23 29 27 31 29 34 34 31 39 39 39 39 31 39 39 45 45 45 23 7	None-BC7
19244097	CHEMICAL	GENE	T21	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] N-(Diphenylmethyl)-2-phenyl-4-quinazolinamine ( SoRI-9804 ) , N-(2,2-diphenylethyl)-2-phenyl-4-quinazolinamine ( @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ ) , and N-(3,3-diphenylpropyl)-2-phenyl-4-quinazolinamine ( SoRI-20041 ) partially inhibited [(125)I]3beta-(4'-iodophenyl)tropan-2beta-carboxylic acid methyl ester ( RTI-55 ) binding , slowed the dissociation rate of [(125)I]RTI-55 from the @GENETgt$ DAT @/GENETgt$ , and partially inhibited [(3)H]dopamine uptake .	18 3 1 3 1 1 8 6|7 6 6|7 8 6 6 6 15 13 15 18 18 26 26 22 26 24 22 24 18 18 18 31 31 28 33 31 36 36 34|31 31 34|31 31 28 41 28 43 41 18	DIRECT-REGULATOR
19244097	CHEMICAL	GENE	T32	T52	True	0	What is [Drugprot] between @CHEMICALSrc$ [(3)H]1-methyl-4-phenylpyridinium @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] In the present study , we report that SoRI-9804 and SoRI-20040 , at doses that do not alter release , partially inhibited d-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ release of @CHEMICALSrc$ [(3)H]1-methyl-4-phenylpyridinium @/CHEMICALSrc$ ( MPP(+))or[(3)H]dopamine from striatal synaptosomes ( " DAT-mediated DA release " ) in a dose-dependent manner .	4 4 4 7 7 7 7 22 22 9 9 9 14 9 18 18 18 14 18 9 22 7 26 26|23 26 26|23 22 28 26 26 26 31 28 34 34 31 39 39 39 39 31 39 39 45 45 45 22 7	None-BC7
19244097	CHEMICAL	GENE	T18	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ DA @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] The two major findings of this study are 1 ) the identification of both " agonist " ( SoRI-9804 and SoRI-20040 ) and " antagonist " ( SoRI-20041 ) allosteric modulators of D-amphetamine-induced @GENETgt$ DAT-mediated @/GENETgt$ @CHEMICALSrc$ DA @/CHEMICALSrc$ release and 2 ) [(3)H]DA uptake and d-amphetamine-induced DAT-mediated efflux can be separately modulated .	4 4 4 9 7 7 4 9 51 9 12 51 16 16 16 31 16 19 16 19 19 19 16 25 16 25 28 31 31 31 12 38 38 33 33 33 34|38 38 34|38 31 31 43 40 43 12 43 47 47 43 51 51 51 51 51	None-BC7
19244097	CHEMICAL	GENE	T41	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and @GENETgt$ DAT @/GENETgt$ ? [SEP] @CHEMICALSrc$ SoRI-20040 @/CHEMICALSrc$ and SoRI-9804 also partially inhibited @GENETgt$ DAT-mediated @/GENETgt$ DA release induced by DA or (+/-)-3,4-methylenedioxyamphetamine , demonstrating that the observed partial inhibition is not specific for a particular DAT substrate .	0|7 7 0|7 1 1 7 7 7 11|6 11 11|6 11 7 11 14 12 14 14 7 7 26 23 23 23 26 26 26 18 31 31 31 31 26 7	None-BC7
11344206	CHEMICAL	GENE	T3	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ hormone-binding domain @/GENETgt$ ? [SEP] This mutation is the first described in exon 9 and impairs the last 27 @CHEMICALSrc$ amino acids @/CHEMICALSrc$ of the @GENETgt$ hormone-binding domain @/GENETgt$ .	2 6 6 6 6 6 8 6 8 6 6 15 15 15 11|14|15 11|14|15 11|15 11|14|15 20 20 17|20|15 17|20|15 20|15 17|20|15 6	PART-OF
11344206	CHEMICAL	GENE	T2	T4	True	0	What is [Drugprot] between @CHEMICALSrc$ sodium @/CHEMICALSrc$ and @GENETgt$ amiloride-sensitive luminal sodium channel @/GENETgt$ ? [SEP] There are 2 forms of PHA1 : the autosomal recessive form with symptoms persisting into adulthood , caused by mutations in the @GENETgt$ amiloride-sensitive luminal @/GENETgt$ @CHEMICALSrc$ sodium channel @/CHEMICALSrc$ , and the autosomal dominant or sporadic form , which shows milder symptoms that remit with age .	2 2 4 2 6 4 4 11 11 11 4 13 11 13 16 14 11 11 20 18 26 26 26|22 26|22 26 26|22 26|20|23 26|20|23 26|20 26|20|23 11 11 32 36 32 33 33 11 36 39 36 41 39 43 41 45 43 2	None-BC7
23500776	CHEMICAL	GENE	T9	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ CYP1B1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity , reflecting almost exclusively CYP1A1 and @GENETgt$ CYP1B1 @/GENETgt$ activities , was measured in brain and liver microsomes as well as in peripheral blood lymphocytes ( PBLs ) .	0|3 3 0|3 15 3 3 7 5 3 8 8 8 8 8 3 15 15 17 20 17 17 15 20 21 21 27 27 27 20 29 27 29 15	None-BC7
23500776	CHEMICAL	GENE	T1	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in liver , which was found to represent 98 % of the observed @GENETgt$ EROD @/GENETgt$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 32|29 32 32|29 29 34 32 34 38 38 32 40 38 42 40 48 48 48 48|44 48 48|44 42 53 53 53 53 48 53 56 58 56 16 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T11	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed @GENETgt$ EROD @/GENETgt$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 32 30 34 32 34 38 38 32 40 38 42 40 48 48 48 48|44 48 48|44 42 53 53 53 53 48 53 56 58 56 17 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T4	T14	True	0	What is [Drugprot] between @CHEMICALSrc$ PHH @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed @GENETgt$ EROD @/GENETgt$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and @CHEMICALSrc$ PHH @/CHEMICALSrc$ .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 31 29 33 31 33 37 37 31 39 37 41 39 47 47 47 44|47 47 44|47 41 52 52 52 52 47 52 55 57 55 16 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59 72 73 74 74 74 74 4	None-BC7
23500776	CHEMICAL	GENE	T2	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @GENETgt$ EROD @/GENETgt$ activity in liver , which was found to represent 98 % of the observed @CHEMICALSrc$ EROD @/CHEMICALSrc$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 32|29 32 32|29 29 34 32 34 38 38 32 40 38 42 40 48 48 48 48|44 48 48|44 42 53 53 53 53 48 53 56 58 56 16 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T5	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ PAH @/CHEMICALSrc$ and @GENETgt$ cytochrome P450 @/GENETgt$ ? [SEP] Little is known in terms of multi-matrix @GENETgt$ cytochrome P450 @/GENETgt$ activity induction under repeated oral exposure to planar halogenated and polycyclic aromatic hydrocarbons ( PHH , @CHEMICALSrc$ PAH @/CHEMICALSrc$ ) .	3 3 3 5 3 12 12 12|7 12|7 12 12|7 12 5 16 16 16 5 23 23 23 19 19 19 16 25 23 25 24|25 25 24|25 25 3	ACTIVATOR
23500776	CHEMICAL	GENE	T1	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ CYP @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to @GENETgt$ CYP @/GENETgt$ inducing PAH and PHH .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 32|29 32 32|29 29 34 32 34 38 38 32 40 38 42 40 47 47 47 47 42 52 52 52 52 47 52 55 57 55 16 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59|70 59 59|70 72 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T1	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @GENETgt$ EROD @/GENETgt$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 33|29 33 33|29 30 35 33 35 39 39 33 41 39 43 41 48 48 48 48 43 53 53 53 53 48 53 56 58 56 17 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T4	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ PHH @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @GENETgt$ EROD @/GENETgt$ activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and @CHEMICALSrc$ PHH @/CHEMICALSrc$ .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 32|29 32 32|29 29 34 32 34 38 38 32 40 38 42 40 47 47 47 47 42 52 52 52 52 47 52 55 57 55 16 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59 72 73 74 74 74 74 4	None-BC7
23500776	CHEMICAL	GENE	T11	T13	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating @GENETgt$ EROD @/GENETgt$ activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 33|29 33 33|29 30 35 33 35 39 39 33 41 39 43 41 48 48 48 48 43 53 53 53 53 48 53 56 58 56 17 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T4	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ PHH @/CHEMICALSrc$ and @GENETgt$ CYP @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to @GENETgt$ CYP @/GENETgt$ inducing PAH and @CHEMICALSrc$ PHH @/CHEMICALSrc$ .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 31 29 33 31 33 37 37 31 39 37 41 39 46 46 46 46 41 51 51 51 51 46 51 54 56 54 16 58 56 61 61 58 64 64 61 66 64 66 66 66 71 58|70 58 58|70 71 73 74 74 74 74 4	None-BC7
23500776	CHEMICAL	GENE	T11	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ CYP @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to @GENETgt$ CYP @/GENETgt$ inducing PAH and PHH .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 32 30 34 32 34 38 38 32 40 38 42 40 47 47 47 47 42 52 52 52 52 47 52 55 57 55 17 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59|70 59 59|70 72 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T3	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ halogenated and polycyclic aromatic hydrocarbons @/CHEMICALSrc$ and @GENETgt$ cytochrome P450 @/GENETgt$ ? [SEP] Little is known in terms of multi-matrix @GENETgt$ cytochrome P450 @/GENETgt$ activity induction under repeated oral exposure to planar @CHEMICALSrc$ halogenated and polycyclic aromatic hydrocarbons @/CHEMICALSrc$ ( PHH , PAH ) .	3 3 3 5 3 12 12 12|7 12|7 12 12|7 12 5 16 16 16 5 19 19 16|19 16|19 16|19 16|19 16|19 16|19 16|19 26 19 26 26 26 3	ACTIVATOR
23500776	CHEMICAL	GENE	T9	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ CYP1A1 @/GENETgt$ ? [SEP] @CHEMICALSrc$ EROD @/CHEMICALSrc$ activity , reflecting almost exclusively @GENETgt$ CYP1A1 @/GENETgt$ and CYP1B1 activities , was measured in brain and liver microsomes as well as in peripheral blood lymphocytes ( PBLs ) .	0|3 3 0|3 15 3 3 7 5 3|6 3 3|6 8 8 8 3 15 15 17 20 17 17 15 20 21 21 27 27 27 20 29 27 29 15	None-BC7
23500776	CHEMICAL	GENE	T12	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ polycyclic aromatic hydrocarbons @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] @GENETgt$ EROD @/GENETgt$ activity induction in peripheral blood lymphocytes , liver and brain tissues of rats orally exposed to @CHEMICALSrc$ polycyclic aromatic hydrocarbons @/CHEMICALSrc$ .	0|4 4 0|4 4 4 8 8 8 4 8 8 10 13 10 15 10 17 15 19 17|19 17|19 17|19 17|19 17|19 4	ACTIVATOR
23500776	CHEMICAL	GENE	T2	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @GENETgt$ EROD @/GENETgt$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed @CHEMICALSrc$ EROD @/CHEMICALSrc$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and PHH .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 32 30 34 32 34 38 38 32 40 38 42 40 48 48 48 48|44 48 48|44 42 53 53 53 53 48 53 56 58 56 17 60 58 63 63 60 66 66 63 68 66 68 68 68 73 60 73 74 75 75 4	None-BC7
23500776	CHEMICAL	GENE	T4	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ PHH @/CHEMICALSrc$ and @GENETgt$ EROD @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that @GENETgt$ EROD @/GENETgt$ activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed EROD activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to CYP inducing PAH and @CHEMICALSrc$ PHH @/CHEMICALSrc$ .	4 3 1 4 6 4 8 6 17 9|12 12 9|12 17 14 12 17 17 8 25 25 25 20 20 22 22 17 30 28 30 28 25 32 30 34 32 34 38 38 32 40 38 42 40 47 47 47 47 42 52 52 52 52 47 52 55 57 55 17 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59 72 73 74 74 74 74 4	None-BC7
23500776	CHEMICAL	GENE	T2	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ EROD @/CHEMICALSrc$ and @GENETgt$ CYP @/GENETgt$ ? [SEP] Correlations between matrices made it possible to conclude that EROD activity in PBL should be considered as a sensitive , convenient and non-destructive approach for ( i ) evaluating EROD activity in liver , which was found to represent 98 % of the observed @CHEMICALSrc$ EROD @/CHEMICALSrc$ activities in the three tested matrices and ( ii ) evaluating oral exposure of homogeneous groups of farm animals ( race , diet ) to @GENETgt$ CYP @/GENETgt$ inducing PAH and PHH .	4 3 1 4 6 4 8 6 16 11 16 13 11 16 16 8 24 24 24 19 19 21 21 16 29 27 29 27 24 31 29 33 31 33 37 37 31 39 37 41 39 47 47 47 44|47 47 44|47 41 52 52 52 52 47 52 55 57 55 16 59 57 62 62 59 65 65 62 67 65 67 67 67 72 59|70 59 59|70 72 74 75 75 4	None-BC7
12414329	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ nitric oxide @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the @CHEMICALSrc$ nitric oxide-cyclic @/CHEMICALSrc$ guanosine monophosphate ( cGMP ) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic @GENETgt$ PDE5 @/GENETgt$ inhibition are assessed .	2 32 13 13 5|4|13 5|4|13 5|13 5|4|13 9 13 11 13 13 2 16 16 13 13 20 20 13 20 21 25 25 21 30 30 25|30 30 25|30 25 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T8	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Therefore , in men with ED , elevation of @CHEMICALSrc$ cGMP @/CHEMICALSrc$ in corpus cavernosal tissue via selective inhibition of cGMP-specific @GENETgt$ PDE5 @/GENETgt$ is a means of improving erectile function at minimal risk of adverse events .	25 25 4 25 6 4 25 25 10 8|9 8 8|9 15 15 15 8 18 18 8 21 21 18|19 18 18|19 25 25 25 27 25 29 27 32 32 27 35 35 32 25	None-BC7
12414329	CHEMICAL	GENE	T11	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ exhibits inhibitory potency against @GENETgt$ PDE5 @/GENETgt$ and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6 , the predominant PDE in the phototransduction cascade in rods .	0|3 3 0|3 3 5 3 7 5 5 5 5 15 12 15 12 15 5 20 20 19 20 15 20 24 24 20 28 28 28 24 30 28 3	INHIBITOR
12414329	CHEMICAL	GENE	T6	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the nitric oxide-cyclic guanosine monophosphate ( @CHEMICALSrc$ cGMP @/CHEMICALSrc$ ) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic @GENETgt$ PDE5 @/GENETgt$ inhibition are assessed .	2 32 13 13 13 5 8 13 10 9|13 13 9|13 13 2 16 16 13 13 20 20 13 20 21 25 25 21 30 30 26|30 30 26|30 25 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T5	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ cyclic guanosine monophosphate @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the nitric @CHEMICALSrc$ oxide-cyclic guanosine monophosphate @/CHEMICALSrc$ ( cGMP ) pathway for penile erection and on PDE5 inhibition using sildenafil as the model for pharmacologic @GENETgt$ PDE5 @/GENETgt$ inhibition are assessed .	2 32 13 13 13 13|5|6 13|5|6 13|5|6 5|13|6 13|5|6 11 13 13 2 16 16 13 13 20 20 13 20 21 25 25 21 30 30 24|30 30 24|30 25 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T3	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ nitric oxide @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the @CHEMICALSrc$ nitric oxide-cyclic @/CHEMICALSrc$ guanosine monophosphate ( cGMP ) pathway for penile erection and on @GENETgt$ PDE5 @/GENETgt$ inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed .	2 32 13 13 5|4|13 5|4|13 5|13 5|4|13 9 13 11 13 13 2 16 16 13 13 21 16|21 21 16|21 13 21 22 26 26 22 30 30 30 26 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T7	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE @/GENETgt$ ? [SEP] PDE5 is the predominant @GENETgt$ PDE @/GENETgt$ in the corpus cavernosum , and @CHEMICALSrc$ cGMP @/CHEMICALSrc$ is its primary substrate .	5 5 5 5 4|5 5 4|5 10 10 10 5 5 5 18|11 18 18|11 18 18 18 5 18	SUBSTRATE
12414329	CHEMICAL	GENE	T7	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] @GENETgt$ PDE5 @/GENETgt$ is the predominant PDE in the corpus cavernosum , and @CHEMICALSrc$ cGMP @/CHEMICALSrc$ is its primary substrate .	0|6 6 0|6 6 6 6 6 10 10 10 6 6 6 18|11 18 18|11 18 18 18 6 18	SUBSTRATE
12414329	CHEMICAL	GENE	T6	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the nitric oxide-cyclic guanosine monophosphate ( @CHEMICALSrc$ cGMP @/CHEMICALSrc$ ) pathway for penile erection and on @GENETgt$ PDE5 @/GENETgt$ inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed .	2 32 13 13 13 5 8 13 10 9|13 13 9|13 13 2 16 16 13 13 21 17|21 21 17|21 13 21 22 26 26 22 30 30 30 26 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Selective inhibition of @GENETgt$ PDE5 @/GENETgt$ is a rational therapeutic approach in ED , as proved by the clinical success of @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ .	2 10 4 2|3 2 2|3 10 10 10 10 10 12 10 10 15 10 19 19 19 15 21 19 19 19 10	INHIBITOR
12414329	CHEMICAL	GENE	T5	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ cyclic guanosine monophosphate @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Published literature on the nitric @CHEMICALSrc$ oxide-cyclic guanosine monophosphate @/CHEMICALSrc$ ( cGMP ) pathway for penile erection and on @GENETgt$ PDE5 @/GENETgt$ inhibition using sildenafil as the model for pharmacologic PDE5 inhibition are assessed .	2 32 13 13 13 13|5|6 13|5|6 13|5|6 5|13|6 13|5|6 11 13 13 2 16 16 13 13 21 21|15 21 21|15 13 21 22 26 26 22 30 30 30 26 32 32 32	None-BC7
12414329	CHEMICAL	GENE	T9	T22	True	0	What is [Drugprot] between @CHEMICALSrc$ cGMP @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] Therefore , in men with ED , elevation of cGMP in corpus cavernosal tissue via selective inhibition of @CHEMICALSrc$ cGMP-specific @/CHEMICALSrc$ @GENETgt$ PDE5 @/GENETgt$ is a means of improving erectile function at minimal risk of adverse events .	25 25 4 25 6 4 25 25 10 8 14 14 14 8 17 17 8 21 18|21 21 18|21 17|19 17 17|19 25 25 25 27 25 29 27 32 32 27 35 35 32 25	INHIBITOR
12414329	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE5 @/GENETgt$ ? [SEP] This approach is validated by the clinical efficacy and safety of @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ , the pioneering drug for selective @GENETgt$ PDE5 @/GENETgt$ inhibitor therapy for ED .	2 4 4 4 8 8 8 4 8 8 12 10|11 10 10|11 8 17 17 8 23 23 18|23 23 18|23 23 17 25 23 4	INHIBITOR
12414329	CHEMICAL	GENE	T11	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE @/GENETgt$ ? [SEP] @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment PDE6 , the predominant @GENETgt$ PDE @/GENETgt$ in the phototransduction cascade in rods .	0|3 3 0|3 3 5 3 7 5 5 14 11 14 11 14 5 19 19 18 19 14 19 23 23 19|21 19 19|21 28 28 28 23 30 28 3	INHIBITOR
12414329	CHEMICAL	GENE	T11	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE6 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Sildenafil @/CHEMICALSrc$ exhibits inhibitory potency against PDE5 and a 10-fold lower dose-related inhibitory potency against rod outer segment @GENETgt$ PDE6 @/GENETgt$ , the predominant PDE in the phototransduction cascade in rods .	0|3 3 0|3 3 5 3 7 5 5 14 11 14 11 14 5 19 19 18 19 17|14 14 17|14 19 24 24 19 28 28 28 24 30 28 3	INHIBITOR
12414329	CHEMICAL	GENE	T2	T15	True	0	What is [Drugprot] between @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ and @GENETgt$ PDE6 @/GENETgt$ ? [SEP] As free @CHEMICALSrc$ sildenafil @/CHEMICALSrc$ plasma concentrations approach concentrations sufficient to inhibit retinal @GENETgt$ PDE6 @/GENETgt$ , usually at higher therapeutic doses , transient , reversible visual adverse events can occur , albeit infrequently .	29 6 2|6 6 2|6 6 8 8 29 8 11 9 13 11 11 11 13 20 20 20 18 13 20 27 22 22 26 27 29 29 29 29 32 29 29	INHIBITOR
23481236	CHEMICAL	GENE	T2	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ increased ceramides , up-regulated PTP1B , and had AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at Ser 50 impaired .	2 1|2|7 1|2|7 1|2|7 1|2|7 2|7 1|2|7 7 7 8 11 8 7 7 7 23 15 12|15 15 12|15 15 21 19 21 14 7	ACTIVATOR
23481236	CHEMICAL	GENE	T20	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4|5 4 4|5 4 10 4 3 3 3 15 3 17 15 19 17 22 22 19|20 19 19|20 22 22 22 30 30 30 22 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T9	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ protein kinase B @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate insulin signaling through the @GENETgt$ protein kinase B @/GENETgt$ ( AKt ) pathway and up-regulate protein @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase 1B ( PTP1B ) , a negative regulator of insulin signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 18 16 28 28 21|20|28 21|20|28 21|20|28 28|21 21|20|28 26 21 26 16 16 16 35 35|28 35 35|28 35 30 37 35 37 35 42 42 35 45 45 42 16	None-BC7
23481236	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] A clear relationship between @GENETgt$ PTP1B @/GENETgt$ phosphorylation levels at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 and its negative effect on insulin signaling is shown .	3 3 21 8 8|4 8 8|4 8 3 10 8 8 8 10 10 16 16 8 19 19 16 21 21 21	PART-OF
23481236	CHEMICAL	GENE	T14	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( DAGs ) ] and @CHEMICALSrc$ ceramides @/CHEMICALSrc$ in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13 15 15 8 8|18 8 8|18 22 3 25 25 22 25 25 3 3 31 29 29 29 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	DIRECT-REGULATOR
23481236	CHEMICAL	GENE	T7	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Only FFAs that increased ceramides caused impairment of AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 .	2 6 4 2 4 6 6 9 7 9 9|10 9 9|10 9 15 13 13 13 15 6	PART-OF
23481236	CHEMICAL	GENE	T20	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4|5 4 4|5 4 10 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 22 22 30 30 30 22 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T3	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased @CHEMICALSrc$ ceramides @/CHEMICALSrc$ , up-regulated PTP1B , and had @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at Ser 50 impaired .	2 6 2 2 6 6 6 6 6 7 11 7 6 6 6 13|23 23 13|23 15 15 15 21 19 21 14 6	None-BC7
23481236	CHEMICAL	GENE	T9	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate @GENETgt$ insulin @/GENETgt$ signaling through the protein kinase B ( AKt ) pathway and up-regulate protein @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase 1B ( PTP1B ) , a negative regulator of insulin signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 16|19 19 16|19 16 28 28 24 24 28 26 24 26 16 16 16 35 35|30 35 35|30 35 30 37 35 37 35 42 42 35 45 45 42 16	None-BC7
23481236	CHEMICAL	GENE	T16	T45	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Normal @CHEMICALSrc$ glucose @/CHEMICALSrc$ regulation is achieved by having adequate @GENETgt$ insulin @/GENETgt$ secretion and effective glucose uptake/disposal .	4 1|4 4 1|4 6 6 6 8 6 12 8|12 12 8|12 8 12 15 16 8 6	None-BC7
23481236	CHEMICAL	GENE	T1	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at serine ( Ser ) 50 , Ser 398 and @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18 21 21|22 21 21|22 21 29 29 29 21 29 29 29 29 33 29 34|29 29 34|29 36 14	PART-OF
23481236	CHEMICAL	GENE	T6	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Only FFAs that increased @CHEMICALSrc$ ceramides @/CHEMICALSrc$ caused impairment of @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at Ser 50 .	2 7 4 2 4 4 4 7 7 10 8 8 8 10 10 10 16 14 16 7	INDIRECT-DOWNREGULATOR
23481236	CHEMICAL	GENE	T20	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4|5 4 4|5 4 11|7 11 11|7 4 3 3 3 16 3 18 16 20 18 23 23 20 23 23 23 30 30 30 23 30 30 30 30 34 30 30 37 16	None-BC7
23481236	CHEMICAL	GENE	T3	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased @CHEMICALSrc$ ceramides @/CHEMICALSrc$ , up-regulated @GENETgt$ PTP1B @/GENETgt$ , and had AKt and PTP1B phosphorylation at Ser 50 impaired .	2 6 2 2 6 6 6 6 6 7 11 9|7 7 9|7 6 6 6 23 16 16 16 21 19 21 15 6	None-BC7
23481236	CHEMICAL	GENE	T22	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at @CHEMICALSrc$ serine @/CHEMICALSrc$ ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 17|14 17 17|14 14 19 17 22 22 19 22 22 22 30 25|30 30 25|30 30 22 30 30 30 30 34 30 30 37 14	None-BC7
23481236	CHEMICAL	GENE	T22	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at @CHEMICALSrc$ serine @/CHEMICALSrc$ ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18 21 21|22 21 21|22 21 30 25|30 30 25|30 30 21 30 30 30 30 34 30 30 37 14	PART-OF
23481236	CHEMICAL	GENE	T8	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] A clear relationship between PTP1B phosphorylation levels at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 and its negative effect on @GENETgt$ insulin @/GENETgt$ signaling is shown .	3 3 21 7 7 7 3 9 8|7 7 8|7 9 9 15 15 7 19 19|15 19 19|15 15 21 21 21	None-BC7
23481236	CHEMICAL	GENE	T13	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( @CHEMICALSrc$ DAGs @/CHEMICALSrc$ ) ] and ceramides in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13|14 13 13|14 15 15 8 8 22 3 26 26|22 26 26|22 22 26 26 3 3 32 30 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T4	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased ceramides , up-regulated @GENETgt$ PTP1B @/GENETgt$ , and had AKt and PTP1B phosphorylation at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 impaired .	2 6 2 2 6 6 6 7 10 9|7 7 9|7 6 6 6 23 15 15 15 20 18 18 18 20 14 6	None-BC7
23481236	CHEMICAL	GENE	T2	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ increased ceramides , up-regulated @GENETgt$ PTP1B @/GENETgt$ , and had AKt and PTP1B phosphorylation at Ser 50 impaired .	2 1|2|7 1|2|7 1|2|7 1|2|7 2|7 1|2|7 7 7 8 11 8|6 8 8|6 7 7 7 23 16 16 16 21 19 21 15 7	None-BC7
23481236	CHEMICAL	GENE	T4	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased ceramides , up-regulated PTP1B , and had AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 impaired .	2 6 2 2 6 6 6 7 10 7 6 6 6 23 14 14|15 14 14|15 14 20 18 18 18 20 13 6	PART-OF
23481236	CHEMICAL	GENE	T13	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( @CHEMICALSrc$ DAGs @/CHEMICALSrc$ ) ] and ceramides in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13|14 13 13|14 15 15 8 8 22 3 25 25 22 25 25 3 3 31 29 29 29 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	DIRECT-REGULATOR
23481236	CHEMICAL	GENE	T24	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at serine ( Ser ) 50 , @CHEMICALSrc$ Ser @/CHEMICALSrc$ 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18 21 21|22 21 21|22 21 29 29 29 21 29 29 29 29|31 29 29|31 33 29 29 37 14	PART-OF
23481236	CHEMICAL	GENE	T19	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased @CHEMICALSrc$ DAGs @/CHEMICALSrc$ , TAGs and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 3 3 4 4 4 11|7 11 11|7 4 3 3 3 16 3 18 16 20 18 23 23 20 23 23 23 30 30 30 23 30 30 30 30 34 30 30 37 16	None-BC7
23481236	CHEMICAL	GENE	T3	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased @CHEMICALSrc$ ceramides @/CHEMICALSrc$ , up-regulated PTP1B , and had AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at Ser 50 impaired .	2 6 2 2 6 6 6 6 6 7 11 7 6 6 6 23 15 15 15 15 15 21 19 21 14 6	None-BC7
23481236	CHEMICAL	GENE	T24	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , @CHEMICALSrc$ Ser @/CHEMICALSrc$ 398 and tyrosine 152 .	2 3 3 3 4 4 4 10|7 10 10|7 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 29 29 29 22 29 29 29 29|31 29 29|31 33 29 29 37 15	None-BC7
23481236	CHEMICAL	GENE	T12	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ diglycerides @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , @CHEMICALSrc$ diglycerides @/CHEMICALSrc$ ( DAGs ) ] and ceramides in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8|12 8 8|12 16 13 16 16 8 8 22 3 26 26|22 26 26|22 22 26 26 3 3 32 30 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T1	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ 152 .	2 3 3 3 4 4 4 10|7 10 10|7 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 29 29 29 22 29 29 29 29 33 29 34|29 29 34|29 36 15	None-BC7
23481236	CHEMICAL	GENE	T6	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Only FFAs that increased @CHEMICALSrc$ ceramides @/CHEMICALSrc$ caused impairment of AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at Ser 50 .	2 7 4 2 4 4 4 7 7 10 8 10 10 10 10 10 16 14 16 7	INHIBITOR
23481236	CHEMICAL	GENE	T12	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ diglycerides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , @CHEMICALSrc$ diglycerides @/CHEMICALSrc$ ( DAGs ) ] and ceramides in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8|12 8 8|12 16 13 16 16 8 8 22 3 25 25 22 25 25 3 3 31 29 29 29 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	DIRECT-REGULATOR
23481236	CHEMICAL	GENE	T9	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ protein tyrosine phosphatase 1B @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate insulin signaling through the protein kinase B ( AKt ) pathway and up-regulate @GENETgt$ protein @/GENETgt$ @CHEMICALSrc$ tyrosine phosphatase 1B @/CHEMICALSrc$ ( PTP1B ) , a negative regulator of insulin signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 18 16 27 27 23 23 27 25 23 25 16 16 16 32|29 32 32|29 32|29|30 32|29|30 32|29|30 32|29 32|29|30 37 32 37 32 42 42 32 45 45 42 16	None-BC7
23481236	CHEMICAL	GENE	T23	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at serine ( @CHEMICALSrc$ Ser @/CHEMICALSrc$ ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18 21 21|22 21 21|22 21 29 29 29 27|21 21 27|21 29 29 29 29 34 29 29 37 14	PART-OF
23481236	CHEMICAL	GENE	T14	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ ceramides @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( DAGs ) ] and @CHEMICALSrc$ ceramides @/CHEMICALSrc$ in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13 15 15 8 8|18 8 8|18 22 3 26 26|22 26 26|22 22 26 26 3 3 32 30 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T23	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at serine ( @CHEMICALSrc$ Ser @/CHEMICALSrc$ ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18|20 18 18|20 21 21 21 29 29 29 27|21 21 27|21 29 29 29 29 34 29 29 37 14	None-BC7
23481236	CHEMICAL	GENE	T17	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ wortmannin @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Cells were also evaluated in the presence of @CHEMICALSrc$ wortmannin @/CHEMICALSrc$ , an inhibitor of phosphatidylinositol 3-kinases and thus @GENETgt$ AKt @/GENETgt$ ( 0 - 100 nM ) .	4 4 4 4 7 7 4 9 8|7 7 8|7 9 13 9 16 16 13 7 7 17|7 7 17|7 25 24 22 25 19 25 4	INDIRECT-DOWNREGULATOR
23481236	CHEMICAL	GENE	T20	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4|5 4 4|5 4 10 4 3 3 3 15 3 18|14 18 18|14 15 20 18 23 23 20 23 23 23 30 30 30 23 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T22	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at @CHEMICALSrc$ serine @/CHEMICALSrc$ ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 10|7 10 10|7 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 30 25|30 30 25|30 30 22 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T23	T48	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and @GENETgt$ PTP1B @/GENETgt$ expression significantly , but cells remained insulin sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( @CHEMICALSrc$ Ser @/CHEMICALSrc$ ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 10|7 10 10|7 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 29 29 29 27|22 22 27|22 29 29 29 29 34 29 29 37 15	None-BC7
23481236	CHEMICAL	GENE	T18	T47	True	0	What is [Drugprot] between @CHEMICALSrc$ phosphatidylinositol @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Cells were also evaluated in the presence of wortmannin , an inhibitor of @CHEMICALSrc$ phosphatidylinositol @/CHEMICALSrc$ 3-kinases and thus @GENETgt$ AKt @/GENETgt$ ( 0 - 100 nM ) .	4 4 4 4 7 7 4 9 7 9 12 9 16 16|13 16 16|13 12 7 7 17|7 7 17|7 25 24 22 25 19 25 4	None-BC7
23481236	CHEMICAL	GENE	T10	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ triglycerides @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ @CHEMICALSrc$ triglycerides @/CHEMICALSrc$ ( TAGs ) , diglycerides ( DAGs ) ] and ceramides in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6|7 6 6|7 11 8 11 8 8 16 14 16 16 8 8 22 3 25 25 22 25 25 3 3 31 29 29 29 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	DIRECT-REGULATOR
23481236	CHEMICAL	GENE	T19	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased @CHEMICALSrc$ DAGs @/CHEMICALSrc$ , TAGs and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 3 3 4 4 4 10 4 3 3 3 15 3 18|14 18 18|14 15 20 18 23 23 20 23 23 23 30 30 30 23 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T21	T45	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Normal glucose regulation is achieved by having adequate @GENETgt$ insulin @/GENETgt$ secretion and effective @CHEMICALSrc$ glucose @/CHEMICALSrc$ uptake/disposal .	3 3 5 5 5 7 5 11 8|11 11 8|11 7 11 14 16|12 16 16|12 7 5	None-BC7
23481236	CHEMICAL	GENE	T10	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ triglycerides @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ @CHEMICALSrc$ triglycerides @/CHEMICALSrc$ ( TAGs ) , diglycerides ( DAGs ) ] and ceramides in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6|7 6 6|7 11 8 11 8 8 16 14 16 16 8 8 22 3 26 26|22 26 26|22 22 26 26 3 3 32 30 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T22	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at @CHEMICALSrc$ serine @/CHEMICALSrc$ ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18|20 18 18|20 21 21 21 30 25|30 30 25|30 30 21 30 30 30 30 34 30 30 37 14	None-BC7
23481236	CHEMICAL	GENE	T9	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate insulin signaling through the protein kinase B ( AKt ) pathway and up-regulate protein @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase 1B ( @GENETgt$ PTP1B @/GENETgt$ ) , a negative regulator of insulin signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 18 16 27 27 23 23 27 25 23 25 16 16 16 34 34|30 34 34|30 34 29 36 34 34 34 36 34 42 42 34 45 45 42 16	None-BC7
23481236	CHEMICAL	GENE	T11	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( @CHEMICALSrc$ TAGs @/CHEMICALSrc$ ) , diglycerides ( DAGs ) ] and ceramides in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8|9 8 8|9 10 8 8 16 14 16 16 8 8 22 3 25 25 22 25 25 3 3 31 29 29 29 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	DIRECT-REGULATOR
23481236	CHEMICAL	GENE	T9	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate insulin signaling through the protein kinase B ( AKt ) pathway and up-regulate protein @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase 1B ( PTP1B ) , a negative regulator of @GENETgt$ insulin @/GENETgt$ signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 18 16 27 27 23 23 27 25 23 25 16 16 16 34 34|30 34 34|30 34 29 36 34 36 34 41 41 34 45 41|45 45 41|45 41 16	None-BC7
23481236	CHEMICAL	GENE	T11	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ TAGs @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( @CHEMICALSrc$ TAGs @/CHEMICALSrc$ ) , diglycerides ( DAGs ) ] and ceramides in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free fatty acids ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8|9 8 8|9 10 8 8 16 14 16 16 8 8 22 3 26 26|22 26 26|22 22 26 26 3 3 32 30 34 2 38 38 38 34 41 41 38 41 45 45 34 45 45 51 51 51 45 53 51 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T24	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at serine ( Ser ) 50 , @CHEMICALSrc$ Ser @/CHEMICALSrc$ 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18|20 18 18|20 21 21 21 29 29 29 21 29 29 29 29|31 29 29|31 33 29 29 37 14	None-BC7
23481236	CHEMICAL	GENE	T23	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( @CHEMICALSrc$ Ser @/CHEMICALSrc$ ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 17|14 17 17|14 14 19 17 22 22 19 22 22 22 29 29 29 27|22 22 27|22 29 29 29 29 34 29 29 37 14	None-BC7
23481236	CHEMICAL	GENE	T24	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , @CHEMICALSrc$ Ser @/CHEMICALSrc$ 398 and tyrosine 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 17|14 17 17|14 14 19 17 22 22 19 22 22 22 29 29 29 22 29 29 29 29|31 29 29|31 33 29 29 37 14	None-BC7
23481236	CHEMICAL	GENE	T1	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 16 14 18 16 21 21 18|20 18 18|20 21 21 21 29 29 29 21 29 29 29 29 33 29 34|29 29 34|29 36 14	None-BC7
23481236	CHEMICAL	GENE	T2	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Saturated @CHEMICALSrc$ palmitic and stearic acids @/CHEMICALSrc$ increased ceramides , up-regulated PTP1B , and had @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at Ser 50 impaired .	2 1|2|7 1|2|7 1|2|7 1|2|7 2|7 1|2|7 7 7 8 11 8 7 7 7 10|23 23 10|23 15 15 15 21 19 21 14 7	INDIRECT-UPREGULATOR
23481236	CHEMICAL	GENE	T4	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Saturated palmitic and stearic acids increased ceramides , up-regulated PTP1B , and had @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 impaired .	2 6 2 2 6 6 6 7 10 7 6 6 6 13|23 23 13|23 14 14 14 20 18 18 18 20 13 6	None-BC7
23481236	CHEMICAL	GENE	T19	T51	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] Unsaturated FFAs increased @CHEMICALSrc$ DAGs @/CHEMICALSrc$ , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust AKt and @GENETgt$ PTP1B @/GENETgt$ phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 3 3 4 4 4 10 4 3 3 3 15 3 17 15 19 17 22 22 19 22 22 22 22 22 30 30 30 22 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T7	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ Ser @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Only FFAs that increased ceramides caused impairment of @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at @CHEMICALSrc$ Ser @/CHEMICALSrc$ 50 .	2 6 4 2 4 6 6 9 8|7 7 8|7 9 9 9 15 13 13 13 15 6	None-BC7
23481236	CHEMICAL	GENE	T9	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Excess lipids in peripheral tissues - skeletal muscle , liver and adipose tissue - may attenuate insulin signaling through the protein kinase B ( @GENETgt$ AKt @/GENETgt$ ) pathway and up-regulate protein @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphatase 1B ( PTP1B ) , a negative regulator of insulin signaling .	2 16 5 5 7 7 8 2 8 8 8 13 8 2 16 16 18 16 28 28 23 23 28 25 24|23 23 24|23 25 16 16 16 35 35|30 35 35|30 35 30 37 35 37 35 42 42 35 45 45 42 16	None-BC7
23481236	CHEMICAL	GENE	T15	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ fatty acids @/CHEMICALSrc$ and @GENETgt$ PTP1B @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( DAGs ) ] and ceramides in relation to insulin signaling and expression and phosphorylation of @GENETgt$ PTP1B @/GENETgt$ by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free @CHEMICALSrc$ fatty acids @/CHEMICALSrc$ ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13 15 15 8 8 21 3 24 24 21 24 24 3 3 30 28|29 28 28|29 33 2 37 37 37 33 40 40 37 40 44 44 33 44 44 49 49 49|44|47 49|44|47 49|44 49|44|47 53 49 53 57 57 53 53 2	None-BC7
23481236	CHEMICAL	GENE	T1	T49	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Unsaturated FFAs increased DAGs , TAGs and PTP1B expression significantly , but cells remained @GENETgt$ insulin @/GENETgt$ sensitive as assessed by robust AKt and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ 152 .	2 3 3 3 4 4 4 9 4 3 3 3 14 3 17|14 17 17|14 14 19 17 22 22 19 22 22 22 29 29 29 22 29 29 29 29 33 29 34|29 29 34|29 36 14	None-BC7
23481236	CHEMICAL	GENE	T17	T46	True	0	What is [Drugprot] between @CHEMICALSrc$ wortmannin @/CHEMICALSrc$ and @GENETgt$ phosphatidylinositol 3-kinases @/GENETgt$ ? [SEP] Cells were also evaluated in the presence of @CHEMICALSrc$ wortmannin @/CHEMICALSrc$ , an inhibitor of @GENETgt$ phosphatidylinositol 3-kinases @/GENETgt$ and thus AKt ( 0 - 100 nM ) .	4 4 4 4 7 7 4 9 8|7 7 8|7 9 13 9 15 13|15 13|15 13|15 13|15 7 7 7 25 24 22 25 20 25 4	INHIBITOR
23481236	CHEMICAL	GENE	T19	T50	True	0	What is [Drugprot] between @CHEMICALSrc$ DAGs @/CHEMICALSrc$ and @GENETgt$ AKt @/GENETgt$ ? [SEP] Unsaturated FFAs increased @CHEMICALSrc$ DAGs @/CHEMICALSrc$ , TAGs and PTP1B expression significantly , but cells remained insulin sensitive as assessed by robust @GENETgt$ AKt @/GENETgt$ and PTP1B phosphorylation at serine ( Ser ) 50 , Ser 398 and tyrosine 152 .	2 3 3 3 3 3 4 4 4 10 4 3 3 3 15 3 17 15 19 17 22 22 19|20 19 19|20 22 22 22 30 30 30 22 30 30 30 30 34 30 30 37 15	None-BC7
23481236	CHEMICAL	GENE	T15	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ fatty acids @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] We studied accumulation of lipid metabolites [ triglycerides ( TAGs ) , diglycerides ( DAGs ) ] and ceramides in relation to @GENETgt$ insulin @/GENETgt$ signaling and expression and phosphorylation of PTP1B by preincubating rat skeletal muscle cells ( L6 myotubes ) with three saturated and three unsaturated free @CHEMICALSrc$ fatty acids @/CHEMICALSrc$ ( FFAs ) ( 200 μM ) .	2 2 2 6 6 3 8 6 10 8 10 8 8 15 13 15 15 8 8 21 3 25 25|22 25 25|22 21 25 25 3 3 31 29 33 2 37 37 37 33 40 40 37 40 44 44 33 44 44 49 49 49|44|47 49|44|47 49|44 49|44|47 53 49 53 57 57 53 53 2	None-BC7
23477419	CHEMICAL	GENE	T11	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ (2-furyl)Map @/CHEMICALSrc$ and @GENETgt$ MOR @/GENETgt$ ? [SEP] Of the new compounds , @CHEMICALSrc$ Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4 @/CHEMICALSrc$ ) ( analogue 12 ) displayed the highest affinity toward @GENETgt$ MOR @/GENETgt$ , in the picomolar range ( Ki(μ ) = 3.72 pM ) .	4 4 4 13 4 4|5 4 4|5 6 10 13 10 10 13 16 16 13 18 16 16 16 13 24 24 24 13 26 24 26 24 30 28 24 13	DIRECT-REGULATOR
23477419	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ (R)-βPro @/CHEMICALSrc$ and @GENETgt$ MOR @/GENETgt$ ? [SEP] Of the new compounds , @CHEMICALSrc$ Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4 @/CHEMICALSrc$ ) ( analogue 12 ) displayed the highest affinity toward @GENETgt$ MOR @/GENETgt$ , in the picomolar range ( Ki(μ ) = 3.72 pM ) .	4 4 4 13 4 4|5 4 4|5 6 10 13 10 10 13 16 16 13 18 16 16 16 13 24 24 24 13 26 24 26 24 30 28 24 13	DIRECT-REGULATOR
23477419	CHEMICAL	GENE	T10	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ Trp @/CHEMICALSrc$ and @GENETgt$ MOR @/GENETgt$ ? [SEP] Of the new compounds , @CHEMICALSrc$ Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4 @/CHEMICALSrc$ ) ( analogue 12 ) displayed the highest affinity toward @GENETgt$ MOR @/GENETgt$ , in the picomolar range ( Ki(μ ) = 3.72 pM ) .	4 4 4 13 4 4|5 4 4|5 6 10 13 10 10 13 16 16 13 18 16 16 16 13 24 24 24 13 26 24 26 24 30 28 24 13	DIRECT-REGULATOR
23477419	CHEMICAL	GENE	T17	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ Endomorphin-1 @/CHEMICALSrc$ and @GENETgt$ μ-Opioid @/GENETgt$ ? [SEP] Design , Synthesis , and Pharmacological Characterization of Novel @CHEMICALSrc$ Endomorphin-1 @/CHEMICALSrc$ Analogues as Extremely Potent @GENETgt$ μ-Opioid @/GENETgt$ Agonists .	1 1 1 3 3 7 3 12 12 9|12 12 9|12 7 18 15 18 18|14 18 18|14 1 1	AGONIST
23477419	CHEMICAL	GENE	T8	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ Dmt @/CHEMICALSrc$ and @GENETgt$ MOR @/GENETgt$ ? [SEP] Of the new compounds , @CHEMICALSrc$ Dmt(1)-(R)-βPro(2)-Trp(3)-(2-furyl)Map(4 @/CHEMICALSrc$ ) ( analogue 12 ) displayed the highest affinity toward @GENETgt$ MOR @/GENETgt$ , in the picomolar range ( Ki(μ ) = 3.72 pM ) .	4 4 4 13 4 4|5 4 4|5 6 10 13 10 10 13 16 16 13 18 16 16 16 13 24 24 24 13 26 24 26 24 30 28 24 13	DIRECT-REGULATOR
1730582	CHEMICAL	GENE	T24	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ PFYAVKC @/GENETgt$ ? [SEP] This @CHEMICALSrc$ lysine @/CHEMICALSrc$ is contained in the sequence @GENETgt$ PFYAVKC @/GENETgt$ , which is found in all known ODCs from eukaryotes .	2 1|5 5 1|5 5 5 9 9 9 5|7 5 5|7 9 14 14 9 18 18 18 14 20 18 5	PART-OF
1730582	CHEMICAL	GENE	T26	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ ODCs @/GENETgt$ ? [SEP] The preceding @CHEMICALSrc$ amino acids @/CHEMICALSrc$ do not conform to the consensus sequence of SXHK , which contains the pyridoxal 5'-phosphate binding lysine in a number of other decarboxylases including @GENETgt$ ODCs @/GENETgt$ from E. coli .	3 3 8|2|3 8|2|3 8|3 8|2|3 8 8 8 12 12 12 8 14 12 14 17 14 22 22 22 22 17 25 25 17 28 28 25 30 27|28 28 27|28 34 34 30 8	None-BC7
1730582	CHEMICAL	GENE	T21	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ NaB[3H]4 @/CHEMICALSrc$ and @GENETgt$ endoproteinase Lys-C @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with @CHEMICALSrc$ NaB[3H]4 @/CHEMICALSrc$ followed by digestion of the carboxymethylated protein with @GENETgt$ endoproteinase Lys-C @/GENETgt$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 10 8 8 5 10 10 12 10 12 17 17 17 12 19 10 24 24 24 24 19 26 24|25 24 24|25 19 30 28 34 34 34 30 36 34|36 34|36 34|36 34|36 36 42 42 36 30 48 48 48 48 43 48 52 52 48 10	None-BC7
1730582	CHEMICAL	GENE	T2	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Using a similar procedure to analyze @GENETgt$ ODC @/GENETgt$ labeled by reaction with [5 - 14C]DFMO , it was found that @CHEMICALSrc$ lysine @/CHEMICALSrc$ 69 and cysteine 360 formed covalent adducts with the inhibitor .	19 4 4 1 6 4 6 6 6 7 11 9 15 15 15 11 19 19 19 19 27 27|19 27 27|19 21 21 21 25 19 29 27 32 32 29 19	PART-OF
1730582	CHEMICAL	GENE	T1	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ [5-14C]DFMO @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Using a similar procedure to analyze @GENETgt$ ODC @/GENETgt$ labeled by reaction with @CHEMICALSrc$ [5 - 14C]DFMO @/CHEMICALSrc$ , it was found that lysine 69 and cysteine 360 formed covalent adducts with the inhibitor .	20 4 4 1 6 4 6 6 6 7 11 9 13 11|13 11|13 11|13 11|13 11|13 20 20 20 20 27 27 22 22 22 25 20 29 27 32 32 29 20	DIRECT-REGULATOR
1730582	CHEMICAL	GENE	T27	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ SXHK @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of @GENETgt$ SXHK @/GENETgt$ , which contains the @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ binding lysine in a number of other decarboxylases including ODCs from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11|12 11 11|12 13 17 13 23 17|23 17|23 23 17|23 23 17 26 26 17 29 29 26 31 29 34 34 31 7	None-BC7
1730582	CHEMICAL	GENE	T22	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ Lys-C @/CHEMICALSrc$ and @GENETgt$ endoproteinase Lys-C @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with @GENETgt$ endoproteinase @/GENETgt$ @CHEMICALSrc$ Lys-C @/CHEMICALSrc$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 10 8 8 5 10 10 12 10 12 17 17 17 12 19 10 24 24 24 24 19 26 24 19 29 27 33 33 33 29 37 34|37 37 34|37 33|35 33 33|35 37 42 42 37 29 48 48 48 48 43 48 52 52 48 10	None-BC7
1730582	CHEMICAL	GENE	T29	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ ornithine @/CHEMICALSrc$ and @GENETgt$ mouse ornithine decarboxylase @/GENETgt$ ? [SEP] Mechanism of the irreversible inactivation of @GENETgt$ mouse @/GENETgt$ @CHEMICALSrc$ ornithine decarboxylase @/CHEMICALSrc$ by alpha-difluoromethylornithine .	1 5 5 5 1 9 9|6 9 9|6 9|5|7 9|5|7 9|5 9|5|7 13 5 1	None-BC7
1730582	CHEMICAL	GENE	T28	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ decarboxylases @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of SXHK , which contains the pyridoxal 5'-phosphate binding @CHEMICALSrc$ lysine @/CHEMICALSrc$ in a number of other @GENETgt$ decarboxylases @/GENETgt$ including ODCs from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11 13 16 13 21 21 21 21 16|20 16 16|20 25 25 16 28 28 25|26 25 25|26 31 28 34 34 31 7	None-BC7
1730582	CHEMICAL	GENE	T16	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Mouse ornithine decarboxylase ( @GENETgt$ ODC @/GENETgt$ ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ ( DFMO ) .	3 3 9 5 3|4 3 3|4 5 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 27 27 24 24 31 31 24 31 35 35 32 38 38 35 43 43 43 43 35 43 43 43 43 48 45 48 9	INHIBITOR
1730582	CHEMICAL	GENE	T21	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ NaB[3H]4 @/CHEMICALSrc$ and @GENETgt$ mouse ODC @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in @GENETgt$ mouse ODC @/GENETgt$ was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with @CHEMICALSrc$ NaB[3H]4 @/CHEMICALSrc$ followed by digestion of the carboxymethylated protein with endoproteinase Lys-C , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 11 7 5|6|7 5|6|7 5|7 5|6|7 11 11 13 11 13 18 18 18 13 20 11 25 25 25 25 20 27 24|25 25 24|25 20 31 29 35 35 35 31 38 38 35 38 42 42 38 31 48 48 48 48 43 48 52 52 48 11	None-BC7
1730582	CHEMICAL	GENE	T22	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ Lys-C @/CHEMICALSrc$ and @GENETgt$ mouse ODC @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in @GENETgt$ mouse ODC @/GENETgt$ was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase @CHEMICALSrc$ Lys-C @/CHEMICALSrc$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 11 7 5|6|7 5|6|7 5|7 5|6|7 11 11 13 11 13 18 18 18 13 20 11 25 25 25 25 20 27 25 20 30 28 34 34 34 30 37 37 34 34 34 37 42 42 37 30 48 48 48 48 43 48 52 52 48 11	None-BC7
1730582	CHEMICAL	GENE	T28	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ SXHK @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of @GENETgt$ SXHK @/GENETgt$ , which contains the pyridoxal 5'-phosphate binding @CHEMICALSrc$ lysine @/CHEMICALSrc$ in a number of other decarboxylases including ODCs from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11|12 11 11|12 13 17 13 22 22 22 22 17|20 17 17|20 26 26 17 29 29 26 31 29 34 34 31 7	None-BC7
1730582	CHEMICAL	GENE	T28	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ ODCs @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of SXHK , which contains the pyridoxal 5'-phosphate binding @CHEMICALSrc$ lysine @/CHEMICALSrc$ in a number of other decarboxylases including @GENETgt$ ODCs @/GENETgt$ from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11 13 16 13 21 21 21 21 16|20 16 16|20 25 25 16 28 28 25 30 28 28 28 34 34 30 7	None-BC7
1730582	CHEMICAL	GENE	T5	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ WGPTCDGL(I)D @/CHEMICALSrc$ and @GENETgt$ eukaryote ODCs @/GENETgt$ ? [SEP] Cysteine 360 , which was the major adduct accounting for about 90 % of the total labeling , is contained within the sequence @CHEMICALSrc$ -WGPTCDGL(I)D- @/CHEMICALSrc$ , which is present in all known @GENETgt$ eukaryote ODCs @/GENETgt$ .	20 1 1 8 8 8 8 1 8 13 12 13 9 17 17 17 13 1 20 20 23 23 20 20|23 20 20|23 20 29 29 20 33 33 33 33|29|31 33|29|31 33|29 33|29|31 20	PART-OF
1730582	CHEMICAL	GENE	T25	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ PFYAVKC @/CHEMICALSrc$ and @GENETgt$ ODCs @/GENETgt$ ? [SEP] This lysine is contained in the sequence @CHEMICALSrc$ PFYAVKC @/CHEMICALSrc$ , which is found in all known @GENETgt$ ODCs @/GENETgt$ from eukaryotes .	2 4 4 4 8 8 8 4|7 4 4|7 8 13 13 8 17 17 17 13|15 13 13|15 20 17 4	PART-OF
1730582	CHEMICAL	GENE	T26	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ decarboxylases @/GENETgt$ ? [SEP] The preceding @CHEMICALSrc$ amino acids @/CHEMICALSrc$ do not conform to the consensus sequence of SXHK , which contains the pyridoxal 5'-phosphate binding lysine in a number of other @GENETgt$ decarboxylases @/GENETgt$ including ODCs from E. coli .	3 3 8|2|3 8|2|3 8|3 8|2|3 8 8 8 12 12 12 8 14 12 14 17 14 22 22 22 22 17 25 25 17 28 28 25 25 25 31 28 34 34 31 8	None-BC7
1730582	CHEMICAL	GENE	T30	T44	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ and @GENETgt$ mouse ornithine decarboxylase @/GENETgt$ ? [SEP] Mechanism of the irreversible inactivation of @GENETgt$ mouse ornithine decarboxylase @/GENETgt$ by @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ .	1 5 5 5 1 7 5|6|7 5|6|7 5|6|7 5|7 5|6|7 12 8|5 5 8|5 1	INHIBITOR
1730582	CHEMICAL	GENE	T18	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ endoproteinase Lys-C @/GENETgt$ ? [SEP] The @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ binding lysine in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with @GENETgt$ endoproteinase Lys-C @/GENETgt$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	6 1|6 1|6 6 1|6 6 11 9 9 6 11 11 13 11 13 18 18 18 13 20 11 25 25 25 25 20 27 25 20 30 28 34 34 34 30 36 33|34|36 33|34|36 34|36 33|34|36 36 42 42 36 30 48 48 48 48 43 48 52 52 48 11	None-BC7
1730582	CHEMICAL	GENE	T6	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ? [SEP] @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ( ODC ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( DFMO ) .	0|1|9 0|1|9 0|1|9 1|9 0|1|9 6 1 6 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 26 24|26|22 24|26|22 24|26 24|26|22 24 32 32 24 32 36 36 33 39 39 36 44 44 44 44 36 44 44 48 46 48 9	DIRECT-REGULATOR
1730582	CHEMICAL	GENE	T3	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ cysteine @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Using a similar procedure to analyze @GENETgt$ ODC @/GENETgt$ labeled by reaction with [5 - 14C]DFMO , it was found that lysine 69 and @CHEMICALSrc$ cysteine @/CHEMICALSrc$ 360 formed covalent adducts with the inhibitor .	19 4 4 1 6 4 6 6 6 7 11 9 15 15 15 11 19 19 19 19 27 27 21 21 21|22 21 21|22 24 19 29 27 32 32 29 19	PART-OF
1730582	CHEMICAL	GENE	T18	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ mouse ODC @/GENETgt$ ? [SEP] The @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ binding lysine in @GENETgt$ mouse ODC @/GENETgt$ was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	6 1|6 1|6 6 1|6 6 12 8 8|5|6 8|5|6 8|6 8|5|6 12 12 14 12 14 19 19 19 14 21 12 26 26 26 26 21 28 26 21 31 29 35 35 35 31 38 38 35 38 42 42 38 31 48 48 48 48 43 48 52 52 48 12	DIRECT-REGULATOR
1730582	CHEMICAL	GENE	T4	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ Cysteine @/CHEMICALSrc$ and @GENETgt$ WGPTCDGL(I)D @/GENETgt$ ? [SEP] @CHEMICALSrc$ Cysteine @/CHEMICALSrc$ 360 , which was the major adduct accounting for about 90 % of the total labeling , is contained within the sequence @GENETgt$ -WGPTCDGL(I)D- @/GENETgt$ , which is present in all known eukaryote ODCs .	0|21 21 0|21 1 1 9 9 9 9 1 9 14 13 14 10 18 18 18 14 1 21 21 24 24 21 21|23 21 21|23 21 30 30 21 35 35 35 35 30 21	PART-OF
1730582	CHEMICAL	GENE	T19	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ mouse ODC @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding @CHEMICALSrc$ lysine @/CHEMICALSrc$ in @GENETgt$ mouse ODC @/GENETgt$ was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 4|12 12 4|12 8 8|5|6 8|5|6 8|5 8|5|6 12 12 14 12 14 19 19 19 14 21 12 26 26 26 26 21 28 26 21 31 29 35 35 35 31 38 38 35 38 42 42 38 31 48 48 48 48 43 48 52 52 48 12	PART-OF
1730582	CHEMICAL	GENE	T19	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ endoproteinase Lys-C @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding @CHEMICALSrc$ lysine @/CHEMICALSrc$ in mouse ODC was identified as lysine 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with @GENETgt$ endoproteinase Lys-C @/GENETgt$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 11|4 11 11|4 9 9 5 11 11 13 11 13 18 18 18 13 20 11 25 25 25 25 20 27 25 20 30 28 34 34 34 30 36 34|36 34|36 34|36 34|36 36 42 42 36 30 48 48 48 48 43 48 52 52 48 11	None-BC7
1730582	CHEMICAL	GENE	T27	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ decarboxylases @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of SXHK , which contains the @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ binding lysine in a number of other @GENETgt$ decarboxylases @/GENETgt$ including ODCs from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11 13 16 13 22 17|22 17|22 22 17|22 22 16 25 25 16 28 28 25 25 25 31 28 34 34 31 7	None-BC7
1730582	CHEMICAL	GENE	T17	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ DFMO @/CHEMICALSrc$ and @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ? [SEP] @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ( ODC ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( @CHEMICALSrc$ DFMO @/CHEMICALSrc$ ) .	0|1|9 0|1|9 0|1|9 1|9 0|1|9 6 1 6 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 27 27 24 24 31 31 24 31 35 35 32 38 38 35 43 43 43 43 35 43 43 47 43|45 45 43|45 47 9	INHIBITOR
1730582	CHEMICAL	GENE	T24	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ ODCs @/GENETgt$ ? [SEP] This @CHEMICALSrc$ lysine @/CHEMICALSrc$ is contained in the sequence PFYAVKC , which is found in all known @GENETgt$ ODCs @/GENETgt$ from eukaryotes .	2 1|5 5 1|5 5 5 9 9 9 5 9 13 13 9 17 17 17 13|15 13 13|15 20 17 5	PART-OF
1730582	CHEMICAL	GENE	T4	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ Cysteine @/CHEMICALSrc$ and @GENETgt$ eukaryote ODCs @/GENETgt$ ? [SEP] @CHEMICALSrc$ Cysteine @/CHEMICALSrc$ 360 , which was the major adduct accounting for about 90 % of the total labeling , is contained within the sequence -WGPTCDGL(I)D- , which is present in all known @GENETgt$ eukaryote ODCs @/GENETgt$ .	0|21 21 0|21 1 1 9 9 9 9 1 9 14 13 14 10 18 18 18 14 1 21 21 24 24 21 21 21 29 29 21 33 33 33 33|29|31 33|29|31 33|29 33|29|31 21	PART-OF
1730582	CHEMICAL	GENE	T27	T43	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ ODCs @/GENETgt$ ? [SEP] The preceding amino acids do not conform to the consensus sequence of SXHK , which contains the @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ binding lysine in a number of other decarboxylases including @GENETgt$ ODCs @/GENETgt$ from E. coli .	4 4 4 7 7 7 7 11 11 11 7 13 11 13 16 13 22 17|22 17|22 22 17|22 22 16 25 25 16 28 28 25 30 27|28 28 27|28 34 34 30 7	None-BC7
1730582	CHEMICAL	GENE	T23	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ ornithine @/CHEMICALSrc$ and @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ? [SEP] @GENETgt$ Mouse @/GENETgt$ @CHEMICALSrc$ ornithine decarboxylase @/CHEMICALSrc$ ( ODC ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( DFMO ) .	0|3 3 0|3 1|10|3 1|10|3 10|3 1|10|3 7 3 7 10 10 13 13 10 10 18 18 18 10 18 21 19 25 25 25 21 28 28 25 25 32 32 25 32 36 36 33 39 39 36 44 44 44 44 36 44 44 48 46 48 10	None-BC7
1730582	CHEMICAL	GENE	T26	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ amino acids @/CHEMICALSrc$ and @GENETgt$ SXHK @/GENETgt$ ? [SEP] The preceding @CHEMICALSrc$ amino acids @/CHEMICALSrc$ do not conform to the consensus sequence of @GENETgt$ SXHK @/GENETgt$ , which contains the pyridoxal 5'-phosphate binding lysine in a number of other decarboxylases including ODCs from E. coli .	3 3 8|2|3 8|2|3 8|3 8|2|3 8 8 8 12 12 12 8 14 11|12 12 11|12 14 18 14 23 23 23 23 18 26 26 18 29 29 26 31 29 34 34 31 8	None-BC7
1730582	CHEMICAL	GENE	T20	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ mouse ODC @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in @GENETgt$ mouse ODC @/GENETgt$ was identified as @CHEMICALSrc$ lysine @/CHEMICALSrc$ 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with endoproteinase Lys-C , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 11 7 5|6|7 5|6|7 5|7 5|6|7 11 11 13 10|11 11 10|11 13 19 19 19 13 21 11 26 26 26 26 21 28 26 21 31 29 35 35 35 31 38 38 35 38 42 42 38 31 48 48 48 48 43 48 52 52 48 11	PART-OF
1730582	CHEMICAL	GENE	T6	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Mouse ornithine decarboxylase ( @GENETgt$ ODC @/GENETgt$ ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for @CHEMICALSrc$ pyridoxal 5'-phosphate @/CHEMICALSrc$ and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( DFMO ) .	3 3 9 5 3|4 3 3|4 5 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 26 24|26 24|26 24|26 24|26 24 32 32 24 32 36 36 33 39 39 36 44 44 44 44 36 44 44 48 46 48 9	DIRECT-REGULATOR
1730582	CHEMICAL	GENE	T23	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ ornithine @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Mouse @CHEMICALSrc$ ornithine @/CHEMICALSrc$ decarboxylase ( @GENETgt$ ODC @/GENETgt$ ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( DFMO ) .	4 1|4 4 1|4 10 6 4 4 4 6 10 10 13 13 10 10 18 18 18 10 18 21 19 25 25 25 21 28 28 25 25 32 32 25 32 36 36 33 39 39 36 44 44 44 44 36 44 44 48 46 48 10	None-BC7
1730582	CHEMICAL	GENE	T20	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ lysine @/CHEMICALSrc$ and @GENETgt$ endoproteinase Lys-C @/GENETgt$ ? [SEP] The pyridoxal 5'-phosphate binding lysine in mouse ODC was identified as @CHEMICALSrc$ lysine @/CHEMICALSrc$ 69 of the mouse sequence by reduction of the purified holoenzyme form with NaB[3H]4 followed by digestion of the carboxymethylated protein with @GENETgt$ endoproteinase Lys-C @/GENETgt$ , radioactive peptide mapping using reversed-phase high pressure liquid chromatography and gas-phase peptide sequencing .	5 5 5 5 10 8 8 5 10 10 12 10|11 10 10|11 12 18 18 18 12 20 10 25 25 25 25 20 27 25 20 30 28 34 34 34 30 36 34|36 34|36 34|36 34|36 36 42 42 36 30 48 48 48 48 43 48 52 52 48 10	None-BC7
1730582	CHEMICAL	GENE	T17	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ DFMO @/CHEMICALSrc$ and @GENETgt$ ODC @/GENETgt$ ? [SEP] Mouse ornithine decarboxylase ( @GENETgt$ ODC @/GENETgt$ ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , alpha-difluoromethylornithine ( @CHEMICALSrc$ DFMO @/CHEMICALSrc$ ) .	3 3 9 5 3|4 3 3|4 5 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 27 27 24 24 31 31 24 31 35 35 32 38 38 35 43 43 43 43 35 43 43 47 45 45 45 47 9	INHIBITOR
1730582	CHEMICAL	GENE	T16	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ and @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ? [SEP] @GENETgt$ Mouse ornithine decarboxylase @/GENETgt$ ( ODC ) was expressed in Escherichia coli and the purified recombinant enzyme used for determination of the binding site for pyridoxal 5'-phosphate and of the residues modified in the inactivation of the enzyme by the enzyme-activated irreversible inhibitor , @CHEMICALSrc$ alpha-difluoromethylornithine @/CHEMICALSrc$ ( DFMO ) .	0|1|9 0|1|9 0|1|9 1|9 0|1|9 6 1 6 9 9 12 12 9 9 17 17 17 9 17 20 18 24 24 24 20 27 27 24 24 31 31 24 31 35 35 32 38 38 35 43 43 43 43 35 43 41|43 43 41|43 48 45 48 9	INHIBITOR
7599160	CHEMICAL	GENE	T10	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin II @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ ) bound to @GENETgt$ transcobalamin II @/GENETgt$ ( transcobalamin , TC ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 30 30 30 26|29 26 26|29 30 26 35 33|35 33|35 33|35 33|35 39 35 39 39 39 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T7	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin @/GENETgt$ ? [SEP] Extracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to transcobalamin II ( @GENETgt$ transcobalamin @/GENETgt$ , TC ) .	2 1|5 5 1|5 5 6 6 6 6 8 6 12 14 14 15 6 15 15 15 20 6 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33 35 38 35|36 35 35|36 38 38 38 6	None-BC7
7599160	CHEMICAL	GENE	T10	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ and @GENETgt$ TC @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ ) bound to transcobalamin II ( transcobalamin , @GENETgt$ TC @/GENETgt$ ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 30 30 30 26|29 26 26|29 30 26 35 33 35 38 35 38 38 38 38 38 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T8	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to transcobalamin II ( @GENETgt$ transcobalamin @/GENETgt$ , TC ) .	2 4 4 5 5 5 5 7 5 11 10|14 14 10|14 14 15 5 15 15 15 20 5 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33 35 38 35|36 35 35|36 38 38 38 5	None-BC7
7599160	CHEMICAL	GENE	T24	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ and @GENETgt$ methylmalonyl-CoA mutase @/GENETgt$ ? [SEP] Intracellular protein-bound @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ fractionated with methionine synthase ( MS ) and @GENETgt$ methylmalonyl-CoA mutase @/GENETgt$ ( MU ) activity .	2 3 2|3 3 2|3 3 8 8 5 10 8 10 8 19|11|13 19|11|13 19|13 19|11|13 17 13 17 5 3	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T10	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( @CHEMICALSrc$ CN-Cbl @/CHEMICALSrc$ ) bound to transcobalamin II ( @GENETgt$ transcobalamin @/GENETgt$ , TC ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 30 30 30 26|29 26 26|29 30 26 35 33 35 38 35|36 35 35|36 38 38 38 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T8	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin II @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to @GENETgt$ transcobalamin II @/GENETgt$ ( transcobalamin , TC ) .	2 4 4 5 5 5 5 7 5 11 10|14 14 10|14 14 15 5 15 15 15 20 5 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33|35 33|35 33|35 33|35 39 35 39 39 39 5	None-BC7
7599160	CHEMICAL	GENE	T8	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ TC @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to transcobalamin II ( transcobalamin , @GENETgt$ TC @/GENETgt$ ) .	2 4 4 5 5 5 5 7 5 11 10|14 14 10|14 14 15 5 15 15 15 20 5 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33 35 38 35 38 38 38 38 38 5	None-BC7
7599160	CHEMICAL	GENE	T25	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ methylmalonyl-CoA mutase @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with @CHEMICALSrc$ methionine @/CHEMICALSrc$ synthase ( MS ) and @GENETgt$ methylmalonyl-CoA mutase @/GENETgt$ ( MU ) activity .	2 3 3 3 8 8|5 8 8|5 4 10 8 10 8 19|11|13 19|11|13 19|13 19|11|13 17 13 17 4 3	None-BC7
7599160	CHEMICAL	GENE	T25	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ MU @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with @CHEMICALSrc$ methionine @/CHEMICALSrc$ synthase ( MS ) and methylmalonyl-CoA mutase ( @GENETgt$ MU @/GENETgt$ ) activity .	2 3 3 3 8 8|5 8 8|5 4 10 8 10 8 14 19 16 14 14 14 16 4 3	None-BC7
7599160	CHEMICAL	GENE	T24	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ and @GENETgt$ methionine synthase @/GENETgt$ ? [SEP] Intracellular protein-bound @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ fractionated with @GENETgt$ methionine synthase @/GENETgt$ ( MS ) and methylmalonyl-CoA mutase ( MU ) activity .	2 3 2|3 3 2|3 3 7 5|7 5|7 5|7 5|7 11 7 11 7 15 19 17 15 17 5 3	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T9	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ and @GENETgt$ transcobalamin @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ ( CN-Cbl ) bound to transcobalamin II ( @GENETgt$ transcobalamin @/GENETgt$ , TC ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 31 27|31 31 27|31 31 26 31 26 35 33 35 38 35|36 35 35|36 38 38 38 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T25	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with @CHEMICALSrc$ methionine @/CHEMICALSrc$ synthase ( @GENETgt$ MS @/GENETgt$ ) and methylmalonyl-CoA mutase ( MU ) activity .	2 3 3 3 8 8|5 8 8|5 4 10 8 8 8 10 8 15 19 17 15 17 4 3	None-BC7
7599160	CHEMICAL	GENE	T24	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Intracellular protein-bound @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ fractionated with methionine synthase ( @GENETgt$ MS @/GENETgt$ ) and methylmalonyl-CoA mutase ( MU ) activity .	2 3 2|3 3 2|3 3 8 8 5 10 8 8 8 10 8 15 19 17 15 17 5 3	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T7	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ TC @/GENETgt$ ? [SEP] Extracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to transcobalamin II ( transcobalamin , @GENETgt$ TC @/GENETgt$ ) .	2 1|5 5 1|5 5 6 6 6 6 8 6 12 14 14 15 6 15 15 15 20 6 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33 35 38 35 38 38 38 38 38 6	None-BC7
7599160	CHEMICAL	GENE	T26	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ and @GENETgt$ MU @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase ( MS ) and @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ mutase ( @GENETgt$ MU @/GENETgt$ ) activity .	2 3 3 3 7 7 4 9 7 9 7 11|14 14 11|14 19 16 14 14 14 16 4 3	None-BC7
7599160	CHEMICAL	GENE	T24	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ and @GENETgt$ MU @/GENETgt$ ? [SEP] Intracellular protein-bound @CHEMICALSrc$ [57Co]Cbl @/CHEMICALSrc$ fractionated with methionine synthase ( MS ) and methylmalonyl-CoA mutase ( @GENETgt$ MU @/GENETgt$ ) activity .	2 3 2|3 3 2|3 3 8 8 5 10 8 10 8 14 19 16 14 14 14 16 5 3	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T9	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ and @GENETgt$ transcobalamin II @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ ( CN-Cbl ) bound to @GENETgt$ transcobalamin II @/GENETgt$ ( transcobalamin , TC ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 31 27|31 31 27|31 31 26 31 26 35 33|35 33|35 33|35 33|35 39 35 39 39 39 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T5	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ Me-Cbl @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Cells propagated in medium containing N5-methyltetrahydrofolate and homocysteine showed a substantial increase in @GENETgt$ MS @/GENETgt$ activity which paralleled the increase in the intracellular concentration of @CHEMICALSrc$ Me-Cbl @/CHEMICALSrc$ and the Cbl bound to the enzyme .	9 1 4 2 4 5 6 6 9 12 12 9 16 16|13 16 16|13 12 18 16 20 18 24 24 24 20 26 24 24 24 24 30 31 9 34 34 31 9	None-BC7
7599160	CHEMICAL	GENE	T9	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ and @GENETgt$ TC @/GENETgt$ ? [SEP] Extracellular Cbl ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of @CHEMICALSrc$ [57Co]cyanocobalamin @/CHEMICALSrc$ ( CN-Cbl ) bound to transcobalamin II ( transcobalamin , @GENETgt$ TC @/GENETgt$ ) .	2 4 4 5 5 5 5 7 5 11 13 13 14 5 14 14 14 19 5 21 19 23 21 26 26 21 31 27|31 31 27|31 31 26 31 26 35 33 35 38 35 38 38 38 38 38 5	DIRECT-REGULATOR
7599160	CHEMICAL	GENE	T26	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with methionine synthase ( @GENETgt$ MS @/GENETgt$ ) and @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ mutase ( MU ) activity .	2 3 3 3 7 7 4 9 8|7 7 8|7 9 7 11|15 15 11|15 19 17 15 17 4 3	None-BC7
7599160	CHEMICAL	GENE	T7	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ transcobalamin II @/GENETgt$ ? [SEP] Extracellular @CHEMICALSrc$ Cbl @/CHEMICALSrc$ ( protein bound and free ) and intracellular Cbl ( protein bound and free ) were determined after culturing L-1210 cells in the presence of [57Co]cyanocobalamin ( CN-Cbl ) bound to @GENETgt$ transcobalamin II @/GENETgt$ ( transcobalamin , TC ) .	2 1|5 5 1|5 5 6 6 6 6 8 6 12 14 14 15 6 15 15 15 20 6 22 20 24 22 27 27 22 31 31 31 27 31 27 35 33|35 33|35 33|35 33|35 39 35 39 39 39 6	None-BC7
7599160	CHEMICAL	GENE	T4	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ homocysteine @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Cells propagated in medium containing N5-methyltetrahydrofolate and @CHEMICALSrc$ homocysteine @/CHEMICALSrc$ showed a substantial increase in @GENETgt$ MS @/GENETgt$ activity which paralleled the increase in the intracellular concentration of Me-Cbl and the Cbl bound to the enzyme .	10 1 4 2 4 5 6 6|7 6 6|7 10 13 13 10 17 17|13 17 17|13 13 19 17 21 19 25 25 25 21 27 25 25 30 31 10 34 34 31 10	ACTIVATOR
7599160	CHEMICAL	GENE	T6	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ Cbl @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Cells propagated in medium containing N5-methyltetrahydrofolate and homocysteine showed a substantial increase in @GENETgt$ MS @/GENETgt$ activity which paralleled the increase in the intracellular concentration of Me-Cbl and the @CHEMICALSrc$ Cbl @/CHEMICALSrc$ bound to the enzyme .	9 1 4 2 4 5 6 6 9 12 12 9 16 16|13 16 16|13 12 18 16 20 18 24 24 24 20 26 24 24 29 27|31 31 27|31 9 34 34 31 9	None-BC7
7599160	CHEMICAL	GENE	T3	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ N5-methyltetrahydrofolate @/CHEMICALSrc$ and @GENETgt$ MS @/GENETgt$ ? [SEP] Cells propagated in medium containing @CHEMICALSrc$ N5-methyltetrahydrofolate @/CHEMICALSrc$ and homocysteine showed a substantial increase in @GENETgt$ MS @/GENETgt$ activity which paralleled the increase in the intracellular concentration of Me-Cbl and the Cbl bound to the enzyme .	10 1 4 2 4 5 5 5 6 6 10 13 13 10 17 17|13 17 17|13 13 19 17 21 19 25 25 25 21 27 25 25 30 31 10 34 34 31 10	ACTIVATOR
7599160	CHEMICAL	GENE	T26	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ and @GENETgt$ methionine synthase @/GENETgt$ ? [SEP] Intracellular protein-bound [57Co]Cbl fractionated with @GENETgt$ methionine synthase @/GENETgt$ ( MS ) and @CHEMICALSrc$ methylmalonyl-CoA @/CHEMICALSrc$ mutase ( MU ) activity .	2 3 3 3 6 4|5|6 4|5|6 4|6 4|5|6 10 6 10 6 10|15 15 10|15 19 17 15 17 4 3	None-BC7
9204085	CHEMICAL	GENE	T10	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ and @GENETgt$ nuclear transcription factors @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ for the @GENETgt$ nuclear transcription factors @/GENETgt$ , retinoic acid receptors ( RARs ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12 14 14|15 14 14|15 20 20 9|18|20 9|18|20 9|18|20 9|20 9|18|20 20 27 27 20 29 27 29 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T3	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ RAR gamma @/GENETgt$ ? [SEP] The nuclear gene transcription factors RAR beta and @GENETgt$ RAR gamma @/GENETgt$ mediate the retinoid activity of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ .	5 5 5 5 12 7 5 7 8|9|7 8|9|7 9|7 8|9|7 12 15 15 12 17 14|15 15 14|15 12	None-BC7
9204085	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ RARs @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and tretinoin for the nuclear transcription factors , retinoic acid receptors ( @GENETgt$ RARs @/GENETgt$ ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12|13 12 12|13 14 14 22 22 22 22 9 22 26 26 22 28 26 26 26 28 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T3	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ nuclear gene transcription factors @/GENETgt$ ? [SEP] The @GENETgt$ nuclear gene transcription factors @/GENETgt$ RAR beta and RAR gamma mediate the retinoid activity of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ .	2 1|2|12 1|2|12 1|2|12 1|2|12 2|12 1|2|12 8 2 8 11 8 12 15 15 12 17 12|15 15 12|15 12	None-BC7
9204085	CHEMICAL	GENE	T1	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoid @/CHEMICALSrc$ and @GENETgt$ RAR beta @/GENETgt$ ? [SEP] The nuclear gene transcription factors @GENETgt$ RAR beta @/GENETgt$ and RAR gamma mediate the @CHEMICALSrc$ retinoid @/CHEMICALSrc$ activity of adapalene .	5 5 5 5 12 5|6 5|6 5|6 5|6 6 11 6 12 16 16|11 16 16|11 12 18 16 12	None-BC7
9204085	CHEMICAL	GENE	T9	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ nuclear transcription factors @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and tretinoin for the @GENETgt$ nuclear transcription factors @/GENETgt$ , retinoic acid receptors ( RARs ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12|13 12 12|13 14 14 20 20 9|18|20 9|18|20 9|18|20 9|20 9|18|20 20 27 27 20 29 27 29 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T9	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ retinoic acid receptors @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and tretinoin for the nuclear transcription factors , @GENETgt$ retinoic acid receptors @/GENETgt$ ( RARs ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12|13 12 12|13 14 14 22 22 22 22 9 22 24|22 24|22 24|22 24|22 24|22 29 24 29 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T10	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ and @GENETgt$ retinoic acid receptors @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ for the nuclear transcription factors , @GENETgt$ retinoic acid receptors @/GENETgt$ ( RARs ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12 14 14|15 14 14|15 22 22 22 22 9 22 24|22 24|22 24|22 24|22 24|22 29 24 29 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T1	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoid @/CHEMICALSrc$ and @GENETgt$ nuclear gene transcription factors @/GENETgt$ ? [SEP] The @GENETgt$ nuclear gene transcription factors @/GENETgt$ RAR beta and RAR gamma mediate the @CHEMICALSrc$ retinoid @/CHEMICALSrc$ activity of adapalene .	2 1|2|12 1|2|12 1|2|12 1|2|12 2|12 1|2|12 8 2 8 11 8 12 16 16|9 16 16|9 12 18 16 12	None-BC7
9204085	CHEMICAL	GENE	T3	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ adapalene @/CHEMICALSrc$ and @GENETgt$ RAR beta @/GENETgt$ ? [SEP] The nuclear gene transcription factors @GENETgt$ RAR beta @/GENETgt$ and RAR gamma mediate the retinoid activity of @CHEMICALSrc$ adapalene @/CHEMICALSrc$ .	5 5 5 5 12 5|6 5|6 5|6 5|6 6 11 6 12 15 15 12 17 14|15 15 14|15 12	None-BC7
9204085	CHEMICAL	GENE	T10	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ and @GENETgt$ RARs @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and @CHEMICALSrc$ tretinoin @/CHEMICALSrc$ for the nuclear transcription factors , retinoic acid receptors ( @GENETgt$ RARs @/GENETgt$ ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12 14 14|15 14 14|15 22 22 22 22 9 22 26 26 22 28 26 26 26 28 6	DIRECT-REGULATOR
9204085	CHEMICAL	GENE	T1	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoid @/CHEMICALSrc$ and @GENETgt$ RAR gamma @/GENETgt$ ? [SEP] The nuclear gene transcription factors RAR beta and @GENETgt$ RAR gamma @/GENETgt$ mediate the @CHEMICALSrc$ retinoid @/CHEMICALSrc$ activity of adapalene .	5 5 5 5 12 7 5 7 8|9|7 8|9|7 9|7 8|9|7 12 16 16|11 16 16|11 12 18 16 12	None-BC7
9204085	CHEMICAL	GENE	T11	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ RARs @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the nuclear transcription factors , @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors ( @GENETgt$ RARs @/GENETgt$ ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12 14 14 21 21 21 21 9 21 26|22 26|22 26 26|22 21 28 25|26 26 25|26 28 6	None-BC7
9204085	CHEMICAL	GENE	T11	T19	True	0	What is [Drugprot] between @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ and @GENETgt$ nuclear transcription factors @/GENETgt$ ? [SEP] Binding and transactivation assays were used to compare affinities and transcriptional activities of adapalene and tretinoin for the @GENETgt$ nuclear transcription factors @/GENETgt$ , @CHEMICALSrc$ retinoic acid @/CHEMICALSrc$ receptors ( RARs ) .	6 1 1 1 6 6 8 6 8 9 12 9 14 12 14 14 19 19 9|18|19 9|18|19 9|18|19 9|19 9|18|19 19 27|20 27|20 27 27|20 19 29 27 29 6	None-BC7
9832994	CHEMICAL	GENE	T11	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21|22 21 21|22 24 24 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T14	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ .	2 3 3 30 9 9|5 9 9|5 9 30 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 43 43 40 43 43 43 41|36 36 41|36 3	None-BC7
9832994	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 24|23 23 24|23 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T7	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ methysergide @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and @CHEMICALSrc$ methysergide @/CHEMICALSrc$ , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 12 12 19 12 19 19 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	ANTAGONIST
9832994	CHEMICAL	GENE	T18	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ plasma prolactin @/GENETgt$ ? [SEP] Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in @GENETgt$ plasma prolactin @/GENETgt$ and ACTH levels after i.v . mCPP , pointing to a general state of arousal in these @CHEMICALSrc$ mCPP-treated @/CHEMICALSrc$ animals .	3 3 10 7 7 7 3 9 7 10 13 13 10 15 13|14|15 13|14|15 13|15 13|14|15 15 15 15 22 13 10 24 24 24 30 30 30 26 32 30 37 37 32|37 37 32|37 30 24	None-BC7
9832994	CHEMICAL	GENE	T12	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 24|23 23 24|23 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T6	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9|10 9 9|10 12 12 12 12 19 12 19 19 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	ANTAGONIST
9832994	CHEMICAL	GENE	T11	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21|22 21 21|22 24 24 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T8	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 16|11 11 16|11 17 17 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T13	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of @CHEMICALSrc$ mCPP-induced @/CHEMICALSrc$ behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 29 8 8 8 29 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 23 29 28 29 3 34 34|30 34 34|30 34 29 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T11	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20|22 20 20|22 23 23 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T17	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ ACTH @/GENETgt$ ? [SEP] Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and @GENETgt$ ACTH @/GENETgt$ levels after i.v . @CHEMICALSrc$ mCPP @/CHEMICALSrc$ , pointing to a general state of arousal in these mCPP-treated animals .	3 3 10 7 7 7 3 9 7 10 13 13 10 16 16 13 16 16|17 16 16|17 16 22 13 10 24|22 24 24|22 24 24 31 31 31 27 33 31 37 37 37 31 24	INDIRECT-UPREGULATOR
9832994	CHEMICAL	GENE	T6	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8|10 8 8|10 11 11 11 11 18 11 18 18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T13	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of @CHEMICALSrc$ mCPP-induced @/CHEMICALSrc$ behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 29 8 8 8 29 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 23 29 28 29 3 34 34|30 34 34|30 34 29 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T7	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ methysergide @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and @CHEMICALSrc$ methysergide @/CHEMICALSrc$ , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 12 12 19 12 19 19 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	ANTAGONIST
9832994	CHEMICAL	GENE	T7	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ methysergide @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and @CHEMICALSrc$ methysergide @/CHEMICALSrc$ , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11|12 11 11|12 11 11 18 11 18 18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T12	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 24 24 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T13	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of @CHEMICALSrc$ mCPP-induced @/CHEMICALSrc$ behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 30 9 9|5 9 9|5 9 30 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 30 29 30 3 35 35|30 35 35|30 35 30 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17|18 17 17|18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T12	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and @CHEMICALSrc$ mirtazapine @/CHEMICALSrc$ are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 24 24 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T13	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of @CHEMICALSrc$ mCPP-induced @/CHEMICALSrc$ behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 30 9 9|5 9 9|5 9 30 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 30 29 30 3 35 35|30 35 35|30 35 30 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T8	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 16|12 12 16|12 18 18 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T14	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ .	2 3 3 29 8 8 8 29 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 23 29 28 29 3 33 33 33 29 35 33 43 43 39 43 43|39 43 43|39 43 41|35 35 41|35 3	ANTAGONIST
9832994	CHEMICAL	GENE	T8	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 16|11 11 16|11 17 17 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T10	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 18 18 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T14	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ .	2 3 3 30 9 9|5 9 9|5 9 30 12 10 9 12 12 12 12 18 12 18 18 12 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 43 43 40 43 43 43 41|36 36 41|36 3	None-BC7
9832994	CHEMICAL	GENE	T18	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ ACTH @/GENETgt$ ? [SEP] Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and @GENETgt$ ACTH @/GENETgt$ levels after i.v . mCPP , pointing to a general state of arousal in these @CHEMICALSrc$ mCPP-treated @/CHEMICALSrc$ animals .	3 3 10 7 7 7 3 9 7 10 13 13 10 16 16 13 16 16|17 16 16|17 16 22 13 10 24 24 24 30 30 30 26 32 30 37 37 33|37 37 33|37 30 24	None-BC7
9832994	CHEMICAL	GENE	T6	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8|10 8 8|10 11 11 11 11 18 11 18 18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T11	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as @CHEMICALSrc$ mianserin @/CHEMICALSrc$ and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20|22 20 20|22 23 23 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T10	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 12 18 18 18 18 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
9832994	CHEMICAL	GENE	T17	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ mCPP @/CHEMICALSrc$ and @GENETgt$ plasma prolactin @/GENETgt$ ? [SEP] Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in @GENETgt$ plasma prolactin @/GENETgt$ and ACTH levels after i.v . @CHEMICALSrc$ mCPP @/CHEMICALSrc$ , pointing to a general state of arousal in these mCPP-treated animals .	3 3 10 7 7 7 3 9 7 10 13 13 10 15 13|14|15 13|14|15 13|15 13|14|15 15 15 15 22 13 10 24|21 24 24|21 24 24 31 31 31 27 33 31 37 37 37 31 24	INDIRECT-UPREGULATOR
9832994	CHEMICAL	GENE	T10	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ and @GENETgt$ 5-HT2C @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and @CHEMICALSrc$ catecholamine @/CHEMICALSrc$ antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11 11 11 17 11 17 17|18 17 17|18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T6	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and @GENETgt$ 5-HT2 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as @CHEMICALSrc$ pizotifen @/CHEMICALSrc$ and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9|10 9 9|10 12 12 12 12 19 12 19 19 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	ANTAGONIST
9832994	CHEMICAL	GENE	T14	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist @CHEMICALSrc$ ritanserin @/CHEMICALSrc$ .	2 3 3 29 8 8 8 29 11 9 8 11 11 11 11 17 11 17 17 11 23 21 20 23 23 29 28 29 3 33 33 33 29 35 33 43 43 39 43 43|39 43 43|39 43 41|35 35 41|35 3	ANTAGONIST
9832994	CHEMICAL	GENE	T7	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ methysergide @/CHEMICALSrc$ and @GENETgt$ 5-HT2A @/GENETgt$ ? [SEP] These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and @CHEMICALSrc$ methysergide @/CHEMICALSrc$ , and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective @GENETgt$ 5-HT2A/5-HT2C @/GENETgt$ antagonist ritanserin .	2 3 3 30 8 8 8 30 11 9 8 11 11|12 11 11|12 11 11 18 11 18 18 11 24 22 21 24 24 30 29 30 3 34 34 34 30 36 34 44 44 40 44 44|39 44 44|39 44 36 3	None-BC7
9832994	CHEMICAL	GENE	T8	T23	True	0	What is [Drugprot] between @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and @GENETgt$ 5-HT1 @/GENETgt$ ? [SEP] These data indicate that mixed @GENETgt$ 5-HT1/5-HT2 @/GENETgt$ receptor antagonists such as pizotifen and methysergide , and mixed @CHEMICALSrc$ 5-HT @/CHEMICALSrc$ and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/5-HT2C antagonist ritanserin .	2 3 3 31 9 9|5 9 9|5 9 31 12 10 9 12 12 12 12 18 16|12 12 16|12 18 18 12 25 23 22 25 25 31 30 31 3 35 35 35 31 37 35 44 44 41 44 44 44 37 3	None-BC7
17350061	CHEMICAL	GENE	T4	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ( HSD17beta7 ; involved in @CHEMICALSrc$ estradiol @/CHEMICALSrc$ production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 17 16|17|15 16|17|15 17|15 16|17|15 21 17 21 21 27 27|22 27 27|22 23 21 8 8 30 33 31 35 33 38 38 35 33 8	PRODUCT-OF
17350061	CHEMICAL	GENE	T6	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ thioether S-methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in @CHEMICALSrc$ methionine @/CHEMICALSrc$ metabolism , such as methionine adenosyltransferase-1a , betaine-homocysteine methyltransferase and @GENETgt$ thioether S-methyltransferase @/GENETgt$ , were suppressed .	2 25 5 5 2 5 10 10|7 10 10|7 6 10 15 12 15 10 15 18 15 18 18|20 18|20 18|20 18|20 2 25 25 25	PRODUCT-OF
17350061	CHEMICAL	GENE	T8	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ betaine @/CHEMICALSrc$ and @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ , @CHEMICALSrc$ betaine-homocysteine @/CHEMICALSrc$ methyltransferase and thioether S-methyltransferase , were suppressed .	2 25 5 5 2 5 9 9 6 9 13 11 9|12|13 9|12|13 9|13 9|12|13 13 19|14 19 19|14 13 19 22 19 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T10	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ thioether @/CHEMICALSrc$ and @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ , betaine-homocysteine methyltransferase and @CHEMICALSrc$ thioether @/CHEMICALSrc$ S-methyltransferase , were suppressed .	2 25 5 5 2 5 9 9 6 9 13 11 9|12|13 9|12|13 9|13 9|12|13 13 18 13 18 17|22 22 17|22 18 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T7	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ thioether S-methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @CHEMICALSrc$ methionine @/CHEMICALSrc$ adenosyltransferase-1a , betaine-homocysteine methyltransferase and @GENETgt$ thioether S-methyltransferase @/GENETgt$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 15 11 12|15 15 12|15 9 15 18 15 18 18|20 18|20 18|20 18|20 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T11	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ S @/CHEMICALSrc$ and @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ , betaine-homocysteine methyltransferase and thioether @CHEMICALSrc$ S-methyltransferase @/CHEMICALSrc$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 13 11 9|12|13 9|12|13 9|13 9|12|13 13 18 13 18 21 18 18 18 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T2	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ 17beta-hydroxysteroid @/CHEMICALSrc$ and @GENETgt$ HSD17beta5 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of @CHEMICALSrc$ 17beta-hydroxysteroid @/CHEMICALSrc$ dehydrogenase-7 ( HSD17beta7 ; involved in estradiol production ) and decreased expression of @GENETgt$ HSD17beta5 @/GENETgt$ ( involved in testosterone production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 19 16|19 19 16|19 15 21 19 21 21 26 26 23 21 8 8 29 32 30 30 30 35 32 38 38 35 32 8	None-BC7
17350061	CHEMICAL	GENE	T22	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ ghrelin @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , CRP-ductin , @GENETgt$ ghrelin @/GENETgt$ , and small proline-rich protein-2A , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 10 10 5 10 13 10 13 16 13 13 13 18 18 18 18 13 13 25 26 13 10 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T23	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ CRP-ductin @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , @GENETgt$ CRP-ductin @/GENETgt$ , ghrelin , and small @CHEMICALSrc$ proline-rich @/CHEMICALSrc$ protein-2A , were dramatically over-expressed .	2 30 2 5 3 5 9 9 5 9 12 9 12 15 12 12 16|12 12 16|12 17 17 12 12 24 26|22 26 26|22 12 9 30 30 30 30	None-BC7
17350061	CHEMICAL	GENE	T1	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ steroid @/CHEMICALSrc$ and @GENETgt$ HSD17beta5 @/GENETgt$ ? [SEP] Several genes involved with @CHEMICALSrc$ steroid @/CHEMICALSrc$ metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( HSD17beta7 ; involved in estradiol production ) and decreased expression of @GENETgt$ HSD17beta5 @/GENETgt$ ( involved in testosterone production ) .	2 9 2 7 4|7 7 4|7 3 9 9 12 12 9 12 16 16 12 19 19 16 21 19 21 21 26 26 23 21 9 9 29 32 30 30 30 35 32 38 38 35 32 9	None-BC7
17350061	CHEMICAL	GENE	T23	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ small proline-rich protein-2A @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , CRP-ductin , ghrelin , and @GENETgt$ small @/GENETgt$ @CHEMICALSrc$ proline-rich protein-2A @/CHEMICALSrc$ , were dramatically over-expressed .	2 30 2 5 3 5 9 9 5 9 12 9 12 15 12 12 12 17 17 12 12 24|21 24 24|21 24|12|22 24|12|22 24|12 24|12|22 9 30 30 30 30	None-BC7
17350061	CHEMICAL	GENE	T8	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ betaine @/CHEMICALSrc$ and @GENETgt$ thioether S-methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase-1a , @CHEMICALSrc$ betaine-homocysteine @/CHEMICALSrc$ methyltransferase and @GENETgt$ thioether S-methyltransferase @/GENETgt$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 14 11 14 9 14 18|15 18 18|15 14 18 18|20 18|20 18|20 18|20 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T9	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ homocysteine @/CHEMICALSrc$ and @GENETgt$ thioether S-methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase-1a , @CHEMICALSrc$ betaine-homocysteine @/CHEMICALSrc$ methyltransferase and @GENETgt$ thioether S-methyltransferase @/GENETgt$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 14 11 14 9 14 18|15 18 18|15 14 18 18|20 18|20 18|20 18|20 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T4	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ HSD17beta5 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( HSD17beta7 ; involved in @CHEMICALSrc$ estradiol @/CHEMICALSrc$ production ) and decreased expression of @GENETgt$ HSD17beta5 @/GENETgt$ ( involved in testosterone production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 18 18 15 20 18 20 20 26 26|23 26 26|23 22 20 8 8 29 32 30 30 30 35 32 38 38 35 32 8	None-BC7
17350061	CHEMICAL	GENE	T11	T35	True	0	What is [Drugprot] between @CHEMICALSrc$ S @/CHEMICALSrc$ and @GENETgt$ thioether S-methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase-1a , betaine-homocysteine methyltransferase and @GENETgt$ thioether @/GENETgt$ @CHEMICALSrc$ S-methyltransferase @/CHEMICALSrc$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 14 11 14 9 14 17 14 17 18|21 21 18|21 17|19 17 17|19 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T22	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ trefoil factor-1 @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including X-inactive-specific transcript , anterior gradient-2 , @GENETgt$ trefoil factor-1 @/GENETgt$ , CRP-ductin , ghrelin , and small proline-rich protein-2A , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 10 10 5 10 13 10 13 13|15 13|15 13|15 13|15 13 13 19 19 13 13 25 26 13 10 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T24	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ Estrogen @/CHEMICALSrc$ and @GENETgt$ Cyp3a25 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Estrogen-regulated @/CHEMICALSrc$ genes including cytokeratin 1 - 19 and Cyp2a4 were over-expressed , although @GENETgt$ Cyp3a25 @/GENETgt$ was suppressed .	0|3 3 0|3 12 5 3 5 5 5 5 5 12 12 12 18 18|13 18 18|13 18 12 12	INDIRECT-DOWNREGULATOR
17350061	CHEMICAL	GENE	T22	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ anterior gradient-2 @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including X-inactive-specific transcript , @GENETgt$ anterior gradient-2 @/GENETgt$ , trefoil factor-1 , CRP-ductin , ghrelin , and small proline-rich protein-2A , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 10 10 5 10 10|12 10|12 10|12 10|12 12 17 12 12 12 19 19 12 12 25 26 12 10 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T22	T41	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ small proline-rich protein-2A @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , CRP-ductin , ghrelin , and @GENETgt$ small proline-rich protein-2A @/GENETgt$ , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 10 10 5 10 13 10 13 16 13 13 13 18 18 13 13 13|21|23 13|21|23 13|21|23 13|23 13|21|23 10 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T24	T42	True	0	What is [Drugprot] between @CHEMICALSrc$ Estrogen @/CHEMICALSrc$ and @GENETgt$ cytokeratin 1-19 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Estrogen-regulated @/CHEMICALSrc$ genes including @GENETgt$ cytokeratin 1 - 19 @/GENETgt$ and Cyp2a4 were over-expressed , although Cyp3a25 was suppressed .	0|3 3 0|3 13 5 3|5 3|5 3|5 3|5 3|5 3|5 5 5 13 13 13 18 18 18 13 13	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T9	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ homocysteine @/CHEMICALSrc$ and @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ , @CHEMICALSrc$ betaine-homocysteine @/CHEMICALSrc$ methyltransferase and thioether S-methyltransferase , were suppressed .	2 25 5 5 2 5 9 9 6 9 13 11 9|12|13 9|12|13 9|13 9|12|13 13 19|14 19 19|14 13 19 22 19 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T2	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ 17beta-hydroxysteroid @/CHEMICALSrc$ and @GENETgt$ HSD17beta7 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of @CHEMICALSrc$ 17beta-hydroxysteroid @/CHEMICALSrc$ dehydrogenase-7 ( @GENETgt$ HSD17beta7 @/GENETgt$ ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 19 16|19 19 16|19 15 21 19 19 19 21 21 27 27 24 21 8 8 30 33 31 35 33 38 38 35 33 8	None-BC7
17350061	CHEMICAL	GENE	T23	T37	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ anterior gradient-2 @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including X-inactive-specific transcript , @GENETgt$ anterior gradient-2 @/GENETgt$ , trefoil factor-1 , CRP-ductin , ghrelin , and small @CHEMICALSrc$ proline-rich @/CHEMICALSrc$ protein-2A , were dramatically over-expressed .	2 30 2 5 3 5 9 9 5 9 9|10|11 9|10|11 9|11 9|10|11 11 16 11 11 11 18 18 11 11 24 26|21 26 26|21 11 9 30 30 30 30	None-BC7
17350061	CHEMICAL	GENE	T7	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as @CHEMICALSrc$ methionine @/CHEMICALSrc$ adenosyltransferase-1a , @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ and thioether S-methyltransferase , were suppressed .	2 25 5 5 2 5 9 9 6 9 15 11 12|15 15 12|15 9 15 17|15 17|15 17|15 17|15 17 22 17 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T22	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ X-inactive-specific transcript @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including @GENETgt$ X-inactive-specific transcript @/GENETgt$ , anterior gradient-2 , trefoil factor-1 , CRP-ductin , ghrelin , and small proline-rich protein-2A , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 9 9|5|7 9|5|7 9|5 9|5|7 9 14 9 14 17 14 14 14 19 19 14 14 25 26 14 9 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T5	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ( HSD17beta7 ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in @CHEMICALSrc$ testosterone @/CHEMICALSrc$ production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 17 16|17|15 16|17|15 17|15 16|17|15 21 17 21 21 26 26 23 21 8 8 29 32 30 34 32 38 33|38 38 33|38 34 32 8	None-BC7
17350061	CHEMICAL	GENE	T22	T39	True	0	What is [Drugprot] between @CHEMICALSrc$ estrogen @/CHEMICALSrc$ and @GENETgt$ CRP-ductin @/GENETgt$ ? [SEP] Various genes controlled by @CHEMICALSrc$ estrogen @/CHEMICALSrc$ , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , @GENETgt$ CRP-ductin @/GENETgt$ , ghrelin , and small proline-rich protein-2A , were dramatically over-expressed .	2 30 2 5 3|4 3 3|4 5 10 10 5 10 13 10 13 16 13 13 16|13 13 16|13 18 18 13 13 25 26 13 10 30 30 30 30	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T5	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ HSD17beta5 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( HSD17beta7 ; involved in estradiol production ) and decreased expression of @GENETgt$ HSD17beta5 @/GENETgt$ ( involved in @CHEMICALSrc$ testosterone @/CHEMICALSrc$ production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 18 18 15 20 18 20 20 25 25 22 20 8 8 28 31 29|30 29 29|30 34 31 38 34|38 38 34|38 34 31 8	PRODUCT-OF
17350061	CHEMICAL	GENE	T4	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ estradiol @/CHEMICALSrc$ and @GENETgt$ HSD17beta7 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( @GENETgt$ HSD17beta7 @/GENETgt$ ; involved in @CHEMICALSrc$ estradiol @/CHEMICALSrc$ production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 18 18 15 20 18|19 18 18|19 20 20 27 27|23 27 27|23 23 20 8 8 30 33 31 35 33 38 38 35 33 8	PRODUCT-OF
17350061	CHEMICAL	GENE	T1	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ steroid @/CHEMICALSrc$ and @GENETgt$ HSD17beta7 @/GENETgt$ ? [SEP] Several genes involved with @CHEMICALSrc$ steroid @/CHEMICALSrc$ metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( @GENETgt$ HSD17beta7 @/GENETgt$ ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .	2 9 2 7 4|7 7 4|7 3 9 9 12 12 9 12 16 16 12 19 19 16 21 19 19 19 21 21 27 27 24 21 9 9 30 33 31 35 33 38 38 35 33 9	None-BC7
17350061	CHEMICAL	GENE	T6	T33	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ ? [SEP] The expression of key genes important in @CHEMICALSrc$ methionine @/CHEMICALSrc$ metabolism , such as @GENETgt$ methionine adenosyltransferase-1a @/GENETgt$ , betaine-homocysteine methyltransferase and thioether S-methyltransferase , were suppressed .	2 25 5 5 2 5 10 10|7 10 10|7 6 10 14 12 10|12|14 10|12|14 10|14 10|12|14 14 19 14 19 22 19 2 25 25 25	PRODUCT-OF
17350061	CHEMICAL	GENE	T11	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ S @/CHEMICALSrc$ and @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase-1a , @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ and thioether @CHEMICALSrc$ S-methyltransferase @/CHEMICALSrc$ , were suppressed .	2 25 5 5 2 5 9 9 6 9 14 11 14 9 14 16|14|15 16|14|15 16|14 16|14|15 16 21 16|18 16 16|18 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T5	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ testosterone @/CHEMICALSrc$ and @GENETgt$ HSD17beta7 @/GENETgt$ ? [SEP] Several genes involved with steroid metabolism also showed remarkable expression changes , including increased expression of 17beta-hydroxysteroid dehydrogenase-7 ( @GENETgt$ HSD17beta7 @/GENETgt$ ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in @CHEMICALSrc$ testosterone @/CHEMICALSrc$ production ) .	2 8 2 6 6 3 8 8 11 11 8 11 15 15 11 18 18 15 20 18|19 18 18|19 20 20 26 26 23 20 8 8 29 32 30 34 32 38 34|38 38 34|38 34 32 8	None-BC7
17350061	CHEMICAL	GENE	T6	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ methionine @/CHEMICALSrc$ and @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in @CHEMICALSrc$ methionine @/CHEMICALSrc$ metabolism , such as methionine adenosyltransferase-1a , @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ and thioether S-methyltransferase , were suppressed .	2 25 5 5 2 5 10 10|7 10 10|7 6 10 15 12 15 10 15 17|15 17|15 17|15 17|15 17 22 17 2 25 25 25	PRODUCT-OF
17350061	CHEMICAL	GENE	T24	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ Estrogen @/CHEMICALSrc$ and @GENETgt$ Cyp2a4 @/GENETgt$ ? [SEP] @CHEMICALSrc$ Estrogen-regulated @/CHEMICALSrc$ genes including cytokeratin 1 - 19 and @GENETgt$ Cyp2a4 @/GENETgt$ were over-expressed , although Cyp3a25 was suppressed .	0|3 3 0|3 13 5 3 5 5 5 5 8|5 5 8|5 13 13 13 18 18 18 13 13	INDIRECT-UPREGULATOR
17350061	CHEMICAL	GENE	T23	T40	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ ghrelin @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including X-inactive-specific transcript , anterior gradient-2 , trefoil factor-1 , CRP-ductin , @GENETgt$ ghrelin @/GENETgt$ , and small @CHEMICALSrc$ proline-rich @/CHEMICALSrc$ protein-2A , were dramatically over-expressed .	2 30 2 5 3 5 9 9 5 9 12 9 12 15 12 12 12 17 17|18 17 17|18 12 12 24 26|22 26 26|22 12 9 30 30 30 30	None-BC7
17350061	CHEMICAL	GENE	T10	T34	True	0	What is [Drugprot] between @CHEMICALSrc$ thioether @/CHEMICALSrc$ and @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ ? [SEP] The expression of key genes important in methionine metabolism , such as methionine adenosyltransferase-1a , @GENETgt$ betaine-homocysteine methyltransferase @/GENETgt$ and @CHEMICALSrc$ thioether @/CHEMICALSrc$ S-methyltransferase , were suppressed .	2 25 5 5 2 5 9 9 6 9 14 11 14 9 14 16|14|15 16|14|15 16|14 16|14|15 16 17|22 22 17|22 16 2 25 25 25	None-BC7
17350061	CHEMICAL	GENE	T23	T36	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ X-inactive-specific transcript @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including @GENETgt$ X-inactive-specific transcript @/GENETgt$ , anterior gradient-2 , trefoil factor-1 , CRP-ductin , ghrelin , and small @CHEMICALSrc$ proline-rich @/CHEMICALSrc$ protein-2A , were dramatically over-expressed .	2 30 2 5 3 5 8 8|5|7 8|5|7 8|5 8|5|7 8 13 8 13 16 13 13 13 18 18 13 13 24 26|21 26 26|21 13 8 30 30 30 30	None-BC7
17350061	CHEMICAL	GENE	T1	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ steroid @/CHEMICALSrc$ and @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ? [SEP] Several genes involved with @CHEMICALSrc$ steroid @/CHEMICALSrc$ metabolism also showed remarkable expression changes , including increased expression of @GENETgt$ 17beta-hydroxysteroid dehydrogenase-7 @/GENETgt$ ( HSD17beta7 ; involved in estradiol production ) and decreased expression of HSD17beta5 ( involved in testosterone production ) .	2 9 2 7 4|7 7 4|7 3 9 9 12 12 9 12 16 16 12 18 16|18 16|18 16|18 16|18 22 18 22 22 27 27 24 22 9 9 30 33 31 35 33 38 38 35 33 9	None-BC7
17350061	CHEMICAL	GENE	T23	T38	True	0	What is [Drugprot] between @CHEMICALSrc$ proline @/CHEMICALSrc$ and @GENETgt$ trefoil factor-1 @/GENETgt$ ? [SEP] Various genes controlled by estrogen , including X-inactive-specific transcript , anterior gradient-2 , @GENETgt$ trefoil factor-1 @/GENETgt$ , CRP-ductin , ghrelin , and small @CHEMICALSrc$ proline-rich @/CHEMICALSrc$ protein-2A , were dramatically over-expressed .	2 30 2 5 3 5 9 9 5 9 12 9 12 12|13|14 12|13|14 12|14 12|13|14 12 12 18 18 12 12 24 26|21 26 26|21 12 9 30 30 30 30	None-BC7
23644213	CHEMICAL	GENE	T3	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ 1,2,4-oxadiazol-5(4H)-one @/CHEMICALSrc$ and @GENETgt$ GPIIb/IIIa @/GENETgt$ ? [SEP] Resulting from this study , a structurally novel class of submicromolar fibrinogen @GENETgt$ GPIIb/IIIa @/GENETgt$ binding inhibitor bearing @CHEMICALSrc$ 1,2,4-oxadiazol-5(4H)-one @/CHEMICALSrc$ moiety is also described .	23 4 4 1 23 9 8 9 23 16 16 16 16|12 16 16|12 16 9 16 16|20 20 16|20 17 23 23 23 23	INHIBITOR
23644213	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ and @GENETgt$ Arg-Gly-Asp @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ with a mimic of the @GENETgt$ Arg-Gly-Asp @/GENETgt$ ( RGD ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 15 15 15 15 10 3|15 3 3|15 20 20 16 28 28 28|21 28 28|21 28 28 28 20 30 28 32 3 32 35 33 39 39 39 33 3	None-BC7
23644213	CHEMICAL	GENE	T1	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ with a mimic of the Arg-Gly-Asp ( RGD ) sequence of @GENETgt$ fibrinogen @/GENETgt$ to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 15 15 15 15 10 3|15 3 3|15 20 20 16 27 27 27 27 27 27 20 29 27 27 27 32 3 32 35 33 39 39 39 33 3	None-BC7
23644213	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ and @GENETgt$ factor Xa @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective @GENETgt$ factor Xa @/GENETgt$ inhibitor rivaroxaban with a mimic of the @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ ( RGD ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 16 16 16|12 16|12 16 16|12 10 3 20 20 17 28 28 20|28 28 20|28 28 28 28 20 30 28 32 3 32 35 33 39 39 39 33 3	None-BC7
23644213	CHEMICAL	GENE	T1	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ and @GENETgt$ RGD @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ with a mimic of the Arg-Gly-Asp ( @GENETgt$ RGD @/GENETgt$ ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 15 15 15 15 10 3|15 3 3|15 20 20 16 28 28 28 28 28|23 28 28|23 28 20 30 28 32 3 32 35 33 39 39 39 33 3	None-BC7
23644213	CHEMICAL	GENE	T2	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ and @GENETgt$ RGD @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ ( @GENETgt$ RGD @/GENETgt$ ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 15 15 15 15 10 3 19 19 16 28 28 28|21 28 28|21 28 28|23 28 28|23 28 19 30 28 32 3 32 35 33 39 39 39 33 3	None-BC7
23644213	CHEMICAL	GENE	T2	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ and @GENETgt$ fibrinogen @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective factor Xa inhibitor rivaroxaban with a mimic of the @CHEMICALSrc$ Arg-Gly-Asp @/CHEMICALSrc$ ( RGD ) sequence of @GENETgt$ fibrinogen @/GENETgt$ to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 15 15 15 15 10 3 19 19 16 27 27 27|21 27 27|21 27 27 27 19 29 27 27 27 32 3 32 35 33 39 39 39 33 3	PART-OF
23644213	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ and @GENETgt$ factor Xa @/GENETgt$ ? [SEP] These compounds resulted from our efforts to merge the pharmacophores of selective @GENETgt$ factor Xa @/GENETgt$ inhibitor @CHEMICALSrc$ rivaroxaban @/CHEMICALSrc$ with a mimic of the Arg-Gly-Asp ( RGD ) sequence of fibrinogen to obtain designed multiple ligands with potential antithrombotic activity .	2 3 3 6 6 3 8 6 10 8 16 16 16|12 16|12 16 16|12 10 3|14 3 3|14 21 21 17 28 28 28 28 28 28 21 30 28 32 3 32 35 33 39 39 39 33 3	INHIBITOR
16248990	CHEMICAL	GENE	T9	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]-ACh @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] The main goal of the present study was to analyse the effects of (+/-)-huprine X ( (+/-)-HX ) and galantamine ( GAL ) , with potentiating action on @GENETgt$ nicotinic receptors @/GENETgt$ , and huperzine A ( HPA ) , devoid of nicotinic activity , on [3H]-acetylcholine ( @CHEMICALSrc$ [3H]-ACh @/CHEMICALSrc$ ) release in striatal slices of rat brain .	3 3 8 7 7 7 3 8 10 8 12 10 17 17 17 17 12 17 17 17 22 20 22 17 27 27 12 29 27|28|29 27|28|29 27|29 27|28|29 27 27 35 51 37 35 37 35 35 43 43 40 35 46 51 48 51|45 51 51|45 51 12 54 54 51 57 57 54 8	None-BC7
16248990	CHEMICAL	GENE	T19	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ ACh @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] Nicotinic-receptor potentiator drugs , huprine X and galantamine , increase @CHEMICALSrc$ ACh @/CHEMICALSrc$ release by blocking AChE activity but not acting on @GENETgt$ nicotinic receptors @/GENETgt$ .	3 3 10 3 6 3 6 6 3 10 10|13 13 10|13 10 15 10 17 15 17 20 15 22 20|22 20|22 20|22 20|22 10	None-BC7
16248990	CHEMICAL	GENE	T12	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ ATR @/CHEMICALSrc$ and @GENETgt$ muscarinic M2 receptor @/GENETgt$ ? [SEP] This effect was reverted in the presence of atropine ( @CHEMICALSrc$ ATR @/CHEMICALSrc$ ; 0.1 microM ) , which blocks the pre-synaptic @GENETgt$ muscarinic M2 receptor @/GENETgt$ .	2 4 4 4 7 7 4 9 11 11 10|7 7 10|7 15 15 11 15 7 19 7 22 22 19|20|22 19|20|22 19|20|22 19|22 19|20|22 4	INHIBITOR
16248990	CHEMICAL	GENE	T3	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ MEC @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] To test the role of @GENETgt$ nicotinic receptors @/GENETgt$ in the drugs ' effects on [3H]-ACh release , mecamylamine ( @CHEMICALSrc$ MEC @/CHEMICALSrc$ ) 100 microM was used to block such receptors .	2 26 4 2 6 4|5|6 4|5|6 4|6 4|5|6 13 11 13 11 4 16 16 13 26 24 20 24|17 24 24|17 24 24 26 26 26 28 26 30 28 26	INHIBITOR
16248990	CHEMICAL	GENE	T14	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ haloperidol @/CHEMICALSrc$ and @GENETgt$ dopamine D2 @/GENETgt$ ? [SEP] After that , a wide range of concentrations of drugs , concomitantly with ATR ( 0.1 microM ) , was studied in the presence of @CHEMICALSrc$ haloperidol @/CHEMICALSrc$ ( HAL ; 0.01 microM ) , a @GENETgt$ dopamine D2 @/GENETgt$ antagonist .	2 6 6 6 6 21 8 6 10 8 8 6 14 6 17 17 14 17 6 21 21 24 24 21 26 24|25 24 24|25 29 26 32 32 29 32 29 39 34|39 34|39 39 34|39 29 21	ANTAGONIST
16248990	CHEMICAL	GENE	T15	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ HAL @/CHEMICALSrc$ and @GENETgt$ dopamine D2 @/GENETgt$ ? [SEP] After that , a wide range of concentrations of drugs , concomitantly with ATR ( 0.1 microM ) , was studied in the presence of haloperidol ( @CHEMICALSrc$ HAL @/CHEMICALSrc$ ; 0.01 microM ) , a @GENETgt$ dopamine D2 @/GENETgt$ antagonist .	2 6 6 6 6 21 8 6 10 8 8 6 14 6 17 17 14 17 6 21 21 24 24 21 26 24 28 26|27 26 26|27 32 32 28 32 28 39 34|39 34|39 39 34|39 28 21	ANTAGONIST
16248990	CHEMICAL	GENE	T13	T27	True	0	What is [Drugprot] between @CHEMICALSrc$ ATR @/CHEMICALSrc$ and @GENETgt$ dopamine D2 @/GENETgt$ ? [SEP] After that , a wide range of concentrations of drugs , concomitantly with @CHEMICALSrc$ ATR @/CHEMICALSrc$ ( 0.1 microM ) , was studied in the presence of haloperidol ( HAL ; 0.01 microM ) , a @GENETgt$ dopamine D2 @/GENETgt$ antagonist .	2 6 6 6 6 22 8 6 10 8 8 6 14 13|6 6 13|6 18 18 14 18 6 22 22 25 25 22 27 25 29 27 32 32 29 32 29 39 34|39 34|39 39 34|39 29 22	None-BC7
16248990	CHEMICAL	GENE	T19	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ ACh @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Nicotinic-receptor potentiator drugs , huprine X and galantamine , increase @CHEMICALSrc$ ACh @/CHEMICALSrc$ release by blocking @GENETgt$ AChE @/GENETgt$ activity but not acting on nicotinic receptors .	3 3 10 3 6 3 6 6 3 10 10|13 13 10|13 10 15 10 18|14 18 18|14 15 18 21 15 24 24 21 10	None-BC7
16248990	CHEMICAL	GENE	T2	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ mecamylamine @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] To test the role of @GENETgt$ nicotinic receptors @/GENETgt$ in the drugs ' effects on [3H]-ACh release , @CHEMICALSrc$ mecamylamine @/CHEMICALSrc$ ( MEC ) 100 microM was used to block such receptors .	2 26 4 2 6 4|5|6 4|5|6 4|6 4|5|6 13 11 13 11 4 16 16 13 26 24|15 24 24|15 21 24 24 24 26 26 26 28 26 30 28 26	INHIBITOR
16248990	CHEMICAL	GENE	T8	T21	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]-acetylcholine @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] The main goal of the present study was to analyse the effects of (+/-)-huprine X ( (+/-)-HX ) and galantamine ( GAL ) , with potentiating action on @GENETgt$ nicotinic receptors @/GENETgt$ , and huperzine A ( HPA ) , devoid of nicotinic activity , on @CHEMICALSrc$ [3H]-acetylcholine @/CHEMICALSrc$ ( [3H]-ACh ) release in striatal slices of rat brain .	3 3 8 7 7 7 3 8 10 8 12 10 17 17 17 17 12 17 17 17 22 20 22 17 27 27 12 29 27|28|29 27|28|29 27|29 27|28|29 27 27 35 51 37 35 37 35 35 43 43 40 35 46 51|43 51 51|43 49 51 51 12 54 54 51 57 57 54 8	None-BC7
16248990	CHEMICAL	GENE	T19	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ ACh @/CHEMICALSrc$ and @GENETgt$ Nicotinic-receptor @/GENETgt$ ? [SEP] @GENETgt$ Nicotinic-receptor @/GENETgt$ potentiator drugs , huprine X and galantamine , increase @CHEMICALSrc$ ACh @/CHEMICALSrc$ release by blocking AChE activity but not acting on nicotinic receptors .	0|4 4 0|4 4 11 4 7 4 7 7 4 11 10|14 14 10|14 11 16 11 18 16 18 21 16 24 24 21 11	None-BC7
16248990	CHEMICAL	GENE	T18	T30	True	0	What is [Drugprot] between @CHEMICALSrc$ galantamine @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] Nicotinic-receptor potentiator drugs , huprine X and @CHEMICALSrc$ galantamine @/CHEMICALSrc$ , increase ACh release by blocking @GENETgt$ AChE @/GENETgt$ activity but not acting on nicotinic receptors .	3 3 11 3 6 3 6 6|7 6 6|7 3 11 13 11 15 11 18|14 18 18|14 15 18 21 15 24 24 21 11	INHIBITOR
16248990	CHEMICAL	GENE	T10	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ ACh @/CHEMICALSrc$ and @GENETgt$ AChE @/GENETgt$ ? [SEP] All compounds are non-covalent and reversible inhibitors of @GENETgt$ AChE. @/GENETgt$ Addition of (+/-)-HX ( 0.01 microM ) , GAL ( 10 microM ) and HPA ( 0.1 microM ) to the superfusion medium decreased the release of the @CHEMICALSrc$ ACh @/CHEMICALSrc$ neurotransmitter to a similar extent : 36 % , 30 % and 34 % , respectively ( P<0.01 ) .	2 4 4 7 4 4 34 11 8|11 11 8|11 7 13 11 16 16 13 16 11 11 22 22 19 22 19 19 28 28 25 28 33 33 33 11 34 36 34 41 41 41|37 41 41|37 36 45 45 45 34 48 48 34 48 51 48 48 54 48 54 48 58 48 58 34	None-BC7
16248990	CHEMICAL	GENE	T1	T20	True	0	What is [Drugprot] between @CHEMICALSrc$ [3H]-ACh @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] To test the role of @GENETgt$ nicotinic receptors @/GENETgt$ in the drugs ' effects on @CHEMICALSrc$ [3H]-ACh @/CHEMICALSrc$ release , mecamylamine ( MEC ) 100 microM was used to block such receptors .	2 26 4 2 6 4|5|6 4|5|6 4|6 4|5|6 13 11 13 11 4 17 17|12 17 17|12 13 26 24 21 24 24 24 26 26 26 28 26 30 28 26	None-BC7
16248990	CHEMICAL	GENE	T18	T28	True	0	What is [Drugprot] between @CHEMICALSrc$ galantamine @/CHEMICALSrc$ and @GENETgt$ Nicotinic-receptor @/GENETgt$ ? [SEP] @GENETgt$ Nicotinic-receptor @/GENETgt$ potentiator drugs , huprine X and @CHEMICALSrc$ galantamine @/CHEMICALSrc$ , increase ACh release by blocking AChE activity but not acting on nicotinic receptors .	0|4 4 0|4 4 12 4 7 4 7 7 7 7 4 12 14 12 16 12 18 16 18 21 16 24 24 21 12	None-BC7
16248990	CHEMICAL	GENE	T11	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ atropine @/CHEMICALSrc$ and @GENETgt$ muscarinic M2 receptor @/GENETgt$ ? [SEP] This effect was reverted in the presence of @CHEMICALSrc$ atropine @/CHEMICALSrc$ ( ATR ; 0.1 microM ) , which blocks the pre-synaptic @GENETgt$ muscarinic M2 receptor @/GENETgt$ .	2 4 4 4 7 7 4 9 8|12 12 8|12 12 7 15 15 12 15 7 19 7 22 22 19|20|22 19|20|22 19|20|22 19|22 19|20|22 4	INHIBITOR
16248990	CHEMICAL	GENE	T18	T29	True	0	What is [Drugprot] between @CHEMICALSrc$ galantamine @/CHEMICALSrc$ and @GENETgt$ nicotinic receptors @/GENETgt$ ? [SEP] Nicotinic-receptor potentiator drugs , huprine X and @CHEMICALSrc$ galantamine @/CHEMICALSrc$ , increase ACh release by blocking AChE activity but not acting on @GENETgt$ nicotinic receptors @/GENETgt$ .	3 3 11 3 6 3 6 6|7 6 6|7 3 11 13 11 15 11 17 15 17 20 15 22 20|22 20|22 20|22 20|22 11	None-BC7
23294255	CHEMICAL	GENE	T1	T6	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ plasmin @/GENETgt$ ? [SEP] The trypsin-like @CHEMICALSrc$ serine @/CHEMICALSrc$ protease @GENETgt$ plasmin @/GENETgt$ is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss .	6 6 2|6 6 2|6 6 10|4 10 10|4 10 10 10 13 13 10 16 16 13 18 13 21 21 18 24 24 21 24 24 24 29 10 32 32 29 10	None-BC7
23294255	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ plasmin @/GENETgt$ ? [SEP] The most potent inhibitor 8 binds to @GENETgt$ plasmin @/GENETgt$ with an inhibition constant of 0.2 nM , whereas K(i ) values > 1 μM were determined for nearly all other tested trypsin-like @CHEMICALSrc$ serine @/CHEMICALSrc$ proteases , with the exception of trypsin , which is also inhibited in the nanomolar range .	4 3 4 6 4 6 8 6|7 6 6|7 13 13 13 6 16 16 13 6 6 6 19 6 26 24 22 26 6 30 29 30 31 35 35 35|31 35 35|31 26 35 39 39 26 41 39 41 46 46 46 41 50 50 50 46 26	None-BC7
23294255	CHEMICAL	GENE	T2	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ trypsin @/GENETgt$ ? [SEP] The most potent inhibitor 8 binds to plasmin with an inhibition constant of 0.2 nM , whereas K(i ) values > 1 μM were determined for nearly all other tested trypsin-like @CHEMICALSrc$ serine @/CHEMICALSrc$ proteases , with the exception of @GENETgt$ trypsin @/GENETgt$ , which is also inhibited in the nanomolar range .	4 3 4 6 4 6 8 6 12 12 12 6 15 15 12 6 6 6 18 6 25 23 21 25 6 29 28 29 30 34 34 34|31 34 34|31 25 34 38 38 25 40 38 38 38 40 46 46 46 40 50 50 50 46 25	None-BC7
23294255	CHEMICAL	GENE	T2	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ trypsin-like serine proteases @/GENETgt$ ? [SEP] The most potent inhibitor 8 binds to plasmin with an inhibition constant of 0.2 nM , whereas K(i ) values > 1 μM were determined for nearly all other tested @GENETgt$ trypsin-like @/GENETgt$ @CHEMICALSrc$ serine proteases @/CHEMICALSrc$ , with the exception of trypsin , which is also inhibited in the nanomolar range .	4 3 4 6 4 6 8 6 12 12 12 6 15 15 12 6 6 6 18 6 25 23 21 25 6 29 28 29 30 33 33|30 33 33|30 25|33|31 25|33|31 25|33 25|33|31 33 39 39 25 41 39 41 46 46 46 41 50 50 50 46 25	None-BC7
23294255	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ trypsin @/GENETgt$ ? [SEP] The @GENETgt$ trypsin-like @/GENETgt$ @CHEMICALSrc$ serine @/CHEMICALSrc$ protease plasmin is a target for the development of antifibrinolytic drugs for use in cardiac surgery with cardiopulmonary bypass or organ transplantations to reduce excessive blood loss .	7 1|7 7 1|7 2|7 7 2|7 7 10 10 10 10 13 13 10 16 16 13 18 13 21 21 18 24 24 21 24 24 24 29 10 32 32 29 10	None-BC7
23493568	CHEMICAL	GENE	T2	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ IRS-1 @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of @GENETgt$ IRS-1 @/GENETgt$ ( pY(896 ) ) , and phosphorylation of Akt , while enhancing @CHEMICALSrc$ serine @/CHEMICALSrc$ phosphorylation ( pS(307 ) ) of IRS-1 .	8 8 4 8 7 7 4 8 10 8 12 10|11 10 10|11 15 12 15 15 10 10 10 22 20 8 25 8 24|28 28 24|28 25 30 28 30 30 34 28 8	None-BC7
23493568	CHEMICAL	GENE	T1	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ IRS-1 @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing serine phosphorylation ( pS(307 ) ) of @GENETgt$ IRS-1 @/GENETgt$ .	8 8 4 8 7 7 4 8 8|11 11 8|11 8 13 11 15 13 15 15 11 11 11 22 20 8 25 8 27 25 29 27 29 29 33 27|31 27 27|31 8	None-BC7
23493568	CHEMICAL	GENE	T2	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ XBP @/GENETgt$ ? [SEP] Interestingly , insulin treatment of @GENETgt$ αXBPKD @/GENETgt$ cells reduced tyrosine phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing @CHEMICALSrc$ serine @/CHEMICALSrc$ phosphorylation ( pS(307 ) ) of IRS-1 .	9 9 4 9 8 8|5 8 8|5 4 9 11 9 13 11 15 13 15 15 11 11 11 22 20 9 25 9 24|28 28 24|28 25 30 28 30 30 34 28 9	None-BC7
23493568	CHEMICAL	GENE	T1	T32	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ XBP @/GENETgt$ ? [SEP] Interestingly , insulin treatment of @GENETgt$ αXBPKD @/GENETgt$ cells reduced @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing serine phosphorylation ( pS(307 ) ) of IRS-1 .	9 9 4 9 8 8|5 8 8|5 4 9 8|12 12 8|12 9 14 12 16 14 16 16 12 12 12 23 21 9 26 9 28 26 30 28 30 30 34 28 9	None-BC7
23493568	CHEMICAL	GENE	T2	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ IRS-1 @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing @CHEMICALSrc$ serine @/CHEMICALSrc$ phosphorylation ( pS(307 ) ) of @GENETgt$ IRS-1 @/GENETgt$ .	8 8 4 8 7 7 4 8 10 8 12 10 14 12 14 14 10 10 10 21 19 8 24 8 24|27 27 24|27 24 29 27 29 29 33 27|31 27 27|31 8	PART-OF
23493568	CHEMICAL	GENE	T5	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ glucagon @/GENETgt$ ? [SEP] αXBPKO mice exhibited @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance , mild insulin resistance and an inability to suppress @GENETgt$ glucagon @/GENETgt$ secretion following glucose stimulation .	2 3 3 3|6 6 3|6 3 6 10 10 6 6 13 6 15 13 18|14 18 18|14 15 21 21 15 3	None-BC7
23493568	CHEMICAL	GENE	T4	T16	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ X-box binding protein 1 @/GENETgt$ ? [SEP] @GENETgt$ X-box binding protein 1 @/GENETgt$ ( XBP1 ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair insulin secretion leading to @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance .	0|1|7 0|1|7 0|1|7 0|1|7 1|7 0|1|7 7 12 7 12 12 12 33 14 12 17 17 14 22 22 22 22 14 24 22 24 22 28 22 30 28 33 33 33 35 33 37 35 37 42 42|35 42 42|35 38 33	None-BC7
23493568	CHEMICAL	GENE	T6	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] αXBPKO mice exhibited glucose intolerance , mild @GENETgt$ insulin @/GENETgt$ resistance and an inability to suppress glucagon secretion following @CHEMICALSrc$ glucose @/CHEMICALSrc$ stimulation .	2 3 3 5 3 5 10 10|7 10 10|7 5 5 13 5 15 13 17 15 21 17|21 21 17|21 15 3	None-BC7
23493568	CHEMICAL	GENE	T3	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ XBP @/GENETgt$ ? [SEP] Consequently the @GENETgt$ αXBPKD @/GENETgt$ cells exhibited blunted suppression of glucagon secretion following insulin treatment in the presence of high @CHEMICALSrc$ glucose @/CHEMICALSrc$ .	6 5 2|5 5 2|5 6 6 6 7 11 11 8 14 14 8 17 17 8 20 20 17|18 17 17|18 6	None-BC7
23493568	CHEMICAL	GENE	T2	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Interestingly , @GENETgt$ insulin @/GENETgt$ treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing @CHEMICALSrc$ serine @/CHEMICALSrc$ phosphorylation ( pS(307 ) ) of IRS-1 .	9 9 2|5 5 2|5 9 8 8 5 9 11 9 13 11 15 13 15 15 11 11 11 22 20 9 25 9 24|28 28 24|28 25 30 28 30 30 34 28 9	None-BC7
23493568	CHEMICAL	GENE	T4	T17	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ XBP1 @/GENETgt$ ? [SEP] X-box binding protein 1 ( @GENETgt$ XBP1 @/GENETgt$ ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair insulin secretion leading to @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance .	6 6 6 3 6 12|5 12 12|5 6 12 12 12 33 14 12 17 17 14 22 22 22 22 14 24 22 24 22 28 22 30 28 33 33 33 35 33 37 35 37 42 42|38 42 42|38 38 33	None-BC7
23493568	CHEMICAL	GENE	T3	T12	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Consequently the αXBPKD cells exhibited blunted suppression of glucagon secretion following @GENETgt$ insulin @/GENETgt$ treatment in the presence of high @CHEMICALSrc$ glucose @/CHEMICALSrc$ .	5 4 4 5 5 5 6 10 10 7 14 11|14 14 11|14 7 17 17 7 20 20 17|18 17 17|18 5	None-BC7
23493568	CHEMICAL	GENE	T6	T26	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ glucagon @/GENETgt$ ? [SEP] αXBPKO mice exhibited glucose intolerance , mild insulin resistance and an inability to suppress @GENETgt$ glucagon @/GENETgt$ secretion following @CHEMICALSrc$ glucose @/CHEMICALSrc$ stimulation .	2 3 3 5 3 5 9 9 5 5 12 5 14 12 17|14 17 17|14 14 21 17|21 21 17|21 14 3	None-BC7
23493568	CHEMICAL	GENE	T1	T31	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] Interestingly , @GENETgt$ insulin @/GENETgt$ treatment of αXBPKD cells reduced @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of Akt , while enhancing serine phosphorylation ( pS(307 ) ) of IRS-1 .	9 9 2|5 5 2|5 9 8 8 5 9 8|12 12 8|12 9 14 12 16 14 16 16 12 12 12 23 21 9 26 9 28 26 30 28 30 30 34 28 9	None-BC7
23493568	CHEMICAL	GENE	T3	T11	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ glucagon @/GENETgt$ ? [SEP] Consequently the αXBPKD cells exhibited blunted suppression of @GENETgt$ glucagon @/GENETgt$ secretion following insulin treatment in the presence of high @CHEMICALSrc$ glucose @/CHEMICALSrc$ .	5 4 4 5 5 5 6 11 8|11 11 8|11 7 14 14 7 17 17 7 20 20 17|18 17 17|18 5	None-BC7
23493568	CHEMICAL	GENE	T5	T25	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] αXBPKO mice exhibited @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance , mild @GENETgt$ insulin @/GENETgt$ resistance and an inability to suppress glucagon secretion following glucose stimulation .	2 3 3 3|6 6 3|6 3 6 11 11|7 11 11|7 6 6 14 6 16 14 18 16 21 21 16 3	None-BC7
23493568	CHEMICAL	GENE	T4	T18	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ insulin @/GENETgt$ ? [SEP] X-box binding protein 1 ( XBP1 ) is a transcription factor that plays a crucial role in the unfolded protein response ( UPR ) and its deficiency in β-cells has been reported to impair @GENETgt$ insulin @/GENETgt$ secretion leading to @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance .	6 6 6 3 6 11 6 11 11 11 32 13 11 16 16 13 21 21 21 21 13 23 21 23 21 27 21 29 27 32 32 32 34 32 34|37 37 34|37 34 37 42 42|38 42 42|38 38 32	None-BC7
23493568	CHEMICAL	GENE	T2	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ serine @/CHEMICALSrc$ and @GENETgt$ Akt @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced tyrosine phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of @GENETgt$ Akt @/GENETgt$ , while enhancing @CHEMICALSrc$ serine @/CHEMICALSrc$ phosphorylation ( pS(307 ) ) of IRS-1 .	8 8 4 8 7 7 4 8 10 8 12 10 14 12 14 14 10 10 10 21 19|20 19 19|20 8 25 8 24|28 28 24|28 25 30 28 30 30 34 28 8	None-BC7
23493568	CHEMICAL	GENE	T6	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ XBP @/GENETgt$ ? [SEP] @GENETgt$ αXBPKO @/GENETgt$ mice exhibited glucose intolerance , mild insulin resistance and an inability to suppress glucagon secretion following @CHEMICALSrc$ glucose @/CHEMICALSrc$ stimulation .	0|3 3 0|3 4 4 6 4 6 10 10 6 6 13 6 15 13 17 15 21 17|21 21 17|21 15 4	None-BC7
23493568	CHEMICAL	GENE	T5	T24	True	0	What is [Drugprot] between @CHEMICALSrc$ glucose @/CHEMICALSrc$ and @GENETgt$ XBP @/GENETgt$ ? [SEP] @GENETgt$ αXBPKO @/GENETgt$ mice exhibited @CHEMICALSrc$ glucose @/CHEMICALSrc$ intolerance , mild insulin resistance and an inability to suppress glucagon secretion following glucose stimulation .	0|3 3 0|3 4 4 3|7 7 3|7 4 7 11 11 7 7 14 7 16 14 18 16 21 21 16 4	None-BC7
23493568	CHEMICAL	GENE	T1	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ Akt @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphorylation of IRS-1 ( pY(896 ) ) , and phosphorylation of @GENETgt$ Akt @/GENETgt$ , while enhancing serine phosphorylation ( pS(307 ) ) of IRS-1 .	8 8 4 8 7 7 4 8 8|11 11 8|11 8 13 11 15 13 15 15 11 11 11 22 20 20 20 8 26 8 28 26 30 28 30 30 34 28 8	None-BC7
23493568	CHEMICAL	GENE	T1	T7	True	0	What is [Drugprot] between @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ and @GENETgt$ IRS-1 @/GENETgt$ ? [SEP] Interestingly , insulin treatment of αXBPKD cells reduced @CHEMICALSrc$ tyrosine @/CHEMICALSrc$ phosphorylation of @GENETgt$ IRS-1 @/GENETgt$ ( pY(896 ) ) , and phosphorylation of Akt , while enhancing serine phosphorylation ( pS(307 ) ) of IRS-1 .	8 8 4 8 7 7 4 8 8|11 11 8|11 8 13 11 11 11 16 13 16 16 11 11 11 23 21 8 26 8 28 26 30 28 30 30 34 28 8	PART-OF
23270805	CHEMICAL	GENE	T4	T8	True	0	What is [Drugprot] between @CHEMICALSrc$ anorexigen @/CHEMICALSrc$ and @GENETgt$ oxytocin @/GENETgt$ ? [SEP] The neuropeptide @GENETgt$ oxytocin @/GENETgt$ has emerged as an important @CHEMICALSrc$ anorexigen @/CHEMICALSrc$ in the regulation of energy balance .	3 3 2|6 6 2|6 6 6 10 10 10 8|6 6 8|6 14 14 10 17 17 14 6	None-BC7
23270805	CHEMICAL	GENE	T3	T10	True	0	What is [Drugprot] between @CHEMICALSrc$ oxytocin @/CHEMICALSrc$ and @GENETgt$ oxytocin @/GENETgt$ ? [SEP] Systemic administration of @CHEMICALSrc$ oxytocin @/CHEMICALSrc$ recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating @GENETgt$ oxytocin @/GENETgt$ contributes to energy regulation .	2 6 4 2|3 2 2|3 6 6 10 10 7 12 6 12 12 12 17 15 19 24 19 23 23 24 27 24|23 24 24|23 6 30 30 27 6	None-BC7
23270805	CHEMICAL	GENE	T5	T9	True	0	What is [Drugprot] between @CHEMICALSrc$ oxytocin @/CHEMICALSrc$ and @GENETgt$ oxytocin @/GENETgt$ ? [SEP] Systemic administration of @GENETgt$ oxytocin @/GENETgt$ recapitulates many of its effects when administered centrally , raising the questions of whether and to what extent circulating @CHEMICALSrc$ oxytocin @/CHEMICALSrc$ contributes to energy regulation .	2 6 4 2|3 2 2|3 6 6 10 10 7 12 6 12 12 12 17 15 19 24 19 23 23 24 27 24|23 24 24|23 6 30 30 27 6	None-BC7
12487427	CHEMICAL	GENE	T15	T55	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK4-8 @/CHEMICALSrc$ and @GENETgt$ BrBK @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and @GENETgt$ BrBK @/GENETgt$ was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , @CHEMICALSrc$ BrBK4 - 8 @/CHEMICALSrc$ and BrBK2 - 8 metabolites not found in human plasma .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 28 28 36 28 36 36 28 42 42 49 42 42 42 42|45 42 42|45 49 28 51 59 51 51 53 57 57 53 57 69 61 59 61 61 63 59 65 65 67 49|67|69 49|67|69 49|67|69 49|69 49|67|69 69 69 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T22	T65	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ BrBK1-8 @/GENETgt$ ? [SEP] @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and omapatrilat increased the production of both @GENETgt$ BrBK1 - 8 @/GENETgt$ and Br-Phe5 but not that of BrBK4 - 8 and BrBK2 - 8 .	0|5 5 0|5 1 1 5 7 5 10 10 8|10|7 8|10|7 8|10|7 10|7 8|10|7 10 10 17 10 10 20 18 20 20 20 20 24 24 5	INDIRECT-UPREGULATOR
12487427	CHEMICAL	GENE	T41	T83	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK1-7 @/CHEMICALSrc$ and @GENETgt$ Br-Phe @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , @CHEMICALSrc$ BrBK1 - 7 @/CHEMICALSrc$ , BrBK1 - 5 and @GENETgt$ Br-Phe @/GENETgt$ .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 48 48 28 50 59 50 50 52 52|53|54 52|53|54 52|53|54 52|54 52|53|54 54 48 61 59 61 59|61 61 59|61 48	None-BC7
12487427	CHEMICAL	GENE	T6	T58	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] In rat plasma the @CHEMICALSrc$ BrBK @/CHEMICALSrc$ half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , @GENETgt$ BrBK1 - 5 @/GENETgt$ and Br-Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 8 8|4 8 8|4 8 29 11 11 8 11 15 15 11 17 15 20 20 17 20 17 17 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 59 51 51 53 57 57 53 57 57|59|70 57|59|70 57|59|70 59|70 57|59|70 59 59 64 59 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T7	T59	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ Br-Phe5 @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and @GENETgt$ Br-Phe5 @/GENETgt$ plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 7 7 7 29 10 10 7 10 14 14 10 16 14|15 14 14|15 20 20 16 20 16 16 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 59 51 51 53 57 57 53 57 70 61 59 61 61 61 61 63 59 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T34	T74	True	0	What is [Drugprot] between @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ and @GENETgt$ BrBK @/GENETgt$ ? [SEP] In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK ( 79/81 Br-Phe5 ) @GENETgt$ BrBK @/GENETgt$ in the presence of two new dual ACE/NEP inhibitors ( GW660511X and @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ ) currently under clinical trial .	3 3 15 6 6 15 6 9 7 11 9 11 11 15 15 17 15 19 17 19 19 19 24 19 27 27 32 30 30 27 30 17|31 17 17|31 36 36 17 42 42 42 42 42 36 44 42 44 44 44 44 44 17 52 52 17 15	None-BC7
12487427	CHEMICAL	GENE	T37	T81	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , @GENETgt$ BrBK1 - 7 @/GENETgt$ , BrBK1 - 5 and Br-Phe .	3 3 29 7 7 7 29 10 10 7 10 14 14 10 16 14|15 14 14|15 20 20 16 20 16 16 26 26 23 26 29 29 29 29 29 32 32 34 29 29 37 37 29 29 43 29 43 29 29 49 49 29 51 60 51 51 53 53|55 53|55 53|55 53|55 53|55 55 49 62 60 62 62 49	None-BC7
12487427	CHEMICAL	GENE	T33	T73	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ 79/81 Br-Phe5 @/GENETgt$ ? [SEP] In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK ( @GENETgt$ 79/81 Br-Phe5 @/GENETgt$ ) BrBK in the presence of two new dual ACE/NEP inhibitors ( @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and omapatrilat ) currently under clinical trial .	3 3 15 6 6 15 6 9 7 11 9 11 11 15 15 17 15 19 17 19 19 19 24 19 27 27 33 29 27|28|29 27|28|29 27|29 27|28|29 29 17 36 36 17 42 42 42 42 42 36 44 41|42 42 41|42 44 44 44 17 52 52 17 15	None-BC7
12487427	CHEMICAL	GENE	T15	T58	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK4-8 @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , @GENETgt$ BrBK1 - 5 @/GENETgt$ and Br-Phe5 plus BrBK2 - 9 , @CHEMICALSrc$ BrBK4 - 8 @/CHEMICALSrc$ and BrBK2 - 8 metabolites not found in human plasma .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 28 28 36 28 36 36 28 42 42 48 42 42 42 42 48 28 50 58 50 50 52 56 56 52 56 57|58|69 57|58|69 57|58|69 58|69 57|58|69 58 58 63 58 65 65 67 48|65|69 48|65|69 48|65|69 48|69 48|65|69 69 69 74 74 48 79 77 82 82 79 48	None-BC7
12487427	CHEMICAL	GENE	T28	T70	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ ACE @/GENETgt$ ? [SEP] This study shows that the potency of @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ in comparison with omapatrilat is more than 100-fold lower in human , but less than 10-fold lower in rat plasma , suggesting that rat may not be a suitable in vivo model for the evaluation of @GENETgt$ ACE/NEP @/GENETgt$ inhibition in relation to effects in humans .	2 3 3 18 6 18 8 6|7 6 6|7 11 6 13 11 18 17 15 18 3 20 18 20 20 25 25 20 20 29 29 26 3 3 41 41 41 41 41 41 41 41 39 31 44 44 41 48 48|44 48 48|44 44 50 48 52 50 54 52 3	INHIBITOR
12487427	CHEMICAL	GENE	T45	T84	True	0	What is [Drugprot] between @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] Unlike GW660511X , @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ abolished the production of @GENETgt$ BrBK1 - 5 @/GENETgt$ and BrBK1 - 7 , suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found .	2 6 6 3|6 6 3|6 6 8 6 17 8|17|10 8|17|10 8|17|10 17|10 8|17|10 10 10 17 8 6 6 24 24 24 24 19 26 24 32 30 30 32 32 6 6	INDIRECT-DOWNREGULATOR
12487427	CHEMICAL	GENE	T6	T57	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] In rat plasma the @CHEMICALSrc$ BrBK @/CHEMICALSrc$ half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , @GENETgt$ BrBK1 - 7 @/GENETgt$ , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 8 8|4 8 8|4 8 29 11 11 8 11 15 15 11 17 15 20 20 17 20 17 17 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 60 51 51 53 53|55 53|55 53|55 53|55 53|55 55 70 62 60 62 62 64 60 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T31	T75	True	0	What is [Drugprot] between @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ and @GENETgt$ ACE @/GENETgt$ ? [SEP] In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK ( 79/81 @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ ) BrBK in the presence of two new dual @GENETgt$ ACE/NEP @/GENETgt$ inhibitors ( GW660511X and omapatrilat ) currently under clinical trial .	3 3 15 6 6 15 6 9 7 11 9 11 11 15 15 17 15 19 17 19 19 19 24 19 27 27 33 30 30 27|29 27 27|29 30 17 36 36 17 43 43 43 43 43|39 43 43|39 36 45 43 45 45 45 17 52 52 17 15	None-BC7
12487427	CHEMICAL	GENE	T40	T79	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK1-8 @/CHEMICALSrc$ and @GENETgt$ BrBK @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and @GENETgt$ BrBK @/GENETgt$ was degraded into @CHEMICALSrc$ BrBK1 - 8 @/CHEMICALSrc$ , BrBK1 - 7 , BrBK1 - 5 and Br-Phe .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 49|45 49 49|45 49 28 51 49|51|60 49|51|60 49|51|60 51|60 49|51|60 51 58 58 51 58 49 62 60 62 62 49	None-BC7
12487427	CHEMICAL	GENE	T8	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ and @GENETgt$ BrBK1-8 @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into @GENETgt$ BrBK1 - 8 @/GENETgt$ , BrBK1 - 7 , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 7 7 7 29 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16|21 16 16|21 26 26 22 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 49|51|60 49|51|60 49|51|60 51|60 49|51|60 51 58 58 51 58 70 62 60 62 62 64 60 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T10	T54	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK1-8 @/CHEMICALSrc$ and @GENETgt$ BrBK @/GENETgt$ ? [SEP] In rat plasma the @GENETgt$ BrBK @/GENETgt$ half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into @CHEMICALSrc$ BrBK1 - 8 @/CHEMICALSrc$ , BrBK1 - 7 , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 8 8|4 8 8|4 8 29 11 11 8 11 15 15 11 17 15 20 20 17 20 17 17 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 49|51|60 49|51|60 49|51|60 51|60 49|51|60 51 58 58 51 58 70 62 60 62 62 64 60 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T15	T57	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK4-8 @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , @GENETgt$ BrBK1 - 7 @/GENETgt$ , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , @CHEMICALSrc$ BrBK4 - 8 @/CHEMICALSrc$ and BrBK2 - 8 metabolites not found in human plasma .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 28 28 36 28 36 36 28 42 42 48 42 42 42 42 48 28 50 59 50 50 52 52|53|54 52|53|54 52|53|54 52|54 52|53|54 54 69 61 59 61 61 63 59 65 65 67 48|65|69 48|65|69 48|65|69 48|69 48|65|69 69 69 74 74 48 79 77 82 82 79 48	None-BC7
12487427	CHEMICAL	GENE	T41	T82	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK1-7 @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , @CHEMICALSrc$ BrBK1 - 7 @/CHEMICALSrc$ , @GENETgt$ BrBK1 - 5 @/GENETgt$ and Br-Phe .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 48 48 28 50 59 50 50 52 52|53|54 52|53|54 52|53|54 52|54 52|53|54 54 48|59|55 48|59|55 48|59|55 48|59 48|59|55 59 59 48	None-BC7
12487427	CHEMICAL	GENE	T39	T83	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ Br-Phe @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and @CHEMICALSrc$ BrBK @/CHEMICALSrc$ was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and @GENETgt$ Br-Phe @/GENETgt$ .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 49|45 49 49|45 49 28 51 59 51 51 53 57 57 53 57 49 61 59 61 61 61 61 49	None-BC7
12487427	CHEMICAL	GENE	T13	T55	True	0	What is [Drugprot] between @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ and @GENETgt$ BrBK @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and @GENETgt$ BrBK @/GENETgt$ was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 28 28 36 28 36 36 28 42 42 49 42 42 42 42|45 42 42|45 49 28 51 59 51 51 53 57 57 53 57 70 61 59 61 61 61 61 63 59 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T32	T73	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ 79/81 Br-Phe5 @/GENETgt$ ? [SEP] In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled BK ( @GENETgt$ 79/81 Br-Phe5 @/GENETgt$ ) @CHEMICALSrc$ BrBK @/CHEMICALSrc$ in the presence of two new dual ACE/NEP inhibitors ( GW660511X and omapatrilat ) currently under clinical trial .	3 3 15 6 6 15 6 9 7 11 9 11 11 15 15 17 15 19 17 19 19 19 24 19 27 27 33 29 27|28|29 27|28|29 27|29 27|28|29 29 17|30 17 17|30 37 37 17 43 43 43 43 43 37 45 43 45 45 45 17 52 52 17 15	None-BC7
12487427	CHEMICAL	GENE	T23	T68	True	0	What is [Drugprot] between @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ and @GENETgt$ BrBK2-8 @/GENETgt$ ? [SEP] GW660511X and @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ increased the production of both BrBK1 - 8 and Br-Phe5 but not that of BrBK4 - 8 and @GENETgt$ BrBK2 - 8 @/GENETgt$ .	5 1 1|2 1 1|2 5 7 5 10 10 7 10 10 12 12 16 10 10 19 17 19 19 19 19|21|23 19|21|23 19|21|23 19|23 19|21|23 5	None-BC7
12487427	CHEMICAL	GENE	T13	T57	True	0	What is [Drugprot] between @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] In rat plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , @GENETgt$ BrBK1 - 7 @/GENETgt$ , BrBK1 - 5 and @CHEMICALSrc$ Br-Phe5 @/CHEMICALSrc$ plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 28 28 36 28 36 36 28 42 42 48 42 42 42 42 48 28 50 59 50 50 52 52|53|54 52|53|54 52|53|54 52|54 52|53|54 54 70 61 59 61 59|61 61 59|61 63 59 66 66 68 48 70 70 70 70 74 74 48 79 77 82 82 79 48	None-BC7
12487427	CHEMICAL	GENE	T44	T85	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] Unlike @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ , omapatrilat abolished the production of BrBK1 - 5 and @GENETgt$ BrBK1 - 7 @/GENETgt$ , suggesting a better ACE inhibition effect over GW660511X as no NEP activity was found .	2 1|6 6 1|6 6 6 6 8 6 14 12 12 14 12 8|12|14 8|12|14 8|12|14 8|12|14 8|12|14 6 6 24 24 24 24 19 26 24 32 30 30 32 32 6 6	None-BC7
12487427	CHEMICAL	GENE	T5	T53	True	0	What is [Drugprot] between @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ and @GENETgt$ Br-Phe5 @/GENETgt$ ? [SEP] The production of @GENETgt$ Br-Phe5 @/GENETgt$ was reduced with GW660511X while no significant change was observed with @CHEMICALSrc$ omapatrilat @/CHEMICALSrc$ after 4 h of incubation .	2 7 4 2|3 2 2|3 7 7 9 7 15 13 13 15 15 7 17 15 15 15 21 21 15 23 21 7	None-BC7
12487427	CHEMICAL	GENE	T6	T56	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ BrBK1-8 @/GENETgt$ ? [SEP] In rat plasma the @CHEMICALSrc$ BrBK @/CHEMICALSrc$ half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into @GENETgt$ BrBK1 - 8 @/GENETgt$ , BrBK1 - 7 , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , BrBK4 - 8 and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 8 8|4 8 8|4 8 29 11 11 8 11 15 15 11 17 15 20 20 17 20 17 17 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 49|51|60 49|51|60 49|51|60 51|60 49|51|60 51 58 58 51 58 70 62 60 62 62 64 60 66 66 68 49 70 70 70 70 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T33	T72	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ BK @/GENETgt$ ? [SEP] In this work a novel approach combining HPLC-UV on-line with oaTOF-MS and ICPMS was applied to investigate in human and rat plasma the metabolism of labelled @GENETgt$ BK @/GENETgt$ ( 79/81 Br-Phe5 ) BrBK in the presence of two new dual ACE/NEP inhibitors ( @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and omapatrilat ) currently under clinical trial .	3 3 15 6 6 15 6 9 7 11 9 11 11 15 15 17 15 19 17 19 19 19 24 19 27 27 33|26 33 33|26 31 31 27 31 17 36 36 17 42 42 42 42 42 36 44 42 42 42 44 44 44 17 52 52 17 15	None-BC7
12487427	CHEMICAL	GENE	T40	T82	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK1-8 @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into @CHEMICALSrc$ BrBK1 - 8 @/CHEMICALSrc$ , BrBK1 - 7 , @GENETgt$ BrBK1 - 5 @/GENETgt$ and Br-Phe .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 48 48 28 50 49|50|59 49|50|59 49|50|59 50|59 49|50|59 50 57 57 50 57 48|59|55 48|59|55 48|59|55 48|59 48|59|55 59 59 48	None-BC7
12487427	CHEMICAL	GENE	T6	T61	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ BrBK4-8 @/GENETgt$ ? [SEP] In rat plasma the @CHEMICALSrc$ BrBK @/CHEMICALSrc$ half-life values in the absence or in the presence of GW660511X ( 530 nM ) or omapatrilat ( 50 nM ) were 9.31 + /- 1.7 , 22.06 + /- 3.1 and 25.3 + /- 1.7 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and Br-Phe5 plus BrBK2 - 9 , @GENETgt$ BrBK4 - 8 @/GENETgt$ and BrBK2 - 8 metabolites not found in human plasma .	3 3 29 8 8|4 8 8|4 8 29 11 11 8 11 15 15 11 17 15 20 20 17 20 17 17 26 26 23 26 29 29 29 29 29 32 29 29 37 29 37 37 29 43 43 49 43 43 43 43 49 29 51 59 51 51 53 57 57 53 57 69 61 59 61 61 63 59 65 65 67 49|67|69 49|67|69 49|67|69 49|69 49|67|69 69 69 74 74 49 79 77 82 82 79 49	None-BC7
12487427	CHEMICAL	GENE	T43	T81	True	0	What is [Drugprot] between @CHEMICALSrc$ Br-Phe @/CHEMICALSrc$ and @GENETgt$ BrBK1-7 @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , @GENETgt$ BrBK1 - 7 @/GENETgt$ , BrBK1 - 5 and @CHEMICALSrc$ Br-Phe @/CHEMICALSrc$ .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 48 48 28 50 59 50 50 52 52|53|54 52|53|54 52|53|54 52|54 52|53|54 54 48 61 59 61 59|61 61 59|61 48	None-BC7
12487427	CHEMICAL	GENE	T48	T86	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ ACE @/GENETgt$ ? [SEP] Unlike GW660511X , omapatrilat abolished the production of BrBK1 - 5 and BrBK1 - 7 , suggesting a better @GENETgt$ ACE @/GENETgt$ inhibition effect over @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ as no NEP activity was found .	2 5 5 5 5 7 5 15 11 11 15 11 11 15 7 5 5 23 23 19|23 23 19|23 23 17 25 23 23 23 32 30 30 32 32 5 5	INHIBITOR
12487427	CHEMICAL	GENE	T39	T82	True	0	What is [Drugprot] between @CHEMICALSrc$ BrBK @/CHEMICALSrc$ and @GENETgt$ BrBK1-5 @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of GW660511X ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and @CHEMICALSrc$ BrBK @/CHEMICALSrc$ was degraded into BrBK1 - 8 , BrBK1 - 7 , @GENETgt$ BrBK1 - 5 @/GENETgt$ and Br-Phe .	3 3 28 7 7 7 28 10 10 7 10 14 14 10 16 14 19 19 16 19 16 16 25 25 22 25 28 28 28 28 28 31 31 33 28 28 36 36 28 28 42 28 42 28 28 49|45 49 49|45 49 28 51 59 51 51 53 57 57 53 57 57|59|49 57|59|49 57|59|49 49|59 57|59|49 59 59 49	None-BC7
12487427	CHEMICAL	GENE	T37	T83	True	0	What is [Drugprot] between @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ and @GENETgt$ Br-Phe @/GENETgt$ ? [SEP] In human plasma the BrBK half-life values in the absence or in the presence of @CHEMICALSrc$ GW660511X @/CHEMICALSrc$ ( 3.8 microM ) or omapatrilat ( 32 nM ) were 38.7 + /- 2.4 , 51.2 + /- 4.7 and 114.7 + /- 9.3 min , respectively and BrBK was degraded into BrBK1 - 8 , BrBK1 - 7 , BrBK1 - 5 and @GENETgt$ Br-Phe @/GENETgt$ .	3 3 29 7 7 7 29 10 10 7 10 14 14 10 16 14|15 14 14|15 20 20 16 20 16 16 26 26 23 26 29 29 29 29 29 32 32 34 29 29 37 37 29 29 43 29 43 29 29 49 49 29 51 59 51 51 53 57 57 53 57 49 61 59 61 61 61 61 49	None-BC7
